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Programmed ribosomal frameshifting (PRF) is an extension of genetic decoding that 
allows a ribosome to produce inframe products and frameshift products from a single 
transcript. In +1 PRF, the ribosome moves one nucleotide to the 3’-end of the mRNA 
while in -1 PRF, the ribosome slips one nucleotide to the 5’-end of the mRNA during 
translation. Organisms from virus to prokaryotes to human have genes known to 
involve PRF. This dissertation presents the development of computational and 
experimental tools to systematically analyze the mechanism of +1 PRF and -1 PRF. 
The computational tools include: (1) a kinetic model for +1 PRF that reveals the 
synergistic effects of ribosome E-, P-, and A-sites on promoting +1 frameshift 
efficiency; (2) a mechanism-based bioinformatic program FSscan that identifies novel 
+1 frameshift cassettes in yehP, pepP, and cheA genes in Escherichia coli; and (3) a 
kinetic model for -1 PRF that predicts translation elongation steps significantly 
affecting -1 frameshift efficiency and the percentage of two types of -1 frameshift 
products. To confirm model predictions, a dual fluorescence reporter system is 
developed in E. coli and Saccharomyces cerevisiae. Additonally, -1 frameshift 
proteins are purified and analyzed by nano-flow liquid chromatography electrospray 
tandem mass spectrometry to obtain the percentage of the two types of -1 frameshift 
proteins. Using the reporter system in E. coli, the experimental results are consistent 
 with model predictions. The combination of computational and experimental works 
accelerates the investigation and expands the range and depth of the understanding. 
These tools can be further adapted to explore PRF in different organisms or to 
discover compounds altering PRF efficiency in a high-throughput manner. This work 
is an example of using systems biology approach to improve our understanding of a 
complex, but critically important, biological process.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background and motivation 
During standard translation, genetic sequences are decoded in a successive, triplet 
manner. A sequence of triplets in mRNA not interrupted by a stop codon is defined as 
an open reading frame (ORF). Generally, a single ORF is expected to encode a single 
protein. However, the relation between a genome and its proteome is not linear. A 
single gene may produce multiple different proteins through different mechanisms 
such as alternative splicing of the mRNA transcript, varying translation start or stop 
sites, or frameshifting. All of these possibilities result in a proteome estimated to be an 
order of magnitude more complex than the genome [1].   
 
Programmed ribosomal frameshifting (PRF) is a mechanism to expand the standard 
decoding. PRF is a coded shift in reading frame during translation of an mRNA 
transcript. In general, there are two types of PRF: in +1 PRF, the ribosome moves one 
nucleotide to the 3’-end of the mRNA while in -1 PRF, the ribosome slips one 
nucleotide to the 5’-end. Consequently, one transcript may yield two different protein 
products, an inframe product and a frameshift product. These products are likely to 
have distinct functions and contribute to the biological proteomic complexity. As of 
November 2009, organisms from virus to prokaryotes to human have genes known to 
involve PRF [2]. 
 
As mentioned above, +1 PRF has been observed in various organisms. In some cases, 
+1 PRF is known to be involved in gene regulation [3,4]. In Escherichia coli, the 
translation of prfB to produce release factor 2 (RF2) utilizes +1 PRF [3]. The reading 
  2 
frame of the first 15% of this gene is determined by the start codon, while the 
remaining 85% of the mRNA is translated as a consequence of a +1 PRF event that 
involves bypassing the stop codon UGA in the frameshift site. Low RF2 levels result in 
inefficient recognition of the UGA codon, stimulating frameshift efficiency. High RF2 
levels enhance the UGA decoding, reducing frameshift efficiency. The result is an 
autoregulatory feedback circuit in which RF2 levels control the production of RF2 via 
frameshifting. In mammalian cells, the expression of ornithine decarboxylase (ODC) 
antizyme involves +1 PRF [4]. Particularly, + 1 PRF provides an autoregulatory 
feedback loop between antizyme and polyamine levels. Antizyme degrades ODC, an 
enzyme that catalyzes the first and rate-limiting step of polyamine biosynthesis, 
decreasing polyamine production. When the level of polyamines rises, the +1 PRF 
efficiency increases, increasing the level of antizyme and thus reducing the abundance 
of ODC. The decrease in the ODC level will result in a lower polyamine level and 
consequently form a feedback loop.  
 
In Saccharomyces cerevisiae, retrotransposable elements, Ty1, Ty2, Ty3 and Ty4 [5-
7], and three genes, ABP140 [8], EST3 [9], and OAZ1 [10] employ +1 PRF. Ty1 uses 
+1 PRF to make a TYA-TYB protein required for transposition. The recoding site is 
CUU AGG C (where spaces separate zero frame codons), and the efficiency of the 
shift is greatly enhanced by the hungry zero-frame AGG codon in the A-site [5,11]. 
Ty3 is a retrotransposon that has overlapping genes Gag3 and Pol3. Gag3 encodes the 
structure protein for Ty3 virus-like particle and POL3 encodes the enzymatic proteins 
required for transposition of Ty3 [12]. POL3 overlaps with the last 38bp of Gag3 in 
the +1 frame and does not have an independent ribosome entry site. The recoding site 
in Ty3 is GCG AGU U (where spaces separate the zero frame). Similar to Ty1, the 
AGU in the A-site of the Ty3 recoding site is a rare serine codon. The low availability 
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of cognate tRNA induces a pause, permitting more time for +1 PRF. +1 PRF permits 
11% of the ribosome to enter POL3 [6].  
 
-1 PRF was first described in 1985 as the way of protein expression from the 
overlapping ORFs in retrovirus Rous Sarcoma Virus (RSV) [13]. Several important 
viruses, including human immunodeficiency virus type 1 (HIV-1) and the coronavirus 
responsible for severe acute respiratory syndrome (SARS), employ -1 PRF to produce 
proteins that are required for viral replication. In these viruses, the ORF encoding the 
viral structural protein (typically the Gag protein) is followed by an out of frame 
coding sequence for enzymatic proteins (typically Pro or Pol) (Figure 1.1). The 
enzymatic proteins are only expressed as a result of PRF with an efficiency of 1-40%, 
depending on the specific virus and the assay system. The frameshift efficiency 
determines the ratio of structural to enzymatic proteins available for virus particle 
assembly. Maintaining this ratio is important for virus particle morphogenesis because 
viruses require a large excess of structural components over the proteins with 
enzymatic activities (Figure 1.2). Previous studies showed that altering PRF efficiency 
affected the ratio of Gag to Gag-Pol protein synthesized and reduced viral titres [14-
18]. Therefore, the PRF provides a unique target for antiviral agents. A reliable, low 
cost and easy-to-perform assay for PRF efficiency monitoring potentially permits a 
large scale screening of antiviral drugs.  
 
In prokaryotes, -1 frameshifting has been documented for dnaX [19-21] and some 
insertion elements [22]. Certain bacteriophages employ -1 frameshift for the 
expression of tail genes [23,24]. In bacteriophage λ, a slippery sequence near the end 
of gene G, GGGAAAG, causes about 4% of -1 frameshift efficiency [25]. This 
ribosomal frameshifting results in producing longer proteins, gpGT. The standard  
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Figure 1.1. The genomic sequences of viruses that use programmed ribosomal 
frameshifting (adapted from [17]). The open reading frame (ORF) of the structure 
protein (e.g. gag) overlaps with the out of frame coding sequence of enzymatic 
proteins (e.g. pol). Programming ribosomal frameshifting results in a Gag-Pol fusion 
protein.  
 
 
 
gag pol
Viral genome
Viral proteins
Gag
Gag-Pol
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Figure 1.2. Altering frameshift efficiency affects virus packaging (adapted from [17]). 
(a) The normal frameshift efficiency provides a correct ratio of Gag to Gag-Pol. (b) 
Increased frameshift efficiency results in incomplete viral particles. (c) Decreased 
frameshift efficiency results in particles without enzymatic proteins.  
 
 
Gag
Gag-Pol
(a)
(b)
(c)
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decoding product gpG and -1 frameshift product gpGT both participate in tail 
assembly. 
 
PRF is suggested to be associated with several human disorders. Ribosomal +1 
frameshifting within the human IL10 gene has been shown to produce a cryptic 
epitope recognized by cytotoxic T cells, which may play a role in precipitating 
autoimmunity [26]. In Alzheimer's disease, aberrant forms of β-amyloid precursor 
protein and ubiquitin have carboxyl-terminal amino acids encoded by a -1 reading 
frame of the mRNA. Therefore, Wills et al. [27] suggested a potential role of 
ribosomal frameshifting in generating aberrant proteins implicated in 
neurodegenerative diseases. Supporting this hypothesis, in a polyglutamine-inducing 
neurodegenerative disorder spinocerebellar axtaxia 3 (SCA3), the expanded CAG 
repeats in MJD-1 transcript is prone to -1 frameshifting [28]. The result is the 
generation of trans-frame polyalanine-containing proteins. These polyalanine products 
may enhance polyglutamine-associated toxicity. Notably, the same study observed that 
anisomycin, which was previously shown to decrease -1 frameshifting [14,29], 
reduces the toxicity. Moreover, a prion protein was shown to cause different 
phenotypes by modulating frameshift efficiency in yeast Saccharomyces cerevisiae 
[30]. The prion [PSI+] is the amyloid conformation of the release factor 3 (eRF3) in 
yeast. [PSI+] can enhance antizyme production by promoting the +1 frameshifting 
required for antizyme expression. Because antizyme is a negative regulator of cellular 
polyamines, the increased level of antizyme by [PSI+] greatly reduces cellular 
polyamines level in yeast, resulting in distinct responses to environmental stress [30]. 
Recently, [PSI+] was also found to increase -1 PRF efficiency [31]. Taken together, 
PRF may involve in different types of diseases, either being a cause or a consequence 
of the disorder. The knowledge of PRF may thus provide insight into new therapeutic 
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strategies. 
 
In summary, the ability of a single mRNA to encode more than one product would add 
to the information content of a genetic sequence, providing the molecule with a greater 
range of options. The discovery and characterization of new mechanism of PRF will 
further expand our understanding of translation control and the relation between 
ribosomes and cis-acting signals encoding in the mRNAs. Furthermore, knowledge of 
PRF may also shed light into novel therapeutic strategies for controlling virus or 
aberrant protein production.  
 
1.2 Project goals 
The overall objective of this project is to develop computational and experimental 
tools to understand the mechanism of +1 and -1 PRF. The main sub-goals of this work 
are: 
1. Develop kinetic frameworks of +1 PRF and -1 PRF. The goal is to use the model 
to explain previous experimental observations and evaluate the significance of 
different parameters in the model. 
2. Construct a reporter system in Escherichia coli and Saccharomyces cerevisiae to 
test PRF efficiency in vivo. The assay should be reliable, easy to perform, and low 
cost to permit a large scale application. 
3. Perform a bioinformatic search for +1 PRF hot spots in the E. coli genome. The 
goal is based on sub-goal 1. The kinetic model of +1 PRF suggests several 
important features to induce +1 PRF. Therefore, searching the E. coli genome 
containing these features may allow identifying +1 PRF hot spots. The candidates 
sequences are further tested in the reporter system constructed in sub-goal 2.  
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1.3 Scope of work 
The dissertation first provides background information for translation elongation, 
which is critical for understanding the mechanism of PRF (Chapter 2). Chapter 3 
describes the development of a dual fluorescence reporter system to test PRF in vivo. 
This reporter system provides a tool to test the model predictions described in the 
following chapters. Chapter 4, adapted from [32], describes the kinetic model for +1 
PRF and the experimental results validating the model predictions. Chapter 5, adapted 
from [33], illustrates the bioinformatic analysis for +1 PRF hot spots in the E. coli 
genome. Chapter 6 focuses on the method to analyze the composition of frameshift 
products using mass spectrometry. Chapter 7 presents a kinetic model for -1 PRF. 
Chapter 8 is a review of the effects of single nucleotide polymorphism (SNP) on 
phenotypes. A SNP may lead to different disease susceptibility, quantitative traits (e.g. 
height, weight, etc.) or drug responses in human. This review introduces how SNPs 
can be connected to a phenotype and the potential of SNPs analysis for 
biotechnological application. Finally, Chapter 9 summarizes the results and 
conclusions of the work and recommends areas of future direction. 
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CHAPTER 2 
TRANSLATION ELONGATION  
 
2.1 Introduction 
Programmed ribosomal frameshifting (PRF) plays a crucial role in gene expression in 
both prokaryotes and eukaryotes (see reviews by Farabaugh [1] and Gesteland and 
Atkins [2]). The integrated model of PRF by Harger et al. proposed that +1 PRF and -
1 PRF occurs at different phases of the elongation cycle [3]. Therefore, the mechanism 
of PRF should be understood within this context. This chapter first describes features 
of a tRNA and a ribosome structure, followed by a description of the mechanism of 
the translation elongation. A more detailed description of aminoacyl-tRNA (aa-tRNA) 
selection and translocation in the elongation are also presented. 
 
2.2 Transfer RNA 
During protein synthesis, transfer RNAs (tRNAs) deliver amino acids to a growing 
polypeptide chain. Transfer RNAs consist of a single strand of RNA folded into a 
precise three-dimensional structure [4]. The tRNAs in bacteria and in the cytosol of 
eukaryotes have between 73 to 93 nucleotides. Most tRNA have a guanylate (pG) 
residue at the 5’ end and all have the trinucleotide sequence CCA-3’ at the 3’ end. 
When drawn in two dimensions, the hydrogen-bonding pattern of all tRNAs forms a 
cloverleaf structure with four arms, or five arms for some longer tRNAs (Figure 2.1). 
Two of the arms of a tRNA are critical in protein synthesis: the acceptor arm can carry 
a specific amino acid and the anticodon arm contains the anticodon.  
 
2.3 Ribosome 
Ribosomes are large ribonucleoprotein complexes that carry on translation in all cells.  
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Figure 2.1. Cloverleaf secondary structure of a tRNA (adapted from [4]). 
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A ribosome is composed of two subunits. In prokaryotes, the subunits are designated 
30S and 50S and together make up a 70S ribosome. The 50S subunit is composed of a 
5S RNA subunit (consisting of 120 nucleotides), a 23S RNA subunit (3200 
nucleotides) and 36 proteins. The 30S subunit has a 1540 nucleotide RNA subunit 
(16S) bound to 21 proteins [4]. A eukaryotic ribosome consists of a small (40S) and 
large (60S) subunit, together an 80S ribosome. The large subunit is composed of a 5S 
RNA (120 nucleotides), a 28S RNA (4700 nucleotides), a 5.8S subunit (160 
nucleotides), and about 49 proteins. The 40S subunit has a 1900 nucleotide (18S) 
RNA and about 33 proteins [4].  
 
A ribosome has three sites for tRNA binding: A-site, P-site, and E-site [5] (Figure 
2.2). The ribosomal A-site is responsible for selecting cognate aa-tRNA and 
positioning of the aminoacyl moiety for the peptidyl transferase reaction. The A-site 
contacts the tRNA and mRNA with only four nucleotides of 16S rRNA [6]. The 
minimal interactions between the 30S A-site and the third-position codon and 
anticodon nucleotides permit the third-position wobble in the genetic code. The roles 
of the P-site include binding the initiator tRNA (a formyl-methionyl-tRNA in bacteria) 
during the initiation of protein synthesis and carrying the tRNA with a nascent 
polypeptide chain in a correct reading frame during elongation. On the small subunit, 
the P-site anticodon stem-loop (ASL) interacts with ten nucleotides of 16S rRNA [7] 
and the C-terminal tails of proteins S9 and S13, in addition to base pairing with its 
codon. In the 50S P-site, the minor groove of the P-site tRNA D stem rests on the 
minor groove of helix 69 of 23S rRNA, and the elbow of the tRNA contacts an 
extended β-hairpin loop of protein L5. A sharp kink was found in the mRNA between 
the A and P codons, which may allow simultaneous codon:anticodon pairing with both 
codons and contribute to maintaining the reading frame [8]. The E-site is believed to  
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Figure 2.2. A representative diagram for a ribosome structure. A ribosome is 
composed of two subunits. E, P, and A denote the three tRNA binding sites in a 
ribosome.  
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provide a favorable free-energy change for movement of the deacylated tRNA out of 
the P-site [9,10]. In the recently solved T. thermophilus 70S ribosomal complexes 
[6,11], a non-cognate E-site tRNA interacts with 16S rRNA through a magnesium-
mediated contact between tRNA phosphate 35 and 16S rRNA phosphate 1340. No 
codon:anticodon pairing has been observed in the E-site in these structures. However, 
whether the codon:anticodon interaction exists in the E-site is not known until the 
structure of an elongation complex containing a cognate E-site tRNA being resolved. 
The major interaction in the ribosome E-site is the binding of 3′-terminal adenosine on 
the tRNA (A76) to 23S rRNA, in which the tRNA must be deacylated and unmodified 
[12,13]. A crystal structure of H. marismortui 50S subunit revealed that A76 is 
positioned by extensive stacking and hydrogen-bonding with C2396 within 23S rRNA 
[14].   
 
2.4 Translation elongation cycle 
2.4.1 Steps in translation elongation 
During translation, the ribosome prolongs a polypeptide chain by adding a single 
amino acid in each elongation cycle (Figure 2.3). There are four basic steps in each 
cycle: (1) decoding: the ribosome recruits an aa-tRNA according the A-site codon. (2) 
accommodation: the ribosome accommodates the selected aa-tRNA. (3) peptidyl 
transfer: the peptidyl residue on the peptidyl tRNA is cleaved off and transferred to the 
aa-tRNA. As a result, the peptidyl-tRNA is now located at the A-site, extended by one 
amino acid. (4) translocation: the tRNA:mRNA complex moves by a codon length. In 
doing so, the peptidyl-tRNA enters the P-site, and the deacylated-tRNA enters the E-
site. Translocation also brings a new codon into the A-site. With the selection of an aa-
tRNA corresponding to this new codon, the ribosome enters into next elongation 
cycle. The allosteric three-site model for the ribosomal elongation cycle suggests a 
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reciprocal linkage between the E-site and A-site [15]. In this model, the E-site is 
occupied at the start of each cycle prior to aa-tRNA accommodation, and aa-tRNA 
binding promotes the release of the E-site tRNA, followed in turn by peptidyl transfer 
and translocation (Figure 2.3).  
 
In the protein synthesis process, tRNAs move in the ribosome in order from A-, to P-, 
to E-sites. The hybrid-site model suggests that tRNA moves through the ribosome in 
an alternating fashion, with one end (the acceptor arm or the anticodon arm) fixed 
while the other is moving [10]. In this model, aa-tRNA accommodation has two states, 
A/T and A/A, while P-site tRNA is in P/P state (the notation before slash indicates the 
localization of the tRNA anticodon arm in the 30S subunit and that after slash 
indicates the localization of the tRNA acceptor arm in 50S subunit). Here, the T state 
refers to a specific site when the aa-tRNA is entering the ribosome. The two states of 
aa-tRNA imply that while the anticodon tip of the tRNA stays in the A-site in the 30S 
subunit, the acceptor arm of the tRNA moves from T- to A- site in the 50S subunit 
during accommodation (Figure 2.4). Similarly, during translocation, two tRNAs in the 
P/P and A/A first move their accepter arms into the E- and P-sites in the 50S subunit, 
forming P/E and A/P. This step is followed by the movement of anticodon arms, 
which will form E and P/P states.   
 
2.4.2 Kinetics of aa-tRNA selection 
The ribosome recognizes aa-tRNA according to the match between anticodon and 
mRNA codon in the A-site. An aa-tRNA binds to the ribosome in a ternary complex 
with elongation factor EF-Tu and GTP in prokaryotes (eEF1α in eukaryotes 
has functions analogous to EF-Tu). An elegant series of biochemical studies have 
produced a detailed kinetic model of aa-tRNA selection in the translation elongation  
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Figure 2.3. Translation elongation cycle. A cycle consists of four steps: decoding, 
aminoacyl-tRNA accommodation, peptidyl transfer, and translocation.  
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Figure 2.4. The hybrid site model. (a) aminoacyl-tRNA accommodation: while 
peptidyl tRNA stays in P/P, aminoacyl-tRNA moves from A/T to A/A. (b) 
translocation: deacylated-tRNA and peptidyl tRNA first move their acceptor arms to 
reach P/E and A/P, followed by moving their anticodon arms to reach E and P/P. 
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cycle [16]. In this model, fast initial binding of the ternary complex EF-Tu:aa-
tRNA:GTP is followed by codon recognition. Codon recognition triggers EF-Tu 
GTPase activation, which leads to the GTP hydrolysis and dissociation of EF-Tu from 
the ribosome. Factor dissociation is followed by the spontaneous accommodation of 
the acceptor arm of the aa-tRNA into the A-site (Figure 2.5).  
 
To ensure high fidelity during aa-tRNA selection, incorrect aa-tRNAs are rejected at 
two stages: initial selection of ternary complexes and proofreading of aa-tRNA. The 
ribosome contributes to the selection by enhancing the stabilities of correct codon-
anticodon duplexes and accelerating the forward rates of GTPase activation and 
accommodation of a correct aa-tRNA. The rate of GTP hydrolysis for a cognate 
ternary complex is 250 s-1, while a near-cognate aa-tRNA with a C-A mismatch at the 
first position results in a GTP hydrolysis rate equal to 0.4 s-1 [16]. Therefore, a much 
faster GTP hydrolysis of cognate compared to near-cognate substrate permits the 
selectivity of correct tRNAs. Similarly, a more restricted conformational space 
accessible to a cognate aa-tRNA increases the rate of the accommodation. In contrast, 
complete dissociation from the ribosome is favored for a near-cognate aa-tRNA in the 
absence of the interactions via EF-Tu and specific contacts to the closed form of the 
30S subunit during proofreading.  
 
2.4.3 Kinetics of translocation 
The last step of each elongation cycle is translocation, which involves the movement 
of two tRNAs and the mRNA on the ribosome (Figure 2.6). The translocation step is 
promoted by elongation factor G (EF-G) in prokaryotes [17,18] (eEF2 in eukaryotes 
has functions analogous to EF-G). The kinetic model of the translocation has been 
proposed previously [19]. The reaction sequence includes: binding of EF-G:GTP to  
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Figure 2.5. The kinetic model of aminoacyl-tRNA selection. 
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Figure 2.6. The kinetic model of translocation. 
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the pretranslocation complex, GTP hydrolysis, unlocking conformation change, tRNA 
movement with Pi release, relocking conformation change, and finally dissociation of 
EF-G:GDP and deacylated tRNA from the ribosome (Figure 2.6). Structurally, EF-G 
undergoes a reorientation and moves from a pretranslocation position outside the 30S 
A site to its posttranslocation position where domain 4 reaches into the 30S A-site, 
occupying the site of the anticodon arm of the A-site tRNA. This movement of EF-G 
may prevent backward tRNA movement. Therefore, EF-G may have two functions in 
the translocation: to unlock ribosome by coupling with GTP hydrolysis, and/or to bias 
tRNA-mRNA movement [20].   
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CHAPTER 3 
 DUAL FLUORESCENCE REPORTER SYSTEM 
 
3.1 Preface  
An in vivo reporter system is essential to experimentally study different effects on 
programmed ribosomal frameshifting. This chapter describes the development of a 
dual fluorescence reporter system in Escherichia coli. The reporter system was later 
transferred into yeast Saccharomyces cerevisiae to test several PRF signals in 
eukaryotic cells.   
 
3.2 Abstract  
Programmed ribosomal frameshifting (PRF) is the process by which ribosomes 
produce two different polypeptides from the same mRNA. A new in vivo dual 
fluorescence reporter system is developed to study PRF in Escherichia coli and yeast 
Saccharomyces cerevisiae. Frameshift sites are inserted between two fluorescence 
reporter genes, monomeric DsRed and EGFP, contained in an E. coli expression 
vector or a yeast shuttle vector. The red and green fluorescence for different strains are 
directly measured by a microwell plate reader. The system allows an easy comparison 
of frameshift efficiency for different recoding sites with the normalized fluorescence 
ratio. By using the system in E. coli, the integrity and the position of the stimulatory 
signal (Shine-Dalgarno-like sequence) are shown to affect +1 PRF efficiency 
significantly. In addition, PRF signals from HIV-1 group M, group O, and yeast L-A 
virus were tested in the yeast system. The dual-fluorescence reporter system has 
potential as a high-throughput and non-invasive in vivo assay for PRF studies. 
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3.3 Introduction  
During protein synthesis, ribosomes translate the nucleotide sequence of an mRNA 
molecule into the amino acid sequence of a protein. Normally, ribosomes read 
mRNAs in successive, adjacent three nucleotide (triplet) codons. The chance for the 
ribosome to switch its reading frame during the translation occurs at a very low 
frequency, about 10-4-10-5 per codon [1]. Programmed ribosomal frameshifting (PRF) 
is a coded shift in reading frame during translation of an mRNA transcript, in which 
the frameshift can occur at rates from 1000- to 10,000- fold higher than 
nonprogrammed sites [2]. Consequently, one transcript may yield two different protein 
products, an inframe product and a frameshift product. PRF has been observed to 
occur in various organisms including prokaryotes and eukaryotes [3,4]. Several 
important viruses including human immunodeficiency virus type 1 (HIV-1) and the 
coronavirus for severe acute respiratory syndrome (SARS-CoV), employ -1 PRF to 
synthesize the precursor of enzymes for their replication [5,6]. Previous studies have 
demonstrated that altering -1 PRF efficiency may damage the viral replication (see 
Chapter 1 and the review by Dinman et al. [7]). Therefore, a system monitoring the 
change in PRF can provide a platform for antiviral drug screening.  
 
A widely used reporter system for studying frameshifting events is based on the β-
galactosidase assay. The frameshift sites are followed by lacZ gene in a different 
reading frame. This sequence is designed to ensure the production of the lacZ gene 
product, β -galactosidase, to be dependent upon PRF events. Frameshift efficiency is 
measured by determining the ratio of β-galactosidase activity produced from a 
construct requiring PRF to express lacZ to that of a construct in which the lacZ is in 
frame [8-10]. The enzymatic-based assay is highly quantitative. However, this reporter 
system does not measure the ratio between the zero-frame translation and PRF events 
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within the same strain. Thus, complicating factors may arise, such as the need to 
normalize for cell number, protein concentration, mRNA abundance, and differential 
translational efficiencies of the PRF reporter and zero-frame reporter mRNAs. 
 
Bicistronic reporter systems present a strategy to internally control for the variability 
between different mutants. In the studies by Baranov et al. [11] and Hansen et al. [12], 
test frameshift cassettes were inserted between glutathione-S-transferase (GST) and 
malE genes and the malE gene was made in the +1 frame. Measurements of frameshift 
efficiency were done by image analysis of SDS gels. Frameshift efficiency was 
estimated from the amount of frameshift product divided by the total protein 
synthesized from the GST-malE reporter (frameshift product + non-frameshift 
product). Grentzmann et al. [13] developed a dual-luciferase reporter system for 
studying recoding signals in vitro. The dual-luciferase assay simultaneously measured 
the luminescence of both the Renilla and firefly luciferase enzymes synthesized from a 
single bicistronic mRNA. The two genes are separated by a functional PRF signal and 
the downstream firefly gene is placed into the -1 or +1 frame relative to the upstream 
Renilla gene. The relative luciferase expression of firefly to Renilla is normalized by a 
zero-frame control plasmid that lacks a frameshift signal and has firefly luciferase 
gene in the zero frame. Harger et al. [14] further applied this system in yeast for 
measurement of Ty1 and Ty3 directed +1 frameshifting. However, this analysis 
requires cell lysis, and is relatively expensive and labor consuming. 
 
Using green fluorescent protein (GFP) of the jellyfish Aequorea victoria as a reporter 
requires neither substrates nor cofactors due to the intrinsically fluorescent nature of 
the protein. Since this gene was first cloned in E. coli and Caenorhabditis elegans in 
1992 [15], efforts have been put into engineering GFP to produce variants with 
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different color, enhanced folding efficiency, increased stability, or altered 
oligomerization (see a review by Tsien [16]). The enhanced GFP (EGFP) contains 
Phe64L and Ser65Thr mutations in the protein and is one of the brightest variant of 
GFP [17]. More recently, fluorescent proteins from other species have been identified 
and isolated [18,19]. The various options of fluorescent proteins provide tools for 
multicolor labeling, fluorescence resonance energy transfer, or a multicolor reporter 
assay [20-22]. Choe et al. used a dual fluorescence reporter for a high-throughput 
clone characterization assay [21]. This dual reporter system was designed such that a 
successful insertion of the foreign DNA caused the loss of DsRed fluorescence 
without interrupting GFP fluorescence. Combined with cell sorting, this approach 
provided rapid screening for isolating clones with successful recombination. To test 
the effect of tunable intergenic regions (TIGRs), Pfleger et al. incorporate various 
TIGRs between DsRed and EGFP under the control of the same promoter [22]. By 
measuring red and green fluorescence levels, this study observed that TIGRs can vary 
the relative expression of two reporters in the same operon over a 100-fold range.   
 
In the present study, a dual fluorescence reporter system for studying PRF is 
developed in E. coli and S. cerevisiae. PRF signals are inserted between the coding 
sequences of DsRed and EGFP (Figure 3.1). In the test strain, the expression of the 
first fluorescent reporter (DsRed in the example of Figure 3.1) depends on the 
translation efficiency, while the expression of the second reporter depends on both 
translation and PRF efficiencies. Therefore, the system enables comparisons of 
frameshift efficiency for different recoding sites with the normalized fluorescence 
ratio. Because the detection of fluorescence requires neither cell lysis nor enzymatic 
assays, the dual fluorescence reporter system is a non-invasive and cost-effective 
assay to monitor PRF efficiency.   
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Figure 3.1. The genetic structure of the dual fluorescence reporter. The coding 
sequence of monomeric DsRed is upstream of an out of frame egfp. The linker 
sequence contains a stop codon in-frame with the DsRed coding sequence. As a result, 
the reporter system expresses DsRed as non-frameshift proteins and DsRed-EGFP as 
frameshift proteins.  
 
 
 
EGFP  (+1 or -1 frame)Monomeric DsRed
STOP
Non-frameshift protein
Frameshift protein
PRF signal
mRNA
Protein
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3.4 Materials and methods 
3.4.1 Stains and plasmids 
Escherichia coli XL1 blue MRF’ (Stratagene, La Jolla, CA) was used in the E. coli 
system. All primers for PCR amplification and mutagenesis in this study were 
obtained from Integrated DNA technologies (Coralville, IA) and listed in Table S3.1 
in Supplementary Data. The gene sequence of monomeric DsRed was PCR amplified 
by using two primers, Hind-mRFP and mRFP-SalI, and pmRFP [23] as a template. 
The PCR product was cloned into HindIII/SalI sites in pEGFP vector (Clontech, 
Mountain View, CA) to create pRG3 plasmid, which can express DsRed-EGFP fusion 
protein. Different linker sequences were made from complementary oligonucleotides 
(Integrated DNA technologies) and were cloned between SalI and BamHI sites 
between the coding sequences of DsRed and EGFP in the pRG3 plasmid. The linker 
sequence for a control kept both DsRed and EGFP coding sequences in frame. In a test 
strain, the linker sequences containing mutated release factor 2 (RF2) frameshift sites 
rendered downstream egfp in the +1 frame. The control strain expressed only the 
DsRed-EGFP fusion protein from the reporter. The test strains expressed DsRed 
proteins as non-frameshift products (because there was an in-frame stop codon in the 
linker sequence) and DsRed-EGFP fusion proteins as frameshift products (because the 
stop codon was bypassed by +1 frameshifting) (Figure 3.1). Different linker sequences 
for +1 PRF studies in this chapter are listed in Table 3.1. 
 
The plasmids for -1 PRF studies were created as the following. A DNA sequence 
GTACAAGCATCATCATCATCATCATTAAGA was cloned into the BsrGI/EcoRI sites in 
pRG3RF (Table 3.1) for the insertion of a 6X histidine tag downstream of egfp. This 
plasmid was named pRG3RFhis. Linker sequences containing -1 PRF signals (Table 
3.2) were then cloned into SalI/BamHI sites in the pRG3RFhis plasmid. These linker 
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sequences made the downstream egfp in the -1 reading frame. Site direct mutagenesis 
was used to create control plasmids for each PRF signal according to manufacturer’s 
protocol (Qiagen, Valencia, CA) (Table 3.2).   
 
In the S. cerevisiae system, yeast strains JD932, JD1228, and JD1229 were used in the 
study [24]. The Kozak sequence upstream of egfp in the pMB2, pMBC, pO2, and pOC 
was first mutated by site direct mutagenesis using two primers, mut-koz and mut-kozc. 
These plasmids were named pMB3, pMB3C, pO3, and pO3C, respectively. The DNA 
fragments from DsRed to egfp in the four plasmids were then PCR amplified using 
two primers, pcr-MB4f and pcr-MB4r. The primer pcr-MB4f included a SpeI site and 
a Kozak sequence (TAAAC) upstream of DsRed. The primer pcr-MB4r included a 6X 
histidine tag and an EcoRI site downstream of egfp. The pcr products were digested by 
SpeI and EcoRI and ligated with SpeI/EcoRI digested p426GPD plasmid, a yeast 
shuttle vector [25], to create p426G1, p426G2, p426G3, and p426G2 (using pMB3, 
pMB3C, pO3, and pO3C as templates in PCR, respectively). These plasmids, p426G1, 
p426G2, p426G3, and p426G4, contained two SalI sites. To facilitate cloning of a 
linker flanked with SalI and BamHI sites, the SalI site downstream of egfp in p426G1 
was removed by site direct mutagenesis using mut-026 and mut-026r, generating 
p026G1. p026G1 could be used as a backbone plasmid for replacing different PRF 
signals in the yeast shuttle vector. For example, yeast LA virus directed -1 PRF signal 
was amplified by using pcr-YLA and pcr-YLAr as PCR primers and pYDL-LA [14] 
as a template. The PCR product was cloned into SalI/BamHI sites in pRG026G1 to 
create pYDF-LA. The control plasmid for yeas LA signal (pYDF-LA0) was creased 
by the same method expects that the PCR template is pYDL-LA0 [26]. 
 
To reverse the order of the fluorescence reporter, a different set of plasmids was 
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Table 3.1 Linker sequences for +1 PRF studies in Chapter 3. The P-site in the 
recoding site is underlined and the mutations are shown in bold. 
Plasmids Linker DNA sequence Strain 
pRG3L TCG ACT TCT GGC TCT GGC TCT GGC GAG RG3L (control) 
pRG3RF TCG ACT AGG GGG TAT CTT TGAC TAC GAG RG3RF 
pRG4NNN TCG ACA GGG GGT NNN CTT TGAC TAC GAG RG4NNN 
pRG6GUN TCG ACT AGG GGG GUN CTT TGAC TAC GAG RG6GUN 
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Table 3.2 Linker sequences containing -1 PRF signals in Chapter 3. The P-site in the 
recoding site is underlined and the mutations are shown in bold. 
 Plasmids  Linker DNA sequence  Strain 
 pMB2 
TCG ACT GCT AAT TTT TTA GGG AAG ATC TGG 
CCT TCC TAC AAG GGA AGG CCA GGG AAT TTT 
CTT GGA TAA AG 
 MB2 
 pMBC 
TCG ACT GCT AAC TTC CTCA GGG AAG ATC TGG 
CCT TCC TAC AAG GGA AGG CCA GGG AAT TTT 
CTT GGA TAA AG  
 MBC 
 pO2 
TCG ACT GCT AAT TTT TTA GGG AAG TAC TGG 
CCT CCG IGG GGC ACG AGG CCA GGC AAT TAT 
GTG CAG AAA CAA GTG TCC CCA TAA AG  
 O2 
 pOC 
tcg act GCT AAC TTC CTCA GGG AAG TAC TGG 
CCT CCG IGG GGC ACG AGG CCA GGC AAT TAT 
GTG CAG AAA CAA GTG TCC CCA TAA AG  
 OC 
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constructed. The coding sequence of DsRed was PCR amplified by using Eco-mRFP 
and mRFP-Spe as primers and pmRFP [23] as a template. The PCR product was 
cloned into EcoRI/SpeI sites in pEGFP vector (Clontech) to create pgr. The BsrGI site 
in pgr was mutated to NheI to generate pgrL4 by using mut-pgr4 and mut-pgr4r. Yeast 
LA virus PRF signal was PCR amplified by using pcr-grLA and pcr-grLAr as primers 
and pYDF-LA or pYDF-LA0 as a template. PCR products were digested with NheI 
and EcoRI and ligated with NheI/EcoRI restricted pgrL4 to create pgrL4-LA (by using 
pYDF-LA as the template in PCR) and pgrL4-LA0 (by using pYDF-LA0 as the 
template in PCR). The DNA fragments from egfp to DsRed were PCR amplified by 
using pcr-gLA and pcr-gLAr as primers and pgrL4-LA or pgrL4-LA0 as a template. 
PCR products were digested with SpeI and XhoI and ligated with SpeI/XhoI restricted 
p026GPD to create pYGR-LA (by using pgrL4-LA as a template in PCR) and pYGR-
LA0 (by using pgrL4-LA0 as a template in PCR).   
 
3.4.2 Fluorescence assay 
In the E. coli system, cells with different plasmids were cultured in 200 µl LB medium 
containing 100 µg/ml ampicillin in a 96-well plate for 24 hours at 37oC and 250 rpm. 
Alternatively, cells can be cultured in 1 ml LB medium with the same concentration of 
ampicillin in a 24-well plate for 24 hours at 37oC and 250 rpm. The fluorescence was 
measured by a plate reader (SpectraMax M5, Molecular Devices, Sunnyvale, CA). 
Green fluorescence was measured with an excitation wavelength at 485nm and 
emission at 528nm. The red fluorescence was measured with an excitation wavelength 
at 530 nm and emission at 590 nm. The frameshift efficiency (FS%) was obtained as 
the ratio of green fluorescence to red fluorescence for test strains, normalized against 
the fluorescence ratio of the control strain. 
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The fluorescence assay for the yeast system was conducted in Dr. Dinman’s laboratory 
at University of Maryland, College Park. The yeast cells were transformed with 
appropriate plasmids every time before the assay. In addition, a negative control strain 
(strain EV, standing for a strain with an empty vector) was transformed with 
p426GPD. Yeast cells were cultured in 1 ml synthetic complete medium (H-uracil) 
[27] in duplicate in 24 well plates at 30 oC. The fluorescence was measured by a plate 
reader (Synergy HT, BioTek Instruments, Inc., Winooski, VT). The green 
fluorescence was measured using a 485/20nm filter for the excitation wavelength and 
a 530/25nm filter for the emission wavelength. The red fluorescence was measured 
using a 512/20nm filter for the excitation wavelength and a 620/40nm filter for the 
emission wavelength. For the time course experiments, fluorescence signals were 
detected every 20 minutes for 45 hours. To account for the yeast autofluorescence [28], 
the fluorescence of test strains and their control strains were first subtracted with that 
of the EV strain (Eq.1 and Eq.2). The processed fluorescence data was then used to 
calculate FS% (Eq.3). 
                                 Eq.1           
 
                                 Eq.2        
 
FS%                             Eq.3 
 
where G is the green fluorescence, R is the red fluorescence, OD is the absorbance at 
595 nm, and subscript strain and ev denote the interested strain and the EV strain, 
respectively. 
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3.5 Results 
3.5.1 Using the dual reporter system in E. coli to study the effect of Shine 
Dalgarno-like sequence on RF2 frameshifting  
To study the effect of the stimulatory signal on +1 PRF by the dual fluorescence 
reporter system, two sets of mutants were created. In the first set, the SD-like sequence 
was shifted one base toward the 5’ end (pRG4NNN in Table 3.1) to change the 
spacing between the stimulatory signals and frameshift sites. In the second set, the SD-
like sequence was interrupted by changing the E-site codon in the frameshift site to 
GUN (pRG6GUN in Table 3.1). +1 frameshift efficiency dropped significantly when 
the spacing between the SD sequence and frameshift sites increased (Figure 3.2.a). +1 
frameshift efficiency also dropped extensively when the SD-like sequence was 
interrupted (Figure 3.2.b). Therefore, the results suggest that the position, as well as 
the integrity, of the stimulatory signals is crucial for +1 frameshifting in RF2 
expression.       
 
3.5.2 Using the dual fluorescence reporter in yeast to study the effect of 
anisomycin on -1 PRF 
Anisomycin was previously shown to decrease -1 PRF efficiency using a dual 
luciferase reporter system [24]. In the present study, the effect of anisomycin on FS% 
was tested in four sets of strains: (1) HIV-MB: HIV-1 group M type B (426G1) and its 
zero frame control (426G2); (2) HIV-O: HIV-1 group O (426G3) and its zero frame 
control (426G4) (3) LA-RG: yeast LA virus signal inserted into a DsRed-EGFP 
reporter (YDF-LA) and its zero frame control (YDF-LA0) (4) LA-GR: yeast LA virus 
inserted into a EGFP-DsRed reporter (YGR-LA) and its zero frame control (YGR- 
LA0). At stationary phase (> 20 hour culture), anisomycin decreased FS% in HIV-MB 
system while increased FS% in HIV-O system (Figure 3.3.a and 3.3.b). Anisomycin  
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Figure 3.2. The effect of a Shine Dalgarno (SD)-like sequence on RF2 frameshifting in 
the E. coli system. Frameshift efficiency (FS%) decreases significantly when (a) the 
position of SD-like sequence is shifted one nucleotide upstream (b) the SD-like 
sequence was inserted with a guanine. Error bars represent the standard deviation. The 
linker sequences for these strains are listed in Table 3.1.  
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also decreased FS% in LA-RG and LA-GR at late stationary phase (> 35 hours) 
(Figure 3.3.c and 3.3.d).   
 
3.5.3 Using the dual fluorescence reporter in yeast to study the effect of ribosomal 
protein mutations on -1 PRF 
In ribosomal protein RPL3/TCM1, mutations that inhibit peptidyl transferase activity 
were found to enhance -1 PRF efficiency in yeast cells by using a dual luciferase assay 
[24]. Yeast strain JD1228/JD1229 isogenic pairs in which the disrupted RPL3/TCM1 
allele is complemented with pRPL3 (wild type RPL3/TCM1) or pmak8-1 (Trp255Cys 
and Pro257Thr in RPL3/TCM1) [29] were used to test the effect of these mutations. 
At stationary phase, JD1229 resulted in lower FS% compared to JD1228 in HIV-MB 
system while no difference was observed in HIV-O system (Figure 3.4.a and 3.4.b). In 
the LA-RG system, FS% was lower in JD1229 than in JD1228 at stationary phase 
(Figure 3.4.c). In LA-GR system, FS% was higher in JD1229 than in JD1228 after 
about 22 hours (Figure 3.4.d).  
 
3.6 Discussion 
3.6.1 Dual fluorescence in E. coli 
The dual fluorescence reporter was successfully used in the E. coli system to study the 
effect of the SD-like sequence on RF2 frameshifting. +1 FS% decreased significantly 
when the spacing between the SD-like sequence and frameshift sites was increased by 
one nucleotide (Figure 3.2.a) or when the SD-like sequence was inserted with a 
guanine (Figure 3.2.b). These results are consistent with previous studies. By using β-
galactosidase as a reporter, Weiss et al. observed that mutations in SD-like sequence 
inhibited RF2 frameshifting [30]. By using an in vitro translation system, Marquez et 
al. suggested that the SD:anti-SD interaction could lead to a pre-mature release of E-  
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Figure 3.3. The effect of anisomycin on -1 programmed ribosomal frameshifting in 
four genetic backgrounds. (a) HIV-MB: HIV-1 group M type B (426G1) and its zero 
frame control (426G2); (2) HIV-O: HIV-1 group O (426G3) and its zero frame control 
(426G4) (3) LA-RG: yeast LA virus signal inserted into a DsRed-EGFP reporter 
(YDF-LA) and its zero frame control (YDF-LA0) (4) LA-GR: yeast LA virus inserted 
into a EGFP-DsRed reporter (YGR-LA) and its zero frame control (YGR-LA0). 
‘JD932’ means the wild type yeast strain (JD932) cultured in the medium without 
anisomycin. ‘aniso 50’ means JD932 cultured in the medium with 50 µg/ml 
anisomycin. Error bars represent the standard deviation. 
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Figure 3.4. The effect of RPL3/TCM1 mutation on -1 programmed ribosomal 
frameshifting in four genetic backgrounds. (a) HIV-MB: HIV-1 group M type B 
(426G1) and its zero frame control (426G2); (2) HIV-O: HIV-1 group O (426G3) and 
its zero frame control (426G4) (3) LA-RG: yeast LA virus signal inserted into a 
DsRed-EGFP reporter (YDF-LA) and its zero frame control (YDF-LA0) (4) LA-GR: 
yeast LA virus inserted into a EGFP-DsRed reporter (YGR-LA) and its zero frame 
control (YGR-LA0). Yeast strain JD1228 contains wild type RPL3/TCM1 on a 
plasmid and JD1229 contains mutated RPL3/TCM1 (Trp255Cys and Pro257Thr) on a 
plasmid. Error bars represent the standard deviation. 
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site tRNA in the RF2 frameshift site [31]. When the position of the SD-like sequence 
was moved two or four bases upstream of the frameshift site, the E-site tRNA bound 
to the ribosome more stably and the incorporation of +1 frame aminoacyl-tRNA  
decreased dramatically [31]. Taken together, the nucleotide composition as well as the 
position of the SD-like sequence is critical for RF2 frameshifting in E. coli and the 
SD:antiSD interaction may exert its effort by disturbing the E-site tRNA binding, 
paving the way for +1 PRF.          
 
3.6.2 Dual fluorescence reporter in yeast S. cerevisiae 
Different -1 PRF signals were incorporated into the dual fluorescence reporter system 
in yeast and their frameshift efficiencies were monitored along the time course. 
Notably, FS% fluctuated seemingly randomly and the variations between duplicates 
were large for the culture at times less than 20 hours (Figure 3.3 and Figure 3.4). 
During the exponential growth phase, the fluorescence per OD may depend on several 
factors: the production of the reporter polypeptide, the maturation of the fluorescent 
protein, and cell division. These factors may contribute to the fluctuation in both red 
and green fluorescence per OD, causing an even greater variation in FS%. Therefore, 
frameshift efficiencies were compared during the stationary phase.  
 
In the present work, anisomycin decreased FS% in three sets of the reporters, HIV-
MB, LA-RG, and LA-GR, while increasing FS% in the HIV-O system at the 
stationary phase. The RPL3/TCM1 mutations (JD1229) resulted in a lower FS% than 
JD1228 in the HIV-MB and LA-RG systems, no or very small change in FS% in the 
HIV-O setting, and a higher FS% in JD1229 than in JD1228 in LA-GR system. 
Because all four systems employed -1 PRF signals, the different trends observed in the 
four systems were not expected. The reason why different sets of the reporter have 
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inconsistent results is not clear at this time. It is possible that different linker 
sequences alter the folding of the fusion protein differently. Because these reporter 
proteins need to develop the correct conformation to fluoresce, the perturbation of the 
protein folding may lead to an underestimation of the protein expression level.  
 
The dual luciferase assay suggested that anisomycin decreased FS% and JD1229 
containing RPL3/TCM1mutations enhanced FS% compared to wild type [24]. Only a 
subset of dual fluorescence reporter results was consistent with the dual luciferase 
assay (anisyomycin experiments: HIV-MB, LA-RG and LA-GR; JD1228/JD1229 
experiments: LA-GR). While the exact cause for the discrepancy is not known, there 
are several differences between a dual luciferase reporter and a dual fluorescence 
reporter: (1) the dual luciferase assay required collecting cells at an OD595nm of 0.7 
while the dual fluorescence assay monitored FS% during the whole time course. (2) 
the dual luciferase assay needed to lyse cells to detect the luciferase activity and the 
dual fluorescence assay kept cells intact; (3) the maturation process of luciferases and 
fluorescent proteins are different. Firefly luciferase does not require post-translational 
processing for enzyme activity [32]. In contrast, fluorescent proteins mature through a 
multi-step process that consists of folding, chromophore formation and chromophore 
modification [33]. Whether these factors cause the observed discrepancy in PRF 
results is not clear and should be investigated further.  
 
3.7 Supplementary data 
Primers for PCR and site direct mutagenesis in this study are listed in Table 3.S1. 
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Table 3.S1 Primers used in Chapter 3  
 
3.8 Conclusion 
A dual fluorescence reporter system was developed in E. coli and S. cerevisiae. 
Different PRF sites were inserted between two fluorescence reporter genes, 
monomeric DsRed and EGFP. For +1 PRF studies in E. coli, the results suggested that 
the position as well as the integrity of the SD-like sequence in RF2 frameshift site 
were crucial for +1 PRF in E. coli. For -1 PRF studies in yeast, the frameshift 
efficiency under different genetic backgrounds and culture conditions was monitored 
in real time. However, the dual fluorescence assay data were not completely consistent 
with the dual luciferase reporter assay results. Therefore, the yeast dual fluorescence 
reporter system still needs to be improved further.  
Name Sequence (5’ to 3’) 
Hind-mRFP CCAAGCTTGATGGCCTCCTCCGAGG 
mRFP-SalI AGGTCGACGCGGCGCCGGTGGAGT 
mut-koz GGATCCCCGGGTACCGGTTGGCTATATGGTGAGCAAGGGCGAGG     
mut-kozc CCTCGCCCTTGCTCACCATATAGCCAACCGGTACCCGGGGATCC 
pcr-MB4f TTACTAGTTAAACATGGCCTCCTCCGAGGACGTCATC 
pcr-MB4r AAGAATTCTTAATGATGATGATGATGATGCTTGTACAGC 
mut-026 CAAGCTTATCGATACCGTCTACCTCGAGTCATGTAATTAG 
mut-026r CTAATTACATGACTCGAGGTAGACGGTATCGATAAGCTTG 
pcr-YLA TTTGTCGACCACTTCTAGGATCAATGCG 
pcr-YLAr TTTGGATCCAAAATTAAGGGATCGGTACCCCCGGG 
Eco-mRFP CCCAGAATTCATGGCCTCCTCCGAGG 
mRFP-Spe TTTACTAGTTTAGGCGCCGGTGGAG 
mut-pgr4 CTCGGCATGGACGAGCTAGCAGTCTGGCTCTGGCTCTGGC 
mut-pgr4r GCCAGAGCCAGAGCCAGACTGCTAGCTCGTCCATGCCGAG 
pcr-grLA CGAGCTAGCTACTTCTAGGATCAATGCG 
pcr-grLAr CCATGAATTCGGGATCGGTACCCC 
pcr-gLA TTACTAGTTAAACATGGTGAGCAAGGGCGAGG 
pcr-gLAr AACTCGAGTTAATGATGATGATGATGATGGGCGCCGGTGGAGTGGCGGCCC 
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CHAPTER 4 
A NEW KINETIC MODEL REVEALS THE SYNERGISTIC EFFECT OF E-, P-, 
AND A- SITES ON +1 RIBOSOMAL FRAMESHIFTING 
 
4.1 Preface 
This chapter is adapted from Liao, P.Y., Gupta, P., Petrov, A., Dinman, J.D., Lee, 
K.H. 2008. A new kinetic model reveals the synergistic effect of E-, P- and A-sites on 
+1 ribosomal frameshifting. Nucleic Acids Research. 36: 2619-2629. This study 
describes a kinetic model for +1 programmed ribosomal frameshifting. The model 
predictions are tested experimentally using a dual fluorescence reporter system in 
Escherichia coli. The results suggest that ribosome E-, P-, and A-sites are all involve 
in +1 frameshifting.  
 
4.2 Abstract 
Programmed ribosomal frameshifting (PRF) is a process by which ribosomes produce 
two different polypeptides from the same mRNA. In this study, we propose three 
different kinetic models of +1 PRF, incorporating the effects of the ribosomal E-, P-, 
and A-sites toward promoting efficient +1 frameshifting in Escherichia coli. 
Specifically, the timing of E-site tRNA dissociation is discussed within the context of 
the kinetic proofreading mechanism of aminoacylated tRNA (aa-tRNA) selection. 
Mathematical modeling using previously determined kinetic rate constants reveals that 
destabilization of deacylated tRNA in the E-site, rearrangement of peptidyl-tRNA in 
the P-site, and availability of cognate aa-tRNA corresponding to the A-site act 
synergistically to promote efficient +1 PRF. The effect of E-site codon:anticodon 
interactions on +1 PRF was also experimentally examined with a dual fluorescence 
reporter construct. The combination of predictive modeling and empirical testing 
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allowed the rate constant for P-site tRNA slippage (ks) to be estimated as ks ≈ 1.9 s-1 
for release factor 2 (RF2) frameshifting sequence. These analyses suggest that P-site 
tRNA slippage is the driving force for +1 ribosomal frameshifting while the presence 
of a “hungry codon” in the A-site and destabilization in the E-site further enhance +1 
PRF in E. coli. 
 
4.3 Introduction 
Programmed ribosomal frameshifting (PRF) is a coded shift in reading frame during 
translation of an mRNA transcript. Consequently, one transcript may yield two 
different protein products, an inframe product and a frameshift product. PRF has been 
observed to occur in various organisms including prokaryotes and eukaryotes. In +1 
PRF, the ribosome skips over one nucleotide toward 3' direction. +1 PRF has been 
observed in Escherichia coli in the translation of prfB to produce release factor 2 
(RF2) [1]. In Saccharomyces cerevisiae two retrotransposable elements, Ty1 and Ty3 
[2,3], and three genes, ABP140 [4], EST3 [5], and OAZ1 [6] use +1 PRF. The 
expression of mammalian antizyme has also been shown to involve +1 PRF [7].  
 
Several features have been shown to facilitate +1 PRF: (1) low levels of 
aminoacylated-tRNA (aa-tRNA) corresponding to the in-frame A-site codon, i.e. 
hungry codons [8]; (2) the ability of P-site tRNA to form near-cognate interactions 
with the shifted frame codon, i.e. slippery sequence [9]; and (3) the presence of a 
stimulatory signal, such as a Shine-Dalgarno (SD)-like sequence upstream of the 
frameshift site [10] or a RNA secondary structure downstream of the frameshift site 
[3]. Both (1) and (3) may promote a pause in translation elongation, which allows 
more time for a recoding event to occur, suggesting that +1 PRF is kinetically driven 
[11].  
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Several mechanistic models have been proposed to explain +1 PRF [11-13]. The 
kinetic model of Baranov et al. [13] illustrated the dependence of frameshift efficiency 
on the stability of the P-site interaction and the concentration of incoming aa-tRNA 
available for the zero and +1 frames. This kinetic model is consistent with 
observations from several frameshifting studies. For example, the codon: anticodon 
interaction in the +1 frame of the P-site has been shown to affect the amount of 
frameshift products [9]. Overexpression of the cognate P-site tRNAs has also been 
shown to dramatically reduce +1 PRF in yeast and vice versa [2,14,15].  
 
Recent experimental observations suggest that the E-site plays a crucial role in the 
efficiency of +1 PRF in E. coli [16]. In that study, premature release of E-site tRNA 
from the ribosome correlated with high levels of frameshifting products. A 
mutagenesis study of 23S rRNA has also illustrated the correlation between E-site 
tRNA binding and the maintenance of reading frame [17]. A recently published study 
shows that RF2 programmed frameshifting is inversely correlated with the E-site 
stability in E. coli [18]. To date, no published kinetic model of +1 PRF has explained 
the effect of E-site tRNA release on +1 PRF.  
 
In the present study, we propose a new mathematical model for +1 PRF in E. coli, 
which incorporates the effects of E-, P-, and A-site interactions in promoting high 
levels of frameshifting. Previously published theories of +1 PRF usually focus on a 
single aspect of +1 PRF (e.g. A-site tRNA abundance, stability of P-site tRNA - 
ribosome interaction and etc. [8,9,14,15]). Here, we present a model synthesizing 
previously observed effects of all three ribosomal tRNA binding sites on +1 PRF 
efficiency in E. coli. Of particular note, this is the first model combining the concepts 
of kinetic proofreading of aa-tRNA selection [19] with the allosteric model [20] to 
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describe +1 PRF. The proposed mathematical model suggests that the rate of P-site 
tRNA slippage is the most significant parameter in the +1 PRF event, while the 
abundance of cognate aa-tRNA and the rate of E-site tRNA release act synergistically 
to promote highly efficient +1 PRF.  
 
4.4 Kinetic model  
An elegant series of biochemical studies have contributed to a very detailed kinetic 
model of A-site tRNA selection [19]. In this model, fast initial binding of the ternary 
complex EF-Tu:aa-tRNA:GTP is followed by codon recognition. Codon recognition 
triggers EF-Tu GTPase activation, which leads to the GTP hydrolysis and dissociation 
of EF-Tu from the ribosome. Factor dissociation is followed by the spontaneous 
accommodation of the acceptor end of the aa-tRNA into the A-site or the rejection of 
the aa- tRNA by proofreading. This concept is illustrated along the top of Figure 4.1. 
 
Other recent studies suggested that events at the ribosomal E-site are involved in 
coordinating this process, specifically that E-site tRNA dissociation occurs prior to 
GTP hydrolysis [21]. Functional studies suggest that +1 PRF efficiency is linked to the 
E-site occupation and the identity of the E-site tRNA [16-18]. Following the allosteric 
model of the elongation cycle, the E-site is occupied at the start of each cycle prior to 
aa-tRNA selection, and A-site tRNA binding promotes release of the E-site tRNA, 
followed in turn by peptidyltransfer and translocation. During translocation the 
deacylated tRNA is shifted from the P-site to the E-site. Thus there are two events that 
affect the E-site occupancy: aa-tRNA selection and translocation. The previously 
observed effects of tRNA abundance and amino acid starvation on +1 PRF efficiency 
strongly suggest that +1 PRF occurs during A-site tRNA selection [2]. Importantly, 
recent X-ray crystal structures show that the E-site tRNA can form 1-3 base pairing 
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Figure 4.1. The three kinetic models for +1 PRF in E. coli. Steps I-VI illustrate the 
non-frameshifting translation elongation process: I. initial binding; II codon 
recognition; III. GTPase activation; IV.GTP hydrolysis; V. EF-Tu dissociation; VI. 
accommodation. In Model 1, both E-site and P-site tRNAs slip into the +1 frame and 
follow the +1 frame aa-tRNA selection to produce frameshift proteins. (P1A1). In 
Model 1A, both E-site and P-site tRNAs are destabilized by stimulatory signals and 
follow the +1 frame aa-tRNA selection to produce frameshift proteins. (P1A1). Model 
2 and 3 differ in the timing of the E-site tRNA dissociation step (In Model 2, E-site 
tRNA dissociation occurs during the codon recognition step while in Model 3, E-site 
tRNA dissociates after codon recognition). Both Models (2 and 3) result in the 
formation of ribosomes with only P-site tRNA (P0), which can slip to the +1 frame to 
form P1 and result in the formation of frameshift proteins (P1A1). 
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interactions with the mRNA [22,23]. Thus E-site tRNA destabilization may make 
ribosomes more prone to frameshifting by reducing the extent of tRNA:mRNA 
interactions. 
 
Because the exact timing of dissociation is unknown, three different models of +1 PRF 
in E. coli that differ in the timing of E-site tRNA release (Figure 4.1) were constructed 
in the present study. In Model 1, simultaneous slippage of E- and P-site tRNAs is 
hypothesized to occur before aa-tRNA selection (shaded in blue). In this model, the 
rate constant of the simultaneous slippage (kse) is determined by the stability of the 
E0P0 complex (ribosomes with E- and P-site occupied). The stability of this complex 
depends on the identity of the P-site tRNA [13,14], and to some extent on the E-site 
tRNA [24,25]. The 3' slippage results in the formation of E1P1 complex, in which both 
E-site and P-site tRNAs have been shifted by one base. Thereafter, the ribosome can 
follow the normal elongation cycle to produce frameshift proteins (P1A1). Similarly, in 
Model 1A (shaded in dark blue in Figure 4.1), stimulatory signals may destabilize 
E0P0, yielding an unstable complex E’0P’0. As this destabilization occurs, the codon at 
the A site is shifted, leaving both zero frame aa-tRNA (A0) and +1 frame aa-tRNA 
(A1) as near-cognate ternary complexes. The binding of A1 to the A site will trigger 
the release of the E-site tRNA. This step is then followed by the slippage of the P-site 
tRNA to base pair with the +1 frame. Frameshift products (P1A1) would then be 
produced by following the remaining steps of aa-tRNA selection by ribosomes. 
 
Slippage could also occur during aa-tRNA selection. To accommodate for the unclear 
timing of E-site tRNA release, two additional models are proposed. In Model 2, E-site 
tRNA dissociation occurs during the codon recognition step. E-site empty ribosomes 
formed at this step can either continue with the subsequent steps of aa-tRNA selection 
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or undergo the reverse reaction to yield initial binding complex P0A0i. P0A0i can again 
undergo the aa-tRNA selection or release the aa-tRNA to form ribosomes with only P-
site tRNA occupied (P0). Depending upon the slippage constant (ks), tRNA in the P0 
state can slip to base pair with the +1 frame and form the P1 state. P1 can then go 
through the +1 frame aa-tRNA selection and produce the frameshift proteins (P1A1). 
Alternatively, the E-site tRNA might dissociate after codon recognition (Model 3). In 
this model, E-site empty ribosomes (P0) can be formed consequent to aa-tRNA 
rejection during the accommodation step. Importantly, because the initial binding of 
aa-tRNA is fast and nonspecific, Model 2 would result in the formation of a 
significantly larger fraction of the ribosomes in P0 states as compared to Model 3. 
 
4.5 Materials and methods 
4.5.1 Computation of the kinetic model 
All three models were mathematically described by systems of ordinary differential 
equations (see Text in Supplementary Data). Assuming steady state, the expressions of 
intermediate concentrations in terms of initial reactant (E0P0) were solved by Matlab 
7.2 (Mathworks Inc., USA). By applying the empirically-determined rate constants 
and assumed ranges of rate constants of P-site tRNA slippage, and rate constants of E-
site tRNA release (Table 4.S1 and 4.S2 in Supplementary Data) with different aa-
tRNA concentrations (Table 4.S3 in Supplementary Data), the amount of non-
frameshift proteins (P0A0) and frameshift proteins (P1A1) were calculated. The 
frameshift efficiency (FS%) in the model is defined as the ratio of P1A1 to total 
proteins (P0A0 + P1A1) multiplied by 100 %.  
 
4.5.2 Plasmids and bacterial strains 
Escherichia coli XL1 blue MRF’ (Stratagene) was used in all experimental studies. 
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The gene sequence of monomeric DsRed [26] was first cloned between HindIII and 
SalI sites in pEGFP vector (Clontech, Mountain View, CA) to create pRG plasmid, 
which can express DsRed-EGFP fusion protein. Different linker sequences were made 
from complementary oligonucleotides (Integrated DNA Technology, Coralville, IA, 
USA) and were cloned between SalI and BamHI sites between the coding sequence of 
DsRed and EGFP in the pRG plasmid. The linker sequence for the control strain is 
tcgacttctggctctggctctggcgag, which kept both DsRed and EGFP coding sequences in 
frame. The linker sequences for the mutants contained mutated RF2 frameshift sites 
(tcgactagggggUNNctttgactacgag) which made EGFP coding sequence in +1 
frame (UNN refers to the E-site codon when +1 frameshifting is taking place and the 
stop codon is underlined). The control strain expressed only the DsRed-EGFP fusion 
protein. The mutants expressed DsRed proteins as non-frameshift proteins (because of 
the stop codon in the linker sequence) and DsRed-EGFP fusion protein as frameshift 
proteins (because the stop codon is bypassed by +1 frameshifting). Thirteen mutants 
differing only in the E-site codon (UNN) in the recoding sites were constructed. 
Among the thirteen mutants, the first base in the E-site codon was kept intact to 
maintain SD-like sequence and stop codons were avoided.   
 
4.5.3 Fluorescence assay 
Cells with different plasmids were cultured in 200 µl Luria-Bertani (LB) medium 
containing 100 µg/ml ampicillin in a 96-well plate for 24 hours at 37oC, 250 rpm. The 
fluorescence was then measured by plate reader (SpectraMax Gemini EM, Molecular 
Devices). The green fluorescence was measured with excitation wavelength at 485 nm 
and emission at 528 nm. The red fluorescence was measured with excitation 
wavelength at 530 nm and emission at 590 nm. From the fluorescence measurement, 
the experimental frameshift efficiency (FS% exp) was obtained as the ratio of green 
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fluorescence to red fluorescence for the mutant strains (containing RF2 sequence with 
different E-site codons), normalized against the fluorescence ratio of the control strain. 
 
4.5.4 Chi-square analysis 
 
Chi-square is defined as:                     , where i refers to different E-site 
codons (i = 1-13, for 13 tested E-site codons), FS% is the frameshift efficiency 
calculated by the model and FS%exp is the frameshift efficiency observed in the 
experiment. The rate constant of E-site tRNA release, kr, was assumed as kr = A’exp(-
mj∆Gc/RT), where A’ is the pre-exponential constant for the effect of the stimulatory 
signals (the same for all tested E-site codons); ∆Gc is the codon:anticodon interaction 
in the E-site [27]; mj is the modifying factor to account for other factors (e.g. 
tRNA:ribosome interactions, base modification etc.) that may affect the contribution 
of the base pairing on kr (j=1-6, see Table 4.S4 in Supplementary Data); R is the gas 
constant (8.314 J · K-1 · mol-1); T is the temperature (310K). Matlab V.7.2 was used to 
optimize the values of ks, A’ and mj that resulted in the minimum chi-square value.  
 
4.6 Results  
4.6.1 Mathematical model.  
The three major variables in the model are the rate constant of P-site tRNA slippage 
(ks), the rate constant of E-site tRNA release (kr), and the concentration of cognate aa-
tRNA for zero-frame codon in the A-site (cog.A0). To understand the synergistic 
effect of ks, kr and cog.A0, surface plots are used to show the effect of any two 
parameters on FS% while keeping the third parameter as a constant. Figure 4.2.a 
shows the effect of ks and kr on FS%. An increase in FS% is observed as kr and ks are 
increased. Figure 4.2.b shows an example of the synergistic effect of E-site (kr) and P-
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site (ks): while a 10 fold increase in kr or ks alone results in an increase in FS%, a 10 
fold increase in both parameters results in a greater increase in FS% than the 
summation of the individual effects. Figure 4.2.c and Figure 4.2.d show the cross 
section curves of Figure 4.2.a. This analysis suggests that the effect of kr is more 
significant when kr is below 10 s-1 (Figure 4.2.c). Interestingly, the effect of kr on FS% 
is less important for smaller values of ks (only 1 % increase in FS% with increasing kr 
for ks = 0.05 s-1), which suggests that the effect of the E-site tRNA release becomes 
prominent above a threshold value of P-site tRNA slippage (represented by ks).  
 
Additionally, the model reveals a synergistic effect of P-site tRNA slippage and the 
hungry codon (Figure 4.3.a). The analysis suggests that FS% increases as cog.A0 
decreases and as ks increases. Figure 4.3.b shows an example of the synergistic effect 
of P-site (ks) and A-site (cog.A0): while a 10 fold decrease in cog.A0 or a 10 fold 
increase in ks results in an increase in FS%, a 10 fold change in both parameters 
results in a greater increase in FS% than the summation of the individual effects. 
Figure 4.3.c and Figure 4.3.d show the cross section curves of Figure 4.3.a. 
Importantly, the effect of cog.A0 on FS% decreases with ks (Figure 4.3.c). As a result, 
the hungry codon effect (represented by a small value of cog.A0) becomes more 
significant as the probability of P-site tRNA slippage increases (represented by larger 
ks).  
 
The model also shows the synergistic effect between hungry codon at the A-site and 
release of tRNAs from the E-site. Examination of Figure 4.2.c and Figure 4.3.c shows 
that the effects of kr and cog.A0 become significant only for higher values of ks. 
Therefore, a higher value of ks (5 s-1) was chosen to study the effect of cog.A0 and kr 
on FS% (Figure 4.4.a). The analysis shows that FS% increases as kr increases and as 
  58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. (a) The effect of P-site tRNA slippage (represented by ks) and E-site tRNA 
release (represented by kr) on FS% at fixed concentration of zero-frame cognate aa-
tRNA (cog.A0 = 1 %). All the other parameters are assumed to be constants (Table 
4.S1. in Supplementary Data). (b) An example of the synergistic effect of E-site (kr) 
and P-site (ks) (data points from Figure 4.2.a). 1x means the parameter is the same as a 
randomly chosen base point (ks = 0.2 s-1, kr = 1 s-1). 10x means a 10 fold increase in 
the parameter. ∆FS% refers to the increase in FS% as compared to the base point. (c) 
The effect of kr on FS% at different values of ks (0.05-5 s-1). (d). The effect of ks on 
FS% at different values of kr (1-100 s-1). 
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Figure 4.3. (a) The effect of P-site tRNA slippage (represented by ks) and the 
concentration of zero-frame cognate aa-tRNA (cog.A0) on FS% at fixed rate constant 
of E-site tRNA release (kr = 100 s-1). All the other parameters are assumed to be 
constants (Table 4.S1. in Supplementary Data). (b) An example of the synergistic 
effect of P-site (ks) and A-site (cog.A0) (data points from Figure 4.3.a). 1x means the 
parameter was the same as a randomly chosen base point (ks = 0.2 s-1, cog.A0 = 10 %). 
10x means a 10 fold increase in the parameter. 0.1x means a 10 fold decrease in the 
parameter. ∆FS% refers to the increase in FS% as compared to the base point. (c) The 
effect of cog.A0 on FS% at different values of ks (0.05-5 s-1). (d) The effect of ks on 
FS% at different values of cog.A0 (0.1-10%). 
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Figure 4.4. (a) The effect of the concentration of zero-frame cognate aa-tRNA 
(cog.A0) and E-site tRNA release (represented by kr) on FS% at fixed rate constant of 
P-site tRNA slippage (ks = 5 s-1). All the other parameters are assumed to be constants 
(Table 4.S1. in Supplementary Data). (b) An example of the synergistic effect of E-
site (kr) and A-site (cog.A0) (data points from Figure 4.4.a). 1x means the parameter 
was the same as a randomly chosen base point (kr = 1 s-1, cog.A0 = 10 %). 10x means 
a 10 fold increase in the parameter. 0.1x means a 10 fold decrease in the parameter. 
∆FS% refers to the increase in FS% as compared to the base point. (c) The effect of kr 
on FS% at different values of cog.A0 (0.1-10%). (d) The effect of cog.A0 on FS% at 
different values of kr (1-100 s-1). 
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cog.A0 decreases, respectively. Figure 4.4.b shows an example of the synergistic effect 
of E-site (kr) and A-site (cog.A0): while a 10 fold increase in kr or a 10 fold decrease in 
cog.A0 results in an increase in FS%, a 10 fold change in both parameters results in a 
greater increase in FS% than the summation of the individual effects. Figure 4.4.c and 
Figure 4.4.d show the cross section curves of Figure 4.4.a. The result shows that for 
small cog.A0, the effect of kr is not important (Figure 4.4.c), i.e. the effect of E-site 
tRNA release is less important if there is hungry codon in the A-site. Therefore, the 
model suggests that in the presence of a slippery P-site (high ks) with no hungry codon 
effect (large cog.A0), a higher rate of E-site tRNA release can still result in a higher 
FS%. In contrast, for lower rates of E-site tRNA release, the model predicts substantial 
FS% in the presence of P-site slippery sites and hungry codons (Figure 4.4.d). 
 
4.6.2 Empirical studies  
To understand the importance of the release of E-site tRNA on +1 PRF, an in vivo 
dual fluorescence reporter system in E. coli is used to study the effect of the E-site 
stability on +1 PRF (see Materials and Methods). The reporter system (Figure 4.5.a) 
allows measurement of frameshift efficiency for different recoding sites by calculating 
the ratio of green to red fluorescence. All possible E-site codons (13 sense codon = 16 
potential codons – 3 stop codons) in the RF2 frameshift site have been tested under the 
condition that SD-like sequence was kept intact. Statistical analysis was applied to all 
datasets according to Jacobs et al., 2004 [28]. Ten replicates for the mutants and 
twenty replicates for the control were performed to satisfy the minimum sample 
requirement. The standard error for FS% for different mutants was less than 2 %. The 
results show that the presence of an A:U pair in the second position of the E-site 
codon in the RF2 frameshift site results in higher frameshifting as compared to a G:C 
pair in the same position (Figure 4.5.b). Importantly, frameshift efficiency can be 
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Figure 4.5. The effect of different E-site codon:anticodon interactions on frameshift 
efficiency. (a) The sequence design of the dual fluorescence reporter system. The E, P 
and A denote the codon in the E-, P-, and A-sites when +1 frameshifting is taking 
place. The +1 frame A-site codon is underlined. (b) Experimentally obtained 
frameshift efficiency for different E-site codons. The error bars indicate the standard 
deviation. * indicates significant difference (p < 0.001). ** indicates significant 
difference (p < 0.01). 
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generally categorized into three levels based on the number of hydrogen bonds in the 
base pair interaction (Table 4.1). A:U pairs in both the second and the third positions 
have the lowest number of hydrogen bonds and promote the highest frameshifting. 
One A:U pair and one C:G pair in the second and the third positions result in the 
intermediate level of frameshifting. With the highest number of hydrogen bonds, C:G 
pairs in both the second and the third positions result in the lowest frameshifting. An 
interestingly unexpected result is UGG as an E-site codon. The frameshift efficiency 
for UGG in the E-site is comparable to that for one G:C and one A:U base pairs in the 
second and third positions in the E-site. This observation may result from factors not 
accounted for in the model or perhaps be a result of the reporter protein. The absence 
of modified nucleoside pseudouridine (Ψ) at position 38-40 in tRNATrpCCA could also 
be a reason for less efficient binding of this tRNA to the E-site. It is suggested that 
deficiency of modified nucleosides may change tRNA structure, resulting in different 
ribosome:tRNA interactions [29]. However, the exact reason for relatively higher FS% 
for UGG in the E-site is not known. These FS% data are less likely to be due to the 
availability of tRNA for the specific codon in the E-site, because we observed no 
obvious correlation between FS% and tRNA concentration for the E-site codons 
(Figure 4.S1 in Supplementary Data). These experimental observations emphasize the 
effect of E-site stability on +1 PRF, which is consistent with the computational 
simulations described above.  
 
4.6.3 Parameter estimation  
The rate constant for the P-site tRNA slippage (ks) can be estimated by combining the 
kinetic model and the experiments results. Changing E-site stabilities by using 
different E-site codons while maintaining the identity of the P-site codon enables 
manipulation of kr at a constant ks. kr is assumed to be a function of stimulatory 
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Table 4.1 Three levels of +1 frameshift efficiency for different E-site codons 
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signals, tRNA:mRNA (codon:anticodon) and tRNA:ribosome interactions in the E-site 
(see Materials and Methods). Chi-square analyses were performed to obtain optimum 
values for ks, and kr, which give the best fit of the model predictions and the 
experimental results. Figure 4.6 shows the data-fitting result of the model prediction 
(solid line) and the experimentally detected FS% (diamonds). ks was determined to be 
1.9 s-1 for the RF2 frameshifting sequence and parameters for calculating kr are listed 
in Table 4.S4 in Supplementary Data. Modifying factors were used to account for 
other factors (e.g. tRNA:ribosome interactions, base modification) that may affect the 
contribution of the base pairing on kr. The modifying factor for tRNAQTATyr was 
observed to be 2.18. The value is consistent with the observation that the binding 
efficiency of Q34-tRNATyr to triplet programmed ribosomes is two fold more than 
G34-tRNATyr [30]. Modifying factors for other tRNAs are less than one, which may 
suggest that for tRNAPhe, tRNALeu, tRNASer, tRNACys, and tRNATrp, other interactions 
in the E-site could reduce the contribution of codon:anticodon interactions on kr. The 
correlation between FS%exp and free energy change of the codon:anticodon 
interactions in the E-site is shown in Figure 4.7.a and the correlation between FS%exp 
and apparent E-site stability (free energy change of codon:anticodon interactions in the 
E-site multiplied by modifying factors) is shown in Figure 4.7.b. Importantly, 
frameshift efficiency is observed to inversely correlate with the E-site stability and this 
observation is more clear when codon:anticodon interactions and other interactions in 
the E-site are all considered.  
 
4.7 Discussion 
4.7.1 Comparison of the three models 
Figure 4.1 presents three possible pathways for ribosomes to synthesize +1 frameshift 
proteins in E. coli. We believe that all three pathways can occur in vivo but that  
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Figure 4.6. Data fit of frameshift efficiency for different codon:anticodon interactions 
in the E-site. By using chi-square analysis, the optimum value for ks is 1.9 s-1 for RF2 
frameshifting sequence. The diamonds show the experimentally obtained frameshift 
efficiency for different E-site codons (kr=A’exp(-m∆Gc/RT), see Materials and 
Methods). The solid line indicates model predicted FS% for different kr at ks = 1.9 s-1. 
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Figure 4.7. (a) The correlation between FS%exp and the free energy change of the E-
site codon:anticodon interactions. (b) The correlation between FS%exp and the 
apparent E-site stability obtained by free energy change of the E-site codon:anticodon 
interactions multiplied by modifying factors (Table 4.S4).  
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Model 2 is the dominant pathway for +1 PRF. Model 1 involves simultaneous slippage 
of E- and P-site tRNAs to the +1 frame, an energetically unfavorable process less 
likely to occur. To test this hypothesis, the effect of kse (the rate constant that 
determines if the ribosome complex would get into Model 1) was studied and it was 
found that FS% remained at a similar level at different values of kse (Figure 4.S2 in 
Supplementary Data). A recently published study observed no correlation between +1 
PRF efficiency and the stability of complex of E-site tRNA base pairing with +1 frame 
[18]. Similarly, the effect of ksd, which governs whether the ribosome complex enters 
Model 1A pathway, was also studied. The effect of ksd is observed to be less 
significant on FS% (Figure 4.S3 in Supplementary Data). These observations suggest 
that Model 1 and Model 1A may contribute much less than Model 2 or 3 to the overall 
FS%. In Model 3, the formation of P0, the major precursor of frameshift products, 
depends on aa-tRNA rejection. The aa-tRNA that reaches the accommodation step is 
more likely to be cognate, because it has already passed through the selective codon 
recognition and GTPase activation steps. As a result, this aa-tRNA is less likely to be 
rejected, and thus the probability for ribosomes to form P0 is less. Although in Model 
2, formation of P0 also depends on dissociation of aa-tRNA, the reversible nature of 
the codon recognition step and higher concentration of non- and near-cognate tRNAs 
relative to cognate tRNA, together with same rates for forward reactions of codon 
recognition for both substrates, make P0 formation likely. Therefore, Model 2 would 
result in formation of a significantly larger fraction of the P0 state ribosomes as 
compared to Model 3. Thus, we propose that Model 2 is the major pathway for +1 
PRF in vivo.  
 
4.7.2 Role of the E-site  
The function of ribosome E-site is still under debate in the literature. Some studies 
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suggest the E-site interactions are functionally important for maintaining the reading 
frame [16,31,32], while others suggest the E-site tRNA binds to the ribosome in a 
labile manner [33,34]. The results presented in this study are fundamentally helpful to 
explain different E-site effects suggested by different studies. In the proposed 
mechanism, kr represents the de-occupation of E-site tRNA. Our model results show 
that the effect of E-site interactions on +1 PRF is more significant when kr is smaller 
than 10 s-1 and the effect is less when kr is in a range of larger values (Figure 4.2.c and 
Figure 4.4.c). We believe that different views of the E-site function can be due to the 
result of different experimental conditions, which produce different ranges of kr. It has 
been suggested that the ionic conditions, physical parameters (pH, temperature, etc.), 
and material preparation methods all affect the binding affinity of tRNA to the 
ribosome [35]. Therefore, for buffer conditions or mRNA sequences for which kr is in 
the range of smaller values, the effect of E-site interactions on +1 frameshift efficiency 
can be observed [16-18,31,32]. On the other hand, for buffer conditions or mRNA 
sequences for which kr is in the range of larger values, the effect of E-site interactions 
is less important for translation elongation [33]. This observation clearly demonstrates 
the utility of a modeling approach to help reconcile disparate observations from the 
literature. 
 
A question may remain: which range of kr should be expected? The data fitting 
(Figure 4.6) shows that the range of kr is actually different for different E-site codons 
in vivo. For E-site codons UAU, UUA, UUG and UUU, kr are in a range of large 
values ( ≥ 10 s-1). For all the other tested E-site codons in the present study, the kr 
values are smaller (< 10 s-1). Previous in vitro studies used polyU programmed 
ribosome to study E-site interactions [33,34], which could be the reason that smaller 
tRNA binding affinities to the ribosome E-site were observed. On the other hand, 
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weaker interactions in the ribosome E-site have been shown to reduce translational 
fidelity in vivo [17,18,32]. In the present study, the experiments support the 
importance of E-site interactions in +1 PRF in E. coli (Figure 4.5.b). The data show 
that an A:U base pairing in the E-site, which contains one less hydrogen bond than a 
G:C base pairing, results in higher frameshift efficiency. A recently published study 
using a monocistronic reporter system also showed that RF2 programmed 
frameshifting is inversely correlated with the E-site stability [18]. Taken together, the 
experimental data in the present study and the study by Sanders et al. [18] provide 
independent evidence that different E-site interactions may result in different ranges of 
kr in vivo, illustrating the role of E-site stability on +1 PRF. 
 
Mechanistically, kr may be a function of mRNA:tRNA and tRNA:ribosome 
interactions at the E-site, stimulatory signals (SD sequence, mRNA structures, etc.), 
and spacing between the stimulatory signals and the E-site. The experimental results in 
the present study suggest that tRNA:mRNA base pairing in the E-site could be 
functionally important, supporting the X-ray crystal structures [22,23]. Previous 
experimental observations also support the effect of stimulatory factors and spacing on 
frameshifting. For example, it has been proposed that the interaction between the SD 
and anti-SD sequence in E. coli prfB mRNA precludes the binding of the E-site tRNA 
and therefore might facilitate destabilization of the E- site tRNA [16]. That study also 
showed that the spacing between the SD sequence and the frameshift site is critical for 
high frameshift efficiency. Mutations in the SD sequence have also been shown to 
cause significant reductions in frameshift efficiency [10]. In our model, the SD:antiSD 
interaction may play its role in RF2 frameshifting in E. coli in two ways. First, the 
presence of an SD:antiSD interaction enhances the release of E-site tRNA. As for the 
data fitting in this study, the rate constant for E-site tRNA release is assumed as  
  71 
kr = A’exp(m∆Gc/RT). The presence of an SD-like sequence will result in a larger A’ 
and therefore result in a higher rate of E-site tRNA release, paving the way for +1 PRF 
in E. coli as described in Model 2. Secondly, the SD:antiSD interaction may 
destabilize the ribosome complex, yielding unstable complex E’0P’0, which can 
directly interact with +1 frame aa-tRNA as described in Model 1A.   
 
Stimulatory elements have also been found in the Ty3 and OAZ1 +1 PRF signals in 
yeast, and their effects also depended on strict spacing from the sites of frameshifting 
[6,36]. However, there is not yet any direct experimental evidence demonstrating the 
effect of E-site destabilization in Ty1 and Ty3 frameshifting. The prokaryotic 
ribosomal structure suggests that although there is no direct contact between E-site 
tRNA and P-site tRNA in the ribosome, the E-site tRNA might interact indirectly with 
the P-site tRNA through the 16S rRNA [37-39]. In agreement with these observations, 
our model of +1 PRF suggests that E-site tRNA dissociation might destabilize the 
mRNA ribosome interactions and affect the P-site tRNA slippage. Thus, ribosomes 
with an empty E-site may be more prone to slip. 
 
4.7.3 Role of the P-site  
The computational modeling shows that for small values of ks (ks=0.05 s-1), the effects 
of hungry codons in the A-site, and of rates of E-site tRNA release on FS% are less 
significant, thus demonstrating that P-site tRNA slippage is the dominant factor for +1 
PRF in E. coli. As illustrated in Figure 4.1, the efficiency of +1 PRF is determined by 
two competing reaction branches: 1) zero-frame aa-tRNA selection followed by 
peptidyl transfer (PT), and 2) P-site tRNA slippage to the +1 frame, which is 
subsequently trapped by aa-tRNA selection and PT. The rate constant of slippage, ks 
depends on the stability of the P0 and P1 states. In other words, the analysis presented 
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here indicates that the less stable P0 and more stable P1 (which gives higher ks) should 
result in higher FS%. This is consistent with the previous experimental observations. 
Curran [9] showed that among 32 polynucleotides differing only in their P-site, tRNAs 
that form more cognate interactions with the +1 frame in the P-site had a 1000-fold 
increase in frameshift proteins than tRNAs mispairing with the +1 frame. Other 
factors such as wobble base modification and tRNA hypomodification have been 
shown to weaken base-pairing and stimulate tRNA slippage in the P-site [29,40-41]. It 
has also been suggested that features of tRNA structure outside of the anticodon 
contribute to the P-site stability and the ability to shift reading frames [42-44]. 
Moreover, in yeast, a mutant form of ribosomal protein L5 (RPL5) that promoted 
decreased ribosomal affinity for peptidyl-tRNA also promoted increased +1 PRF at a 
Ty1 signal [45].  
 
The rate constant for P-site tRNA slippage has not been previously reported in the 
literature. Our kinetic model combined with experiments using different E-site 
interactions provides an approach to estimate ks. Fitting the experimental data for RF2 
frameshifting sequence (CUU U sequence in the P-site) yielded a rate constant of 
slippage ≈ 1.9 s-1. The small magnitude of ks, as compared to other rate constants in 
the model, is consistent with the idea that the slippage is the rate-limiting reaction in 
the +1 PRF mechanism.  
 
4.7.4 Role of the A-site 
Our model suggests that in the presence of a slippery P-site, a low availability of 
cognate aa-tRNA for zero frame (cog.A0) can enhance FS% by about two fold (Figure 
4.3.a and 3C). A low concentration of cognate tRNA at the A-site (hungry codon) has 
been experimentally observed to promote frameshifting [46], consistent with the 
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model. We believe that the low availability of the zero frame cognate aa-tRNA 
(cog.A0) can affect +1 PRF in two ways. First, the low availability of cog.A0 slows 
down translation, which allows more time for the kinetically-driven +1 PRF event to 
take place. Secondly, the low availability of cog.A0 increases the chance for the near-
cognate tRNA to bind to the A-site. During the elongation cycle, both cognate and 
near-cognate tRNAs compete for the A-site. Since a near-cognate tRNA has more 
chances to be rejected after the codon recognition step or GTP hydrolysis step than the 
cognate tRNA, a low concentration of cognate tRNA is more likely to result in the 
ribosomes containing only P-site tRNA (P0), thus enhancing the probability of 
slippage. In support of this, studies in yeast show that mutants that only affect A-site 
affinities for aa-tRNAs do not affect +1 PRF efficiency [47,48].  
 
4.7.5 +1 PRF in eukaryotes 
The rate constants used in this study are based on data obtained using E. coli 
ribosomes. The finding of synergistic effects among E-, P-, and A-site interactions on 
+1 PRF is likely to be applicable to Ty1 expression in yeast and antizyme expression 
in mammalian cells. However, owing to differences in aa-tRNA abundance and 
ribosome structures between prokaryotes and eukaryotes, eukaryotic +1 PRF signals 
were not tested in the present study. For Ty3 frameshifting in yeast, it is suggested that 
a special P-site interaction may interfere with the binding of in-frame aa-tRNA and 
stabilize out-of-frame decoding [6]. According to our model, this observation suggests 
the possibility that a special tRNA interaction in the P-site may change k1s. It is also 
likely that the Ty3 mechanism includes another reaction pathway for P0 to directly 
interact with a +1 frame aa-tRNA ternary complex. We believe that a quantitative 
kinetic model, similar to our current model, can be built for Ty3 frameshifting in yeast 
to understand this unique frameshifting process better. 
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4.8 Supplementary data 
From the mechanism (Figure 4.1), the formation rate of each component can be 
written as the following:  
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By assuming steady state, the formation rates of the intermediates equal to zero. The 
expressions of non-frameshifed (P0A0) and frameshift proteins (P1A1) in terms of E0P0 
are solved by Matlab V7.2 (MathWorks Inc., USA). Frameshift efficiency has been 
defined as: 
Frameshift Efficiency (FS %) =  %100
1100
11 ×
+ APAP
AP
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Table 4.S1 The rate constants for different steps at 20oC. The rate constants used in the 
model equal to the rate constant at 20 oC times the fold change from 20oC to 37oC 
(Table 4.S2). 
 
 Rate constants(s-1) 
Step  Symbols 
 Cognate  Near-cognate 
Initial binding  k1, k1s  110a,b  110a,b 
   k
-1, k-1s  25a  25a 
Codon Recognition  k2, k2s  100 a  100 a 
   k
-2, k-2s  0.2 a  80 a 
GTPase activation and GTP hydrolysis*  k3, k4 
 k3s, k4s  260
 a
  0.4 a 
EF-Tu conformational change 
(dissociation)  k5, k5s  60
 a
  70 a 
tRNA rejection  k6, k6s  0.3 a  6 a 
Accommodation  k7, k7s  7 a  0.1 a 
E-tRNA, P-tRNA slippage  kse,   0.01c 0.01 c 
  k
-se  0.01 c 0.01 c 
E-tRNA, P-tRNA destabilization  ksd 1 c 1 c 
   k
-sd 100 c 100 c 
P-tRNA slippage  ks  0.05-5 d 0.05-5d 
  k
-s 5 c 5 c 
E-tRNA release  kr 1-100 d 1-100 d 
 
a Rodnina et al., 2005 [19]. 
b
 µM-1s-1 
c Assumed values in the model 
d
 Assumed range of values in the model 
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Table 4.S2 The activation energy for different steps in the model and the fold change 
of the rate constants (k310K/k293K, from 20oC to 37oC). 
     
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Rodnina et al. 1996 [49].  
b
 Thompson et al. 1980 [50]. 
c
 Gromadski et al. 2006 [51]. 
d
 Karim et al.1986. [52] 
e
 Assumed values in the model 
 
 Ea (kJ/mol) k310k/k293k 
k1, k1s 10 ± 6a 1.25 
k
-1, k-1s 46 ± 5 a 2.82 
k2, k2s 38 ± 8a 2.36 
k
-2c, k-2s 44 ± 5 a 2.7 
k
-2nc 38e 2.36  
k3c, k3s 55b 3.45 
k3nc 55b+15c 4.85 
k4c, k4s 55b 3.45 
k4nc 55b+15c 4.85 
k5c, k5s 155 d 33  
k5nc 155 d 33  
k6c, k6s 55 e 3.45  
k6nc 55 e -8 e 2.88  
k7c, k7s 55 e 3.45  
k7nc 55 e +8c 4.13  
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Table 4.S3 The concentration of the components used in the model  
Components Symbols Parameter values 
Initial reactant  E0P0 1a 
Cognate zero-frame aa-tRNA cog.A0 (%) 0.1-10b 
Near cognate zero frame aa-tRNA nc.A0 (%) 19.9-10b 
+1 frame aa-tRNAb A1 (%) 10c 
 
a
 Assumed value in the model (µM). 
b
 Assumed range of values in the model. We assume that the total concentration of the 
near cognate aa-tRNA and the cognate aa-tRNA for a particular codon equals to 20% 
of the total aa-tRNA pool, i.e. nc.A0 + cog.A0 = 20%.  
c
 Assumed value in the model. We assume that the +1 frame A-site is always a non 
hungry codon and the corresponding aa-tRNA is always cognate. 
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Table 4.S4 Optimum parameter values for calculating kr obtained from data fitting. 
kr is calculated as kr=A’exp(-m∆Gc/RT). From data fitting, pre-exponential factor A’ 
is obtained to be 135 s-1 and modifying factors are listed as the following.  
 
E-site codon tRNA Modifying factor 
Parameter 
values 
UAU tRNAQTATyr m1 2.18 
UAC tRNAQTATyr m1 2.18 
UCA tRNAcmo5UGASer m2 0.66 
UCC tRNAGGASer - 1.00a 
UCG tRNACGA
Ser
 
tRNAcmo5UGASer m2 0.66 
UCU tRNAGGA
Ser
 
tRNAcmo5UGASer m2 0.66 
UUA tRNAUAALeu m3 0.41 
UUG tRNACAALeu m3 0.41 
UUU tRNAGAAPhe m4 0.85 
UUC tRNAGAAPhe m4 0.85 
UGU tRNAGCACys m5 0.59 
UGC tRNAGCACys m5 0.59 
UGG tRNACCATrp m6 0.53 
 
 
aUCC is read by tRNA without modification at either position 34 or position 37. Thus 
we assume modifying factor for tRNAGGACys equals 1.  
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4.9 Conclusion 
A detailed kinetic model for +1 PRF in E. coli has been presented and the effect of E-
site stabilities on +1 PRF has been experimentally demonstrated. According to the 
model results, a combination of stimulatory signals leading to the release of deacylated 
tRNA in the E-site, tRNA slippage in the P-site, and the hungry codon effect in the A-
site synergistically promote efficient +1 ribosomal frameshifting. The experimental 
result suggested that weaker codon:anticon interactions in the E-site correlate with 
higher +1 PRF efficiency in E. coli. Our mathematical analysis shows that the rate of 
P-site tRNA slippage is the dominant factor, while the effect of hungry codon in the 
A-site and E-site tRNA destabilization further enhance +1 PRF. We propose that E-
site empty ribosomes, which facilitate the P-site tRNA slippage, is the driving force 
for +1 PRF. 
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CHAPTER 5 
FSSCAN: A MECHANISM-BASED PROGRAM TO IDENTIFY +1 RIBOSOMAL 
FRAMESHIFT HOT SPOTS 
 
5.1 Preface 
This chapter is adapted from Liao, P.Y., Choi, Y.S., Lee, K.H. 2009 FSscan: a 
mechanism-based program to identify +1 ribosomal frameshift hotspots. Nucleic Acids 
Research, doi:10.1093/nar/gkp796. Motivated by the result from Chapter 3, a 
bioinformatic program is developed to detect +1 programmed ribosomal frameshifting 
hotspots in the Escherichia coli genome. Candidate sequences identified by the 
program showed higher frameshift efficiency compared to a randomly design 
sequence in vivo.   
 
5.2 Abstract 
In +1 programmed ribosomal frameshifting (PRF), ribosomes skip one nucleotide 
toward the 3' end during translation. Most of the genes known to demonstrate +1 PRF 
have been discovered by chance or by searching homologous genes. Here, a 
bioinformatic framework called FSscan is developed to perform a systematic search 
for potential +1 frameshift sites in the Escherichia coli genome. Based on a current 
state of the art understanding of the mechanism of +1 PRF, FSscan calculates scores 
for a 16-nucleotide window along a gene sequence according to different effects of the 
stimulatory signals, and ribosome E-, P-, and A-site interactions. FSscan successfully 
identified the +1 PRF site in prfB and predicted yehP, pepP, nuoE and cheA as +1 
frameshift candidates in the E. coli genome. Empirical results demonstrated that 
potential +1 frameshift sequences identified promoted significant levels of +1 
frameshifting in vivo. Mass spectrometry analysis confirmed the presence of the 
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frameshift proteins expressed from a yehP-egfp fusion construct. FSscan allows a 
genome-wide and systematic search for +1 frameshift sites in E. coli. The results have 
implications for bioinformatic identification of novel frameshift proteins, ribosomal 
frameshifting, coding sequence detection, and the application of mass spectrometry on 
studying frameshift proteins.  
 
5.3 Introduction 
Translation is a highly accurate process. The frequency of decoding error is estimated 
to be on the order of 10-5 per codon [1]. Programmed ribosomal frameshifting (PRF) is 
a coded shift in the reading frame during translation. Consequently, mRNAs with PRF 
features may yield two different protein products, an inframe product and a frameshift 
product. In +1 PRF, the ribosome skips over one nucleotide toward the 3' direction. As 
of September 2009, 88 cases of +1 PRF have been found in different organisms in the 
RECODE database [2]. +1 PRF has been observed to occur during the translation of 
prfB to produce release factor 2 (RF2) in Escherichia coli [3]. In Saccharomyces 
cerevisiae four retrotransposable elements, Ty1, Ty2, Ty3, and Ty4 [4-6], and three 
genes, ABP140 [7], EST3 [8], and OAZ1 [9] use +1 PRF. The expression of 
mammalian antizyme has also been shown to involve +1 PRF [10].  
 
A genome-wide prediction of +1 frameshift sites is currently a difficult task because 
the sequence elements for +1 frameshifting are diverse among the organisms. To date, 
most of the known genes involving +1 PRF have been discovered by chance, and in 
some cases, by searching homologous genes. Several computer programs have been 
developed to identify +1 frameshift sites [11-12]. Shah et al. [11] hypothesized that 
selective pressure would have rendered potential frameshift sites under-abundant in 
protein coding sequences. In this study, a computer program was developed to identify 
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oligos that are over- or under-represented for reasons other than codon bias. Their 
result suggested that the heptanucleotides CUU AGG C and CUU AGU U, +1 PRF 
sites for the production of ABP140 and EST3, respectively, rank among the least 
represented of the heptanucleotides in the coding sequence of S. cerevisiae. While the 
approach is able to identify novel sequences, this method did not account for 
stimulatory signals. The program “FSFinder” by Moon et al. [12] used known 
components of a frameshift cassette for predicting both -1 and +1 PRF sites. This 
method achieves a high sensitivity and a high specificity (0.88 and 0.97, respectively) 
for predicting +1 PRF. However, FSFinder does not predict novel +1 frameshift sites 
in E. coli. A novel antizyme gene, whose expression requires +1 frameshifting, was 
found in the zebrafish Danio rerio by a protein BLAST search against the translated 
nucleotide database of the known antizyme family sequence [13]. While the method 
successfully identified novel genes requiring +1 frameshifting, the approach is limited 
to the antizyme family in eukaryotic cells. 
 
Recently, a mathematical model revealed that destabilization of the deacylated tRNA 
in the ribosomal E-site, rearrangement of the peptidyl-tRNA in the ribosomal P-site, 
and availability of the cognate aminoacylated tRNA (aa-tRNA) corresponding to the 
ribosomal A-site act synergistically to promote efficient +1 PRF in E. coli [14]. 
Motivated by this result, one might identify potential +1 frameshift sites in the E. coli 
genome by searching sequences with a combination of stimulatory, E-, P-, and A-site 
features. In this study, FSscan is developed to perform a systematic and genome-wide 
search for potential +1 frameshift sites in E. coli. Based on a current state of art 
understanding of the mechanism of +1 PRF, FSscan looks for a 16-nucleotide 
sequence with possible synergistic effects in the E. coli genome. Potential +1 
frameshift sequences so identified are shown to promote significant levels of +1 
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frameshifting in vivo. The mass spectrometry data obtained from a multiple reaction 
monitoring assay (MRM), a specific and sensitive mass scan method [15], 
experimentally confirms the expression of the predicted frameshift protein. 
Importantly, current methods of coding sequence detection generally do not take into 
account the shift of the reading frames and only a few algorithms assign a frameshift 
as a possible regulatory process [16]. FSscan presented in the study provides an 
algorithm to predict potential +1 frameshift products in E. coli.  
 
5.4 FSscan algorithm 
FSscan is developed in Python (v2.4.3, Python Software Foundation, Hampton, NH) 
to search for potential +1 frameshift sites in the E coli genome. The program assigns 
scores for a 16-nucleotide window along a gene sequence according to different 
effects of the stimulatory signals (S score) and interactions of the E-, P-, and A-site in 
the ribosome (E, P, and A scores, respectively) (Figure 5.1). A stimulatory signal in E. 
coli for +1 PRF can be a Shine Dalgarno (SD) - like sequence upstream of the 
frameshift site [17]. FSscan assigns zero to the S score if less than four base pairings 
can be formed between the six nucleotides upstream of the E-site position and the anti-
SD sequence (3’UCCUCC5’); otherwise, FSscan assigns the number of base pairings 
divided by three to the S score (Eq.1).  
 
(Number of base pairings with UCCUCC) < 4, S = 0                                                                           
(Number of base pairings with UCCUCC)≥ 4, S = (Number of base pairings with UCCUCC)/3         
 
Sanders et al., [18] suggested that zero frame condon:anticodon interactions in the E-
site can affect frameshifting. The E score is calculated as exp (-∆Gc), where ∆Gc is the 
codon:anticodon interaction [19] in the ribosome E-site. For the P-site, both zero 
Eq.1 
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frame and +1 frame interactions can influence +1 frameshifting [20]. The P score in 
the program represents the stability difference between the zero frame and the +1 
frame interactions for the P-site tRNA, normalized with the maximum stability 
difference obtained among 256 possible P-site sequences (Supplementary Data). The 
A score is the combination of the A0 score and the A1 score. The A0 score is the ratio 
of the arrival frequency, on the basis of transport by diffusion, of the near-cognate aa-
tRNA versus the cognate aa-tRNA corresponding to the zero frame A-site codon [21], 
normalized with the maximum ratio of the arrival frequency obtained among 64 
possible zero frame A-site codons.  The A1 score is the ratio between the 
concentration of the cognate aa-tRNA for the +1 frame A-site codon to that of the 
cognate aa-tRNA for the zero frame A-site codon [21], normalized with the maximum 
concentration ratio obtained among 256 possible A-site sequences. For a stop codon in 
the zero frame A-site, the A0 and A1 scores were set to be 0.9 for TAG and TGA, and 
0.6 for TAA. If the summation of the E, P, and A scores is less than three, the S score 
is then reset to zero (Eq. 2).  
 
E + P + A < 3, S = 0, for any number of base pairings with UCCUCC          Eq.2 
 
Eq. 2 has a higher priority than Eq. 1, which means, as long as the summation of the E, 
P, and A score is less than three, the program assigns zero to the S score no matter 
how many base pairings can be formed between the mRNA sequence and the anti-SD 
sequence. The frameshift index (FSI) for a 16-nucleotide window is calculated as Eq. 
3.  
 
Frameshift Index (FSI) = S + E + P +A                          Eq.3 
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Figure 5.1. The scoring system for FSscan program. FSscan calculates scores for a 16-
nucleotide window along the gene sequence. Each step is 3 nucleotides. FS index 
(FSI) = S + E + P +A. 
 
1 step = 3 bases
E P AS
FSI = S + E + P + A ; A = A0+A1
S score is based on the number of base pairings with anti-Shine Dalgarno sequence.
E score is based on the tRNA:mRNA interaction in the E-site. 
P score is based on the stability difference between the zero frame and the +1 frame 
interactions in the P-site.
A score is based on (1) the competition between the near-cognate aa-tRNA versus 
the cognate aa-tRNA for the zero frame A-site codon (A0 score) (2) the competition 
between the cognate aa-tRNA for the +1 frame A-site codon and the cognate aa-tRNA
for the zero frame A-site codon (A1 score).  
mRNA
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A higher FSI suggests the sequence contains more features for +1 frameshifting. It is 
important to note that FSI is not set for quantitatively predicting the level of the +1 
frameshifting, but rather how likely a sequence is a frameshift site. 
 
5.5 Materials and methods 
5.5.1 Plasmids and bacterial strains 
Escherichia coli XL1 blue MRF’ (Stratagene, La Jolla, CA) was used in all 
experimental studies. All constructs were verified by DNA sequencing. The 
construction of the dual fluorescence reporter was performed as described previously 
[14]. The control strain has both DsRed and enhanced green fluorescence protein 
(EGFP) coding sequences in frame. For the test strain, the linker sequences inserted 
between the two reporters contained predicted frameshift sequences followed by an in-
frame stop codon and the downstream egfp in the +1 frame. The control strain 
expressed the DsRed-EGFP fusion protein from the reporter. The test strains 
expressed DsRed proteins as non-frameshift proteins (due to the stop codon in the 
linker sequence) and DsRed-EGFP fusion protein as frameshift proteins (because the 
stop codon is bypassed by +1 frameshifting). Table 5.1 lists the nucleotide sequences 
incorporated into the dual fluorescence reporter for testing +1 frameshift efficiency in 
vivo in this study. A negative control strain, ran1, was transformed with a plasmid 
containing a randomly designed linker (rand) inserted between the two fluorescence 
reporters with egfp in the +1 frame. 
 
The first 915 nucleotides in yehP were PCR-amplified with the forward primer, yehPf, 
5’-AAACTGCAGAATGTCTGAACTGAACGATCTTCTG -3’ (PstI site underlined) and 
two reverse primers, yehPr0 5’-ATTGGTACCACGAGGATAATGACGCTTTTCGCTGG-
3’ and yehPr1 5’ATTGGTACCCACGAGGATAATGACGCTTTTCGCTGG -3’ (KpnI site 
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underlined) using E. coli genomic DNA as a template. The PstI/KpnI restricted PCR 
products were ligated with a PstI/KpnI-restricted pEGFP (Clontech, Mountain View, 
CA) vector to yield pYehP0 (using yehPr0 as the reverse primer for PCR) and pYehP1 
(using yehPr1 as the reverse primer for PCR). The predicted frameshift sequence in 
pYehP1 was mutated by using QuikChange II site-directed mutagenesis kit 
(Stratagene) to create pYehPC. BsrGI/EcoRI restricted pYehP0, pYehP1, and pYehPC 
were ligated with a nucleotide sequence, 5’-
GTACAAGCATCATCATCATCATCATTAAG-3’, to create pYehP20, pYehP21, and 
pYehP2C to add a 6X-histidine tag downstream of egfp. KpnI/NcoI restricted 
pYehP20, pYehP21, and pYehP2C were ligated with a nucleotide sequence, 5’-
CGTCTAGCTCTGGCTCTGGCTCTGGCAC-3’, to create pYehP40, pYehP41, and 
pYehP4C to incorporate an in-frame stop codon and a flexible linker between yehP 
and egfp. E. coli strains transformed with pYehP40, pYehP41, and pYehP4C are 
named yehP40, yehP41, and yehP4C, respectively.  
 
5.5.2 Fluorescence assay 
Cells with the appropriate plasmids were cultured in 1 ml Luria-Bertani (LB) medium 
containing 100 µg/ml ampicillin in a 24-well plate for 24 hours at 37oC. The 
fluorescence was then measured by a plate reader (SpectraMax M5, Molecular 
Devices, Sunnyvale, CA). The fluorescence measurement was performed as described 
previously [14]. Frameshift efficiency (FS%) was obtained as the ratio of the green 
fluorescence to the red fluorescence for the test strains, normalized against the 
fluorescence ratio of thecontrol strain. Statistical analysis was applied to all datasets 
according to Jacobs et al., [22]. Eleven to twelve replicates for test strains and control 
strains were performed to satisfy the minimum sample requirement for statistical 
significance.  
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Table 5.1 Nucleotide sequences incorporated into the dual fluorescence reporter 
system for testing +1 frameshift efficiency in vivo in Chapter 5. yehP, nuoE, pepP, 
cheA, ygcH, and yeaI are the top ranking candidates identified by FSscan. glnD, yjgN, 
and cysD are selected genes with one or two frameshifting features. rand is a 
randomly designed sequence to serve as a negative control.    
 
Original 
Gene 
16-nucleotide window with max FSI in 
the gene (the P-site position is underlined) 
Strain (transformed with 
corresponding reporter 
plasmids) 
yehP GTG GAG TAT GGT CGG C yehP6 
nuoE GAG CGG TAT AAA TGA A nuoE6 
pepP AGT GAG ATA TCC CGG C pepP6 
cheA AGT CGC TAT CCC CGG C cheA6 
ygcH CCA CTC TAT TTT CGG C ygcH6 
yeaI AAT ATT TAT AAT CGG C yeaI6 
pspD CAG CGT TAT AAA AGG T pspD6 
glnD GGT GGG ATA AAA GCC C glnD6 
yjgN GAG AGA TAT TTT CTT A yjgN6 
cysD CAG GGG TAT TTT TAA G cysD6 
rand TCT GGC TCT GGC TGA G ran1 
yehP GTG GAG TTA GGT CGG C  
(mutated sequence shown in bold) 
yehP7 
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5.5.3 Western analysis 
Cells with the appropriate plasmids were cultured in 3 ml LB medium containing 100 
µg/ml ampicillin in 17 ml round bottom tubes at 37oC. Aliquots of cells were 
harvested after 24hr cultivation and pelleted by centrifugation for 20 min at 4 oC and 
4,000×g. The cell pellet was resuspended in 50 µl phosphate buffered saline per 
OD600 and resolved by SDS-PAGE (10% w/v) using Tris-HCl. Immunoblot was 
performed as described by Gupta et al. [23], except rabbit anti-GFP (1:5000, Clontech) 
and alkaline phosphatase conjugated mouse anti-rabbit IgG antibody (1:10,000; Sigma, 
St. Louis, MO) were used as the primary and secondary antibodies, respectively.  
 
5.5.4 Protein digestion 
yeh41 cell lysate was purified by Ni-NTA under denaturing conditions according to 
the manufacturer’s protocol (Qiagen, Valencia, CA). The purified protein sample was 
exchanged into 0.2 M ammonium bicarbonate using Amicon Ultra 10 kDa molecular 
cutoff filter (Millipore, Billerica, MA). The buffer-exchanged sample was denatured 
and reduced by 6 M urea and 200 mM dithiothreitol (DTT) at room temperature for an 
hour. Then, the sample was alkylated by 200 mM iodoacetamide at room temperature 
for an hour in the dark. The remaining iodoacetamide in the sample was quenched by 
200 mM DTT at room temperature for an hour and the sample was digested by trypsin 
(Promega, Madison, WI) at 37 oC for 14 hours. The digestion was stopped by 
decreasing the pH of the solution with 88% formic acid (FA) and vacuum dried, and 
the digested sample was reconstituted with 25 µL of 0.1% FA. 
 
5.5.5 Liquid chromatography tandem mass spectrometry (LC-MS/MS) 
1.2 µL of the digested sample was separated by Dionex 3000 nLC system (Sunnyvale, 
CA) with an Acclaim PepMap 100 C18 trap column (300 µm × 5 mm, 5 µm, for the 
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on-line desalting at a flow rate of 30 µL/min for 3 minutes) and an Acclaim PepMap 
100 C18 analytical column (75 µm × 15 cm, 3 µm) at a flow rate of 250 nL/min. 
Peptides were eluted with gradients of 2-90% acetonitrile with 0.1% FA and the eluent 
was directly introduced into 4000 QTRAP MS through Nanospray II source (Applied 
Biosystems, Foster City, CA) for MRM study. To determine the appropriate MRM 
transitions that would be specific to the peptide of interest, the frameshift protein 
sequence was imported into the MIDAS Workflow software system (Applied 
Biosystems). The software generates a list of possible MRM transitions (Table 5.S2), 
including mass to charge ratios of precursor ions, fragment ions, and collision energy 
values for fragmentation. MS and MS/MS data obtained through MRM were searched 
within a custom sequence database that included the addition of the frameshift protein 
sequence. The spectral assignment of MS/MS were performed using ProteinPilot (v1.2 
Applied Biosystems). 
 
5.6 Results 
5.6.1 FSscan identifies a +1 frameshift hot spot in prfB gene 
FSscan successfully identifies the +1 framshift site in prfB. Figure 5.2 shows the FSI 
along the prfB gene sequence. The FSI is at maximum when the ribosome P-site is 
positioned at the 25th codon in the coding sequence, the frameshift site for prfB in the 
literature [3].  
 
5.6.2 Analysis of 4132 protein coding sequences in the E. coli genome reveals 
additional potential +1 frameshift candidates 
To identify potential +1 framshifting sites, FSscan analyzed 4132 protein coding 
sequences in E. coli K12 MG1655 genome (Genbank: U00096). Because the FSI 
calculation requires an additional nucleotide downstream of the A-site codon, the 4132 
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Figure 5.2. FSscan identifies the +1 frameshift site in prfB. A peak FSI is observed as 
the ribosome P-site is positioned at the 25th codon. 
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coding sequences were adjusted to include one more nucleotide downstream of the 
stop codon. The maximum FSI obtained in each protein coding sequence is plotted in 
Figure 5.3. prfB, whose expression has been shown to involve +1 PRF [3], has the 
highest FSI among all tested coding sequences (maximum FSI in prfB = 5.05). The 
next four highest ranking genes are yehP, nuoE, pepP, and cheA, with a maximum FSI 
4.47, 4.39, 4.39, and 3.54 in their coding sequences, respectively. The potential +1 
frameshift sequences in these genes are listed in Table 5.1. None of these candidates 
have been reported by previous approaches to identify +1 PRF genes [11, 12]. The 
other 4127 protein coding sequences all have a maximum FSI lower than 3.50.  
 
5.6.3 In vivo examination of +1 frameshift sequences agrees with the program 
predictions 
Several +1 frameshift candidates were examined in vivo by using a dual fluorescence 
reporter system. A randomly designed sequence with FSI=1.70 (rand, Table 5.1) was 
constructed to serve as a negative control strain (see Materials and Methods). Potential 
frameshift sequences from yehP, nuoE, pepP, and cheA resulted in FS% significantly 
higher than rand (Figure 5.4). A lower FS% was observed for sequences with FSI less 
than 3.5, suggesting that FSI 3.5 may serve as a threshold for identifying potential 
frameshift cassettes. 
 
5.6.4 FSscan identifies yehP as a +1 frameshift candidate 
yehP contains a potential +1 frameshift sequence with the second highest FSI, only 
after prfB. The predicted frameshifting sequence is GTG GAG TAT GGT CGG C 
(where each zero frame codon is separated by a space and the P-site position for 
obtaining the maximum FSI is underlined). In this sequence, an ATG in the +1 frame 
(shown in bold in the sequence above) together with an upstream GGAG may result in 
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Figure 5.3. Maximum FSI in each of the 4132 E. coli protein coding sequences. Five 
genes with a maximum FSI above 3.5 are indicated in red. prfB has the maximum FSI 
5.05. yehP has the maximum FSI 4.47. nuoE has the maximum FSI 4.39. pepP has the 
maximum FSI 4.39. cheA has the maximum FSI 3.55.   
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Figure 5.4 Frameshift efficiency (FS%) for potential frameshift sequences identified 
by FSscan. The histogram indicates the experimentally observed FS% for different test 
strains listed in Table 5.1. Error bars show the standard deviation. Diamonds 
demonstrate the program calculated FSI for the potential frameshift cassettes 
(sequences are shown in Table 5.1).  
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internal translation, causing non-frameshifting based EGFP expression in the dual 
reporter system. To further confirm yehP as a candidate +1 PRF gene, the sequence 
was mutated to GTG GAG TTA GGT CGG C (mutation shown in bold) to remove 
ATG in the +1 frame while keeping a weaker E-site interaction (yehP7 in Table 5.1). A 
small decrease in FS% was observed (Figure 5.5), but the mutation still resulted in a 
significantly higher FS% as compared to the negative control strain, ran1 (Figure 5.4). 
This observation suggests that the higher FS% for yehP6 is not likely due to the 
internal translation of EGFP starting from the linker sequence.  
 
To study the frameshift site in yehP, the fusion constructs yehP40, yehP41, and 
yehP4C were made with egfp 3’ to yehP (Figure 5.6a). Proteins from cell lysate were 
subjected to Western analysis. Protein bands with molecular weight 63 kDa, the 
expected mass for the fusion protein, were observed for yehP40 and yehP41. 
Interestingly, no or very few proteins with this mass were observed when the potential 
frameshift sequence was mutated to GTG GAG TCT TGT CGA C to remove 
frameshifting features (yehP4C, mutated nucleotides shown in bold) (Figure 5.6a and 
6b). The result suggests that the +1 frameshift event is specific to the predicted 
sequence. 
Proteins from yehP41 cell lysate were purified, buffer-exchanged and digested by 
trypsin. The digest was analyzed by liquid chromatography tandem mass spectrometry 
(LC-MS/MS) using multiple reaction monitoring (MRM). MRM is a highly sensitive 
scanning technique for peptide identification. The greater specificity is achieved by 
fragmenting the analyte and monitoring both parent and one or more product ions 
simultaneously (see review by Kitteringham et al., [24]). Figure 5.7 presents the 
amino acid sequence derived from the frameshift site and the tryptic peptides observed 
by MRM. The presence of the peptide VQLGGGTNIASAVEYGGNLLNNQR (Figure 
  102 
5.S3 in the Supplementary Data), whose coding sequence spans the potential 
frameshift site, is a result of the +1 frameshifting at the 291st codon, GTT CGG C 
(where the P-site position is underlined), in yehP. This result further confirms the 
frameshift site in yehP, as suggested by FSscan.  
 
For +1 frameshifting at the 291st codon in yehP, the ribosome encounters a stop codon 
15 codons downstream of the frameshift site. As a result, the frameshift product is 303 
amino acids in length, which is 75 amino acids shorter than the non-frameshift yehP 
product. Importantly, yehP is highly conserved in different E. coli strains and is also 
observed in several other eubacteria (Table 5.2). The consensus of the yehP frameshift 
cassette for the 31 sequences in Table 5.2 is shown by a sequence logo (Figure 5.8) 
[25, 26]. Only a minor diversity is observed at position 1, 6, 12, and 14 in the 16-
nucleotide frameshifting window.  
 
5.7 Discussion 
5.7.1 The scoring system 
In FSscan, the S score represents the stimulatory effect on +1 frameshifting. FSscan 
assigns zero to the S score for less than four base pairings between the six nucleotides 
upstream of the E-site and the anti-SD sequence (Eq.1). Eq.1 implies that at least four 
base pairing between mRNA and the anti-SD sequence are required to reveal the 
stimulatory effect. FSscan identifies yehP as the second best candidate for +1 
frameshifting by using four as a threshold value in Eq.1, while the program identifies 
cheA as the second best candidate by using five as a threshold value. The in vivo 
observation that yehP6 results in higher frameshift efficiency than cheA6 (Figure 5.4) 
suggests that four base pairings could be sufficient to induce a stimulatory effect. In 
addition, FSscan assigns zero to the S score if the summation of the E, P, and A scores 
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Figure 5.5. Frameshift efficiency (FS%) for yehP6 and yehP7. In yehP6, the linker 
inserted between the two fluorescence reporters contains the predicted yehP frameshift 
sequence: GTG GAG TAT GGT CGG C. In yehP7, the frameshift sequence is 
mutated to GTG GAG TTA GGT CGG C (where zero frame codons are separated 
by spaces).   
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Figure 5.6. (a) The nucleotide sequence design for yehP40, yehP41, and yehP4C. (b) 
Western blot for the cell lysate to detect the frameshift protein. Lane 1: total lysate 
from yehP40. Lane 2: total lysate from yehP41. Lane 3: total lysate from yehP4C. The 
amount of the protein loaded for yehP40 is one third of the amount of the protein for 
yehP41 and yehP4C. 
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Figure 5.7. Nucleotide and amino acid sequence for the YehP-EGFP frameshift 
protein in yehP41. (a) The nucleotide and amino acid sequence for the predicted 
frameshift region in YehP-EGFP. The predicted frameshift sequence is shown in bold, 
with the P-site codon underlined. The zero frame and the +1 frame amino acid 
sequences are shown under the nucleotide sequence. The peptide spanning the 
frameshift site, with the zero frame translation before the site and the +1 frame 
translation after the site, is shown in red. (b) Amino acid sequence for the frameshift 
protein in yehP41 strain. The YehP-EGFP was expressed as a result of +1 
frameshifting. Tryptic peptides observed by MRM are marked in red (>95% 
confidence level). The sequence coverage is 21.7%. 
 
 
yehP                                                                                                                       
  
        ctcacggcagacgttgccgatccggtagagttattaatgaaagtacagttgggcggcggg 
         L  T  A  D  V  A  D  P  V  E  L  L  M  K  V  Q  L  G  G  G  
 accaatatcgccagtgccgtggagtatggtcggcaacttattgaacaaccagcgaaaagcg 
0 frame  T  N  I  A  S  A  V  E  Y  G  R  Q  L  I  E  Q  P  A  K  S  
+1frame                                 G  N  L  L  N  N  Q  R  K  A 
 
egfp (+1 frame)                                                                                                                              
(a)
(b)
MSELNDLLTTRELQRWRLILGEAAETTLCGLDDNARQIDHALEWLYGRDPERLQRGERSG 
GLGGSNLTTPEWINSIHTLFPQQVIERLESDAVLRYGIEDVVTNLDVLERMQPSESLLRA 
VLHTKHLMNPEVLAAARRIVCQVVEEIMARLAKEVRQAFSGVRDRRRRSFIPLARNFDFK 
STLRANLQHWHPQHGKLYIESPRFNSRIKRQSEQWQLVLLVDQSGSMVDSVIHSAVMAAC 
LWQLPGIRTHLVAFDTSVVDLTADVADPVELLMKVQLGGGTNIASAVEYGGNLLNNQRKA 
SLSSWVPSSSGSGSGTMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLT 
LKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDD 
GNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKV 
NFKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSALSKDPNEKRDHMVLLEF 
VTAAGITLGMDELYKHHHHHH- 
 
Red letters: peptides identified with confidence level higher than 95% from ProteinPilot 
Yellow background: peptides originated from YehP 
Black-outlined box: peptides spanning the frameshift site 
Blue background: peptides originated from EGFP 
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is less than three (Eq.2). Eq.2 implies that for a less prominent synergic effect of the 
E-, P-, and A-site for +1 frameshifting, the stimulatory effect by SD: antiSD 
interaction is negligible.  
 
The E score in the program represents the effect of E-site interaction on +1 
frameshifting. FSscan calculates the E score as exp (-∆Gc), where ∆Gc is the 
codon:anticodon interaction [19] in the ribosome E-site. The interaction in ribosome 
E-site has been shown to affect the reading frame maintenance [14, 18, 27-30]. 
Weaker codon:anticodon interactions in the ribosome E-site have also been observed 
to result in a higher +1 frameshift efficiency [14,18]. Notably, FSscan does not 
account for different tRNA:ribosome interactions in the E-site. While the 
tRNA:ribosome interactions are important for the E-site interaction, there has not been 
a well-established method to estimate these interactions. Previously, it has been 
suggested that a major fraction of the E-site tRNA binding is contributed by the 
binding of the 3’-terminal adenine to the ribosome [31]. Because the 3’-terminal 
adenine is conserved in all E. coli tRNAs, FSscan assumes a similar level of 
tRNA:ribosome interactions for different tRNAs and considers only codon:anticodon 
interactions in the E-site.  
 
The P score represents for the stability difference between the +1 frame and the zero 
frame interaction for the P-site tRNA. FSscan assumes the stability difference between 
the +1 frame and the zero frame interaction (∆ stability*) as M1S1- M2S0, where S1 is 
the stability of the +1 frame interaction, S0 is the stability of the zero frame 
interaction, and M1 and M2 are weighting factors. A separate data fitting program 
suggests M1 and M2 as 0.63 and 0.26, respectively, for the best linear correlation 
between the ∆ stability* and the logarithm of +1 frameshift efficiency observed by 
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Table 5.2 BLAST result for yehP. blastn was used as the algorithm to search the 
nucleotide collection database in National Center for Biotechnology Information’s  
website. The search was optimized for highly similar sequences. 
a
 maximum identities 
 
 
 
 
Accession Description Max 
score 
Total 
score 
Query 
coverage E value 
Max 
identa 
CP000948.1 Escherichia coli str. K12 substr. DH10B, complete genome 2254 2290 100% 0.0 100% 
AP009048.1 Escherichia coli str. K12 substr. W3110 DNA, complete genome 2254 2290 100% 0.0 100% 
U00096.2 Escherichia coli str. K-12 substr. MG1655, complete genome 2254 2290 100% 0.0 100% 
U00007.1 47 to 48 centisome region of E.coli K12 BHB2600 2254 2254 100% 0.0 100% 
CU928160.2 Escherichia coli str. IAI1 chromosome, complete genome 2119 2155 100% 0.0 100% 
AP009240.1 Escherichia coli SE11 DNA, complete genome 2095 2132 100% 0.0 100% 
CP000800.1 Escherichia coli E24377A, complete genome 2095 2132 100% 0.0 100% 
CP000036.1 Shigella boydii Sb227, complete genome 2095 2168 100% 0.0 100% 
AB426057.1 Escherichia coli O111:H- DNA, genomic island GEI2.21 2087 2087 100% 0.0 98% 
CP000034.1 Shigella dysenteriae Sd197, complete genome 2087 2160 100% 0.0 100% 
CP000946.1 Escherichia coli ATCC 8739, complete genome 2056 2092 100% 0.0 100% 
CP000802.1 Escherichia coli HS, complete genome 2032 2068 100% 0.0 100% 
AE005674.1 Shigella flexneri 2a str. 301, complete genome 1992 2065 100% 0.0 100% 
AE014073.1 Shigella flexneri 2a str. 2457T, complete genome 1992 2065 100% 0.0 100% 
AE014075.1 Escherichia coli CFT073, complete genome 1976 2085 100% 0.0 100% 
CU928164.2 Escherichia coli str. IAI39 chromosome, complete genome 1961 2033 100% 0.0 100% 
BA000007.2 Escherichia coli O157:H7 str. Sakai DNA, complete genome 1961 2033 100% 0.0 100% 
AE005174.2 Escherichia coli O157:H7 EDL933, complete genome 1961 2033 100% 0.0 100% 
CP001164.1 Escherichia coli O157:H7 str. EC4115, complete genome 1953 2025 100% 0.0 100% 
CP000970.1 Escherichia coli SMS-3-5, complete genome 1937 2009 100% 0.0 100% 
CU928162.2 Escherichia coli str. ED1a chromosome, complete genome 1913 2021 100% 0.0 100% 
FM180568.1 Escherichia coli 0127:H6 E2348/69 complete genome, 
strain E2348/69 1905 1977 100% 0.0 100% 
CU928161.2 Escherichia coli str. S88 chromosome, complete genome 1897 2006 100% 0.0 100% 
CP000468.1 Escherichia coli APEC O1, complete genome 1897 2006 100% 0.0 100% 
CP000243.1 Escherichia coli UTI89, complete genome 1897 2006 100% 0.0 100% 
CU928158.2 Escherichia fergusonii str. ATCC 35469T chromosome, 
complete genome 1850 1924 100% 0.0 95% 
CP000247.1 Escherichia coli 536, complete genome 1850 1958 100% 0.0 100% 
CU928163.2 Escherichia coli str. UMN026 chromosome, complete genome 1842 1914 100% 0.0 100% 
CU651637.1 Escherichia coli LF82 chromosome, complete sequence 1818 1926 100% 0.0 100% 
AP000400.1 Enterobacteria phage VT1-Sakai genomic DNA, prophage inserted region in  Escherichia coli O157:H7 1542 1542 81% 0.0 96% 
CP000038.1 Shigella sonnei Ss046, complete genome 603 675 29% 8e-169 100% 
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Figure 5.8. Sequence conservation of the predicted frameshift cassette in yehP. The 
sequence logo was generated by aligning 31 sequences in Table 5.2.  
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Curran (1993) [20] (Supplementary Data). The weighting factor for the +1 frame 
stability is 2.4-fold larger than that for the zero frame stability. Interestingly, zero 
frame duplexes are in general cognate but the realigned complexes contain a much 
wilder array of pairing and stabilities. Taken together, a favorable +1 frame interaction 
in the P-site may contribute more than an unsTable 5.zero frame interaction to a higher 
+1 frameshift efficiency.  
 
FSscan accounts for two A-site features that enhance +1 frameshifting: (1) the 
competition between the cognate and the near cognate aa-tRNA for the zero frame A 
site codon (A0 score); (2) the competition between the cognate aa-tRNA for the zero 
frame A-site codon and the cognate aa-tRNA for the +1 frame A-site codon (A1 
score). A ribosome pause because of a stop codon or a rare codon in the A-site is a key 
factor for +1 frameshifting [32, 33]. It has been shown that the competition between 
the near-cognate aa-tRNA and the cognate aa-tRNA to the ribosome A-site plays an 
important role on the translation rate [21]. The imbalance of the zero frame A-site 
tRNA and the +1 frame A-site tRNA was also shown to enhance +1 frameshifting 
[34]. Three +1 frameshift candidates, yehP, pepP and cheA, all have CGG C in the A-
site (where the zero frame codon is separated by the space). While the average A score 
is 0.44, the A score for CGG C is 1.58. CGG has one cognate tRNA, tRNAArgCCG, with 
639 molecules per cell, and four near-cognate tRNAs, tRNAArgACG, tRNAGlnCUG, 
tRNALeuCAG, and tRNAProCGG, with 4752, 881, 4470, and 900 molecules per cell, 
respectively [21]. The fact that near-cognate tRNAs outnumber cognate tRNAs for 
CGG results in a competition between these tRNAs for the ribosome A-site. In addition, 
the concentration of the cognate tRNA for the +1 frame A-site codon (GGC) is about 
seven-fold higher than that for the zero frame A-site codon (CGG). These two features 
may result in a longer pause during translation, making CGG C a likely A-site codon 
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for +1 frameshifting. The other candidate nuoE has TGA A in the A-site. The A score 
for TGA A is 1.8, which is also much higher than the average A score.  
 
FSI for a 16-nucleotide window sums up S, E, P, and A scores. The S score ranges 
from 0 to 2. The E score ranges from 0 to 1. The P score ranges from -1 to 1. The A 
score ranges from 0 to 2 because it combines A0 and A1, each ranging from 0 to 1. As 
a result, FSscan weighs the stimulatory, P-site, and A-site effects more than the E-site 
effect. This algorithm is supported by the kinetic model of +1 PRF, which suggested 
that +1 frameshift efficiency is more sensitive to the change in the stimulatory signal, 
P-site, and A-site effects [14]. 
 
5.7.2 Analysis of six reading frames and pseudogenes  
Analysis of the six reading frames of the E. coli genome by FSscan reveals that 192 
sequences have FSI higher than 3.5. 83 of these sequences are located in the annotated 
coding regions, but only five sequences are in-frame with the start codon. The five 
cassettes are in prfB, yehP, nuoE, pepP, and cheA. This result is consistent with the 
analysis of the 4132 protein coding sequences (Figure 5.3). The function of intergenic 
sequence with FSI higher than 3.5 is not clear and requires further investigation. In 
addition, none of the 163 pseudogenes in the E. coli genome had a maximum FSI 
higher than 3.5 (data not shown). 
 
5.7.3 yehP 
yehP contains a potential +1 frameshift site with the second highest FSI, only after 
prfB. The predicted frameshift site in yehP is highly conserved in different E. coli 
strains (Table 5.2 and Figure 5.8). The potential cassette, GTG GAG TAT GGT CGG 
C (the zero frame is separated by a space and the P-site position is underlined), forms 
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four base pairings with the anti-SD sequence and allows a weaker interaction in the E-
site. In the P-site, tRNAGlyGCC may form two canonical base pairings with the +1 
frame although a central position mismatch can also occur. Notably, it has been 
proposed that less than two base parings in the shifted codon:anticodon complex may 
be sufficient for the efficient frameshifting [35]. In a more extreme case, mRNA sites 
with little or no potential for canonical base pairing with the peptidyl-tRNA in the 
ribosome can also be used as landing positions for ribosomal bypassing [36]. In the A-
site, CGG is one of the four codons with the highest near-cognate tRNA competition 
[21]. All of these features make yehP a potential +1 frameshifting candidate.  
 
To date, the function of the yehP product is not well described in the literature. A 
known +1 PRF case in E. coli is the expression of RF2 from prfB gene [3]. RF2 
frameshifting is auto-regulated, meaning higher frameshift efficiency is driven by a 
lower level of the frameshift products [3]. It is suggested that this auto-regulation 
property may be evolved to evade a newly discovered fidelity control system: the 
ribosome would trigger a pre-mature termination of protein synthesis when a 
mismatch P-site interaction is presented [37]. RF2 frameshifting occurs more 
frequently when RF2 level is low, making it more difficult for ribosomes to trigger 
early termination in the presence of mismatch P-site. Whether yehP has involved in 
any regulation feedback loop or other mechanisms to escape from this fidelity control 
mechanism is uncertain. A yehP knockout E. coli strain was previously shown to 
result in a different swarming phenotype [38]. yehP was suggested to have been 
introduced to the E. coli genome by the horizontal gene transfer [39]. The predicted 
frameshift product is 75 amino acids shorter than the standard decoding product. The 
function of the yehP frameshift protein remains unclear and needs to be investigated 
further.  
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5.7.4 Other frameshift-prone sequences 
FSscan did not identify several shift-prone sequences observed experimentally in 
previous studies [40, 41]. argI was found to have a high level of +1 frameshifting at 
the very beginning of the coding sequence, UUU UAU [40]. However, the maximum 
FSI in the gene is relatively low (2.0 for the P-site at the 110th codon). For the P-site 
positioned at the fourth codon UUU, FSI equals 0.38. Because argI frameshifting does 
not involve ribosomal pausing at a stop codon or a hungry codon in the A-site, the 
recoding may be achieved through mechanisms not considered by FSscan. In addition, 
CCC TGA containing genes, pheL, yjeF, ykgD and yrhB, were also shown to result in 
a higher level of +1 frameshifting [41]. Notably, these sequences do not form more 
than three base pairings with the anti-SD sequence and their E-site interactions are 
relatively strong, which result in lower FSI. It is possible that a slippery sequence in 
the P-site (i.e. P-site tRNA can form complementary interactions with the +1 frame) 
along with a stop codon in the A-site can efficiently induce +1 frameshifting, which 
FSscan does not consider. On the other hand, not all of the CCC TGA containing 
genes promotes efficient +1 frameshifing, suggesting different mechanisms may be 
involved for pheL, yjeF, ykgD and yrhB framshifting. As growing numbers of the +1 
frameshifting features are discovered, these features can be incorporated into FSscan 
to better predict frameshift sites.  
    
5.7.5 FSscan as a bioinformatic program to search for novel +1 frameshift 
sequences 
FSscan locates a 16-nucleotide sequence with features for stimulatory signals, E-, P-, 
and A-site effects in the E. coli genome. As compared to previous +1 frameshift site 
searching programs [11, 12], FSscan differs in several major ways: (1) FSscan is not 
limited to a specific P- or A-site codon. Instead, FSscan looks for any P-site codon 
  113 
with a higher opportunity for tRNA rearrangement and any A-site codon with a higher 
possibility for a ribosome pausing during translation; (2) The algorithm does not 
search for overlapping genes. Thus it is not necessary that predicted frameshifting 
cassettes yield C-terminally extended fusion products; (3) FSscan is intended for 
searching the E. coli genome, because the tRNA data for the score calculation and the 
experimental system are specific to E. coli. FSscan may be directly applied to screen 
the genome of E. coli bacteriophage, whose proteins can be translated by using E. coli 
ribosomes and tRNA pool. The strategy can be extended to other organisms with 
minor adjustments for the scoring system. (4) FSscan predicts how likely a sequence is 
a frameshift site, but not the +1 frameshift efficiency. (5) FSscan needs no prior 
knowledge of the mRNA secondary structure involved in recoding. This method can 
be modified by varying the size of the recoding window to include mRNA structures 
serving as stimulatory signals.  
 
5.8 Supplementary data 
The estimation of the P score 
The stability of the zero frame and the +1 frame codon: anticodon interactions in the 
P-site were estimated according to Curran’s study (1993) (Table 5.S1). Fig. S1a shows 
a good correlation between log frameshift efficiency (FS%) and the stability difference 
(∆ stability), which is the stability of the +1 frame interaction (S1) minus that of the 
zero frame interaction (S0). To improve the correlation between log(FS%) and ∆ 
stability, we assumed ∆ stability* = M1S1- M2S0, where M1 and M2 are weighting 
factors for S1 and S0, respectively. The sum of squared errors is calculated 
as ∑ ∆−=
i
iierr stabilityFSSS
22 )*%)(log( , where i refers to different codons (i = 1-32, 
for 32  codons in Curran’s study, 1993). Matlab (v.7.6.0, The MathWorks, Inc., 
Natick, MA) was used to obtain the values of M1 and M2 that resulted in the minimum 
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sum of the squared errors. The program identified a pair value of M1 and M2 as 0.63 
and 0.26, respectively. The R2 value increased from 0.56 to 0.63 when M1 and M2 
were applied. (Fig. S1a and S1b). Consequently, the P score is calculated as (0.63S1- 
0.26S0)/maximum (0.63S1- 0.26S0) among 256 P-site codons. For example, for a UUC 
U (where the zero frame codon is separated by the space) in the P-site (anticodon 
3’AAG5’), S0 = 2 + 2 + 3 = 7, S1 = 2 + (-1) +1 = 2, 0.63S1- 0.26S0 = (-0.56) and the P 
score = (-0.56)/3.33 = -0.1682, where 3.33 is the 0.63S1- 0.26S0 value for CCC C, 
which is the maximum value obtained among the 256 P-site codons.  
 
In addition, UUU U, AAA A, and AAA U in the P-site (where the zero frame codon is 
separated by the space) showed lower frameshift efficiency in vivo (Fig.S2). As the 
result, for these three sequences in the P-site, the P-site score was set to 0.3. 
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Table 5.S1 The stability of the base pairing in the ribosome P-site according to Curran 
[20]. Marked in grey are assumed values in this study. A, G, C and U are the standard 
bases; I = inosine; V = uridine-5-oxyacetic acid; Q = queuosine; S = 5-
methylaminomethyl-2-thiouridine; E = unidentified derivative of U that pairs with A; 
F = modified pyrimidine that pairs with A. 1st, 2nd, and 3rd mean the position in the 
codon.  
 
  1st 2nd 3rd    1st 2nd 3rd 
AU 2 2 2  CU 0 0 0 
AC 0 -1 0  CC -1 -1 -1 
AG 0 -2 0  CG 3 3 3 
AA 0 -2 0  CA 0 -1 0 
         
  1st 2nd 3rd    1st 2nd 3rd 
GU 1 0 1  UU 0 1 0 
GC 3 3 3  UC 0 0 0 
GG 0 -2 0  UG 1 0 1 
GA 0 -2 0  UA 2 2 2 
         
  1st 2nd 3rd   1st 2nd 3rd 
IU 1 0 1  VU 1 0 1 
IC 1 0 1  VC 0 0 0 
IG 0 -2 0  VG 1 0 1 
IA 1 0 1  VA 1 0 1 
         
 1st 2nd 3rd   1st 2nd 3rd 
QU 1 0 1  SU 1 0 1 
QC 1 0 1  SC 0 0 0 
QG 0 -2 0  SG 1 0 1 
QA 0 -2 0  SA 1 0 1 
         
E 1st 2nd 3rd  F 1st 2nd 3rd 
EU 0 0 0  FU 0 0 0 
EC 0 0 0  FC 0 0 0 
EG 1 0 1  FG 0 0 0 
EA 1 0 1  FA 1 0 1 
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Table 5.S2 Peptides detected by MRM and identified by ProteinPilot 
 
 
a
 Confidence level (%) 
b
 Experimental molecular weight (Da) 
c
 Theoretical molecular weight (Da)  
d
 Delta mass (Da) = Exp MW – Theor MW 
e
 Precursor ion m/z in a MRM transition 
f
 Fragment ion m/z in a MRM transition 
g
 Charge state of a precursor ion in a MRM transition 
h
 Collision energy (V) used for a MRM transition 
Origin Confa Sequence Modifications Exp MWb Theor MWc dMass
d
 
Prec 
m/ze 
Frag 
m/zf z
g
 CEh 
yehP 99 LILGEAAETTLCGLDDNAR Carbamidomethyl(C) 2030.981 2030.994 -0.01317 678.001 760.354 3 32.832 
yehP 99 YGIEDVVTNLDVLER  1733.87 1733.884 -0.01344 578.964 631.336 3 28.474 
yehP 99 HLMNPEVLAAAR  1320.683 1320.697 -0.01411 441.235 501.310 3 22.414 
yehP 99 RIVCQVVEEIMAR Carbamidomethyl(C) 1601.825 1601.838 -0.01307 534.949 619.319 3 26.538 
yehP 99 IVCQVVEEIMAR Carbamidomethyl(C) 1445.727 1445.737 -0.00967 723.871 847.430 2 41.194 
linker 99 VQLGGGTNIASAVEYGGNLLNNQR  2444.225 2444.241 -0.01556 815.749 871.470 3 38.893 
EGFP 99 FSVSGEGEGDATYGK  1502.643 1502.653 -0.00911 752.329 840.369 2 42.616 
EGFP 98 SAMPEGYVQER  1265.562 1265.571 -0.00954 633.788 751.369 2 36.689 
EGFP 99 AEVKFEGDTLVNR  1476.743 1476.757 -0.01407 493.255 501.310 3 24.703 
117
116
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Figure 5.S1. The correlation between log frameshift efficiency (FS%) and the stability 
difference in the P-site. (a) The stability difference is estimated as S1-S0 (where S1 is 
the stability of the +1 frame interaction and S0 is the stability of the zero frame 
interaction in the P-site). (b) The stability difference is estimated as 0.63S1-0.26S0. 
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Figure 5.S2. Frameshift efficiency (FS%) for selected P-site codons. Error bars 
indicate the standard deviation. The linker sequences incorporated into the dual 
fluorescence reporter system are shown in the right, where the P-site codons in the 
frameshift site are shown in bold. 
 
Plasmid Linker sequence 
pRG3RF agg ggg tat ctt tga cta 
pRG51 agg ggg tat ttt tga cta 
pRG52 agg ggg tat aaa tga cta 
pRG53 agg ggg tat ccc tga cta 
pRG54 agg ggg tat gtt tga cta 
pRG55 agg ggg tat cct tga cta 
pRG56 agg ggg tat aaa agg tga  
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Figure 5.S3. Tandem mass spectrum (MS/MS) of the peptide derived form the 
predicted frameshift site in yehP. 
 
 
Red: y ion
Green: b ion
@: -NH3
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$: 2+
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5.9 Conclusion 
FSscan performs a mechanistic-based genetic algorithm search for potential +1 
frameshift sites in E. coli. The program successfully identifies prfB as a +1 frameshift 
candidate and predicts the frameshift site in this gene. Other predicted frameshift 
cassettes are shown to result in frameshift efficiency higher than a randomly designed 
sequence in vivo. These results suggest that the synergistic effects of ribosome E-, P-, 
and A-sites are functionally important for +1 frameshifting. Importantly, FSscan 
provides the ability to perform a genome-wide systematic search for +1 frameshift 
sites. Further investigation of the predicted +1 frameshift sequences are in progress. 
The knowledge of different frameshift sites will enable researchers to better 
understand translational control.  
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CHAPTER 6 
DIFFERENTIATING TWO TYPES OF THE FRAMESHIFT PROTEINS BY MASS 
SPECTROMETRY USING MULTIPLE REACTION MONITORING 
 
6.1 Preface 
This chapter discusses a method to detect the composition of frameshift products for 
various -1 programmed ribosomal frameshift (PRF) signals. This study will be an 
accompanying paper to support the experiments in Chapter 7, which will describe a 
kinetic model for -1 PRF. 
 
6.2 Abstract 
The -1 programmed ribosomal frameshift (PRF) motif in the human 
immunodeficiency virus type 1 (HIV-1) genome directs the ribosome to make two 
types of -1 frameshift proteins: those incorporating the zero frame A-site tRNA and 
products incorporating the -1 frame A-site tRNA in the recoding site. To date, there 
has not been a well-established method to quantitatively analyze the two types of 
frameshift proteins. This study applied nano-flow liquid chromatography electrospray  
tandem mass spectrometry (nLC-ESI-MS/MS) using multiple reaction monitoring 
(MRM) to quantify the relative ratio of the two kinds of frameshift proteins. This MS 
method detected 20.4% and 23.2% of the frameshift proteins incorporating -1 frame 
A-site tRNAs in the recoding sites of HIV-1 group M type B and group O PRF 
signals, respectively. A sensitive method to detect the relative population of the 
frameshift proteins will aid into our understanding of the -1 PRF mechanism.  
 
6.3 Introduction 
In -1 programmed ribosomal frameshifting (PRF), stimulatory signals in the mRNA 
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direct the ribosome to translate the -1 reading frame at a certain efficiency. Several 
viruses, including human immunodeficiency virus type 1 (HIV-1) and the coronavirus 
for severe acute respiratory syndrome (SARS-CoV), employ -1 PRF to synthesize the 
enzyme precursors for their replication [1-3]. Importantly, the perturbation of -1 PRF 
efficiency can damage viral replication (see review by Dinman et al., [4]), which 
suggests that -1 PRF may serve as a target for antiviral therapeutics. 
 
Viral gene expression involving -1 PRF usually occurs on a heptanucleotide ‘slippery 
motif’, X XXY YYZ [1,5,6]. A common hypothesis in the field is that P- and A-site 
tRNAs, decoding XXY and YYZ, reposition with the -1 reading frame to XXX and YYY 
codons during frameshifting. However, in HIV-1 frameshifting, protein sequencing by 
Edman degradation revealed that about 70% of the products corresponded to a result 
of P- and A-site tRNA slippage [1,7]. The other 30% of the products corresponded to 
PRF that may involve a single P-site tRNA slippage [8]. In Chapter 7, a new kinetic 
model for -1 PRF is proposed to explain the formation of the two kinds of frameshift 
products. In SARS-CoV frameshifting, only the product corresponding to a slippage of 
P- and A-site tRNAs was identified by electrospray mass spectrometry [2]. A recently 
discovered -1 PRF in alphavirus occurred at a conserved UUUUUUA motif within the 
coding sequence of 6k [9]. Peptides derived from frameshift products via slippage of 
P- and A-site tRNAs and a single P-site tRNA slippage were both detected in liquid 
chromatography tandem mass spectrometry (LC-MS/MS) [9]. However, the ratio 
between the two products was not determined.  
 
To date, a method to quantitatively analyze the two types of frameshift proteins has 
not been reported. The two types of -1 PRF proteins differ in only one amino acid in 
the polypeptide sequences. Therefore, differentiating the two products requires high 
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mass accuracy. In our previous study, mass spectrometry using MRM successfully 
detected a peptide derived from a +1 PRF product in E. coli [10]. Mass spectrometry 
using MRM can achieve high specificity and sensitivity by simultaneously monitoring 
both parent and one or more product ions [11]. The parent ion is the intact analyte and 
the product ions are generated by the fragmentation of the parent ions. The appropriate 
parent/product ion pairs, i.e. transitions, must be defined or predicted for the analyte of 
interest. The selected analytes are detected and integrated as peaks in one-dimensional 
chromatography. Because of the high specificity and sensitivity, MRM assays have 
been widely applied to the measurement of specific peptides in complex mixtures such 
as tryptic digests of plasma [11,12].  
 
In this study, FS0 and FS-1 denote proteins incorporating the zero frame and the -1 
frame A-site tRNA in the recoding motif, respectively. Figure 6.1 summarizes the 
procedure to detect the fraction of FS
-1 in total frameshift proteins. Purified frameshift 
proteins containing FS0 and FS-1 were digested with trypsin. Peptides spanning the 
recoding cassette (i.e. target peptides) with a single amino acid variation in FS0 and 
FS
-1 were quantified by nLC-ESI-MS/MS using MRM. Our result suggested that the 
MS method is a sensitive approach to detect peptides from frameshift proteins 
qualitatively and quantitatively.  
 
6.4 Materials and methods 
6.4.1 Plasmids and bacterial strains 
Escherichia coli XL1 blue MRF’ (Stratagene, La Jolla, CA) was used in all 
experimental studies. All constructs were verified by DNA sequencing at the Cornell 
Bioresource Center. The construction of the dual fluorescence reporter was performed 
as described previously [13] except that the linker sequences rendered the downstream 
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Figure 6.1. Differentiating two types of frameshift products by mass spectrometry. FS0 
and FS
-1 represent frameshift proteins incorporating zero frame and -1 frame A-site 
tRNAs in the frameshift site, respectively. Tripsin cleaves lysine and arginine residues 
in the polypeptides. Peptides spanning the PRF motif (target peptides) are analyzed by 
nano-flow liquid chromatography electrospray tandem mass spectrometry (nLC-ESI-
MS/MS) using multiple reaction monitoring (MRM). 
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green fluorescence protein (EGFP) coding sequence in the -1 frame. In addition, the 
reporter plasmid was digested with BsrGI and EcoRI to make the insertion of a 6X 
histidine tag downstream of egfp. The linker sequences were made from 
complementary oligonucleotides (Integrated DNA Technology, Coralville, IA) and 
then cloned into SalI and BamHI sites between the coding sequence of DsRed and 
EGFP in the reporter plasmid. Table 6.1 lists the nucleotide sequences incorporated 
into the dual fluorescence reporter for testing the compositions of frameshift protein in 
this study. 
 
6.4.2 Protein sample preparation 
Test strains were grown in 100 ml Luria-Bertani (LB) medium containing 100 µg/ml 
ampicillin in 500 ml flasks at 250 rpm and 37oC. After 24 hours, 200 OD600 units of 
cells were collected by centrifugation at 4000×g and 4oC for 20 minutes. Cells were 
lysed and purified by Ni-NTA under native conditions according to the manufacturer’s 
protocol (Qiagen, Valencia, CA). The purified protein samples were resolved by SDS-
PAGE (10% w/v) using Tris-HCl. Gel band excision and in gel trypsin digestion were 
performed using standard method described previously [14].  
 
6.4.3 Mass spectrometry  
For the standard curves, different concentrations (10 fmol/µl - 0.1 fmol/µl) of a 
custom synthesized peptide (Bio-Synthesis, Lewisville, TX) solution in 0.1% formic 
acid (FA) were prepared and 200 nl of each standard solution was injected into Dionex 
3000 nLC system (Sunnyvale, CA). First, the sample was loaded in an Acclaim 
PepMap 100 C18 trap column (300 µm ×  5 mm, 5 µm) and on-line desalting was 
carried out with water (0.1% FA) at a flow rate of 30 µL/min for 5 minutes. Then, 
peptides trapped in the trap column were delivered to/separated on an Acclaim 
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Table 6.1 The nucleotide sequences incorporated into the dual fluorescence reporter 
for testing the compositions of frameshift protein in Chapter 6. The heptanucleotide  
slippery motifs in the sequence are underlined. 
 
Strain  Plasmid Linker sequence PRF cassette origin 
MB2 pMB2 TCG ACT GCT AAT TTT TTA GGG AAG ATC 
TGG CCT TCC TAC AAG GGA AGG CCA GGG 
AAT TTT CTT GGA TAA AG 
HIV-1 group M, 
type B, gag/pol 
overlap 
O2 pO2 TCG ACT GCT AAT TTT TTA GGG AAG TAC 
TGG CCT CCG IGG GGC ACG AGG CCA GGC 
AAT TAT GTG CAG AAA CAA GTG TCC CCA 
TAA AG 
HIV-1 group O 
gag/pol overlap 
P2 pP2 TCG ACT GCC GGT AAG GTG GTC GGT TTT 
TTG TCG CCG AAC TCG GTG TAA AG 
Bacteriophage P2, 
gene E-E’ 
PSP3 pPSP3 TCG ACT GCC GCT AAG GTG ATT GGT TTT 
TTG TCA CCG CTT CGG TAA AG 
Bacteriophage 
PSP3, gene E-E’ 
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PepMap 100 C18 analytical column (75 µm ×  15 cm, 3 µm) with gradients of 2-50% 
acetonitrile with 0.1% FA over 75 minutes. The eluent was directly introduced into a 
4000 QTRAP mass spectrometer through a Nanospray II source (Applied Biosystems, 
Carlsbad, CA). For MRM, the MIDAS Workflow software (Applied Biosystems) 
generated a list of possible MRM transitions (Table 6.2) before MS analysis. MS and 
MS/MS data obtained through MRM were searched using Mascot [15] (v. 2.2, Matrix 
Science, Boston, MA) within a custom sequence database that included frameshift 
protein sequences. During the database search, the spectral assignment of MS/MS was 
performed under parameters of MS tolerance of 1.2 Da, MS/MS tolerance of 0.6 Da, 
and p<0.05 and searches were manually confirmed. In addition, peak areas of MRM 
transitions were calculated using Analyst (v. 1.5, Applied Biosystems). For the test 
samples, the trypsin digested sample was vacuum dried and reconstituted with 30 µl of 
0.1% FA. The analysis was performed as the method for standards except 8 µl of 
reconstituted samples were used. 
 
6.5 Results 
6.5.1 Correlation between peptide concentrations and peak area  
Standard peptides with different concentrations were analyzed by nLC-ESI-MS/MS 
using MRM. These standard peptides mimic the tryptic peptides spanning the PRF 
motifs in HIV frameshift proteins FS0 and FS-1 (Figure 6.2.a). The peak areas 
correlated well with peptide concentrations for both peptides (Figure 6.2.b and Figure 
6.2.c), suggesting that the method is suitable for quantification. For the test samples 
containing the two peptides in various ratios, the fractions of FS
-1 in total frameshift 
proteins were calculated in two ways: (1) Peak areas obtained by the MS method were 
first converted to concentrations by using the standard curves (Figure 6.2). The 
fraction of FS
-1 was then calculated as the concentration of FS-1 target peptide over the 
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Table 6.2 The list of target peptides and their MRM parameters (All peptides except 
VIGFFVTASVK were confirmed by Mascot search of their MS/MS spectra against a 
custom-made database (p<0.05). 
 
 
a
 Type of frameshift protein 
b
 Theoretical molecular weight (Da) 
c
 Precursor ion m/z 
d
 Fragment ion m/z 
e
 Charge state 
f
 Collision energy (V) 
Origin FSa Sequence Theor MWb Prec m/zc Frag m/zd ze CEf 
MB2, O2 FS0 HSTGAASTANFLR 1331.68 444.90 620.40 3 22.580 
MB2, O2 FS
-1 HSTGAASTANFFR 1365.58 456.20 654.30 3 23.073 
P2 FS0 VVGFLVAELGVK 1229.73 615.87 199.14 2 35.794 
P2 FS
-1 VVGFFVAELGVK 1263.70 632.86 199.14 2 36.643 
PSP3 FS0 VIGFLVTASVK 1132.69 567.35 604.36 2 33.370 
PSP3 FS
-1 VIGFFVTASVK 1166.65 584.34 604.36 2 34.217 
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sum of the concentration of FS0 and FS-1 target peptides (Eq.1); and (2) the fraction of 
FS
-1 was directly calculated as the peak area of FS-1 target peptide divided by the sum 
of peak areas of FS
-1 and FS0 target peptides (Eq.2).  
 
The fraction of FS
-1 estimated by concentration =                        (Eq.1) 
where CFS-1 and CFS0 are the concentrations, obtained by converting peak areas in MS 
to concentrations using the standard curve (Figure 6.2), of FS
-1 and FS0 target peptides 
in the sample, respectively. 
 
The fraction of FS
-1 estimated by peak area =                            (Eq.2) 
where AFS-1 and AFS0 are peak areas for FS-1 and FS0 target peptides in MS, 
respectively.  
 
Figure 6.3 shows a good correlation between the fraction of FS
-1 values calculated by 
Eq.1 and Eq.2 (R2=0.9839). This result suggests that peak area ratios can be used for 
the relative estimation of FS
-1 fraction in total frameshift proteins. Therefore, Eq.2 was 
used for later experiments. 
 
6.5.2 Detection of two target peptides by nLC-ESI-MS/MS using MRM  
Four frameshift signals were investigated for the fraction of FS
-1 in total frameshift 
proteins (sequences and corresponding strains in Table 6.1): HIV-1 group M type B, 
HIV-1 group O, bacteriophage P2 and bacteriophage PSP3. In the HIV-1 genome, the 
PRF cassette located at the gag/pol overlap [1]. While the downstream stimulatory 
signal for the HIV-1 group M type B sequence was suggested to be a stem loop [1], 
PRF motif in HIV-1 group O may involve a pseudoknot [16]. Bacteriophage P2 is a 
double stranded DNA phage. Christie et al. identified a small reading frame 
%100
01
1 ×
+
−
−
FSFS
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Figure 6.2. Standard curves for HIV-1 target peptides. (a) The mRNA sequence (top) 
and the polypeptide sequence (bottom) spanning the PRF cassette in HIV-1 group M 
type B. The P-site in the PRF cassette is underlined. FS0 incorporates a zero frame A-
site tRNA (codon uua for lysine). FS
-1 incorporates a -1 frame A-site tRNA (codon 
uuu for phenylalanine). Trypsin digestion results in peptides with mass 1332.45 Da 
and 1366.47 Da from FS0 and FS-1, respectively. (b) Peak areas correlate well with 
concentrations for HIV-1 FS0 target peptide HSTGAASTANFLR in log scale. (c) Peak 
areas correlate well with concentrations for HIV-1 FS
-1 target peptide 
HSTGAASTANFFR in log scale. 
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Figure 6.3. Correlation between the fraction of FS
-1 values calculated by concentration 
ratios (Eq.1) and peak area ratios (Eq.2). 
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overlapping the end of the gene E that was translated as a -1 frameshifted extension, 
namely E+E’ [17]. This study observed FS0 in E+E’ frameshifting by Edman 
degradation, but did not report FS
-1. In addition, a P2 related phage, PSP3, has a 
similar genetic structure compared to the P2 frameshift cassette. In the present study, 
nLC-ESI-MS/MS using MRM detected 20.4 ± 1.9% and 23.2 ± 1.7% of FS
-1 in total 
frameshift proteins for MB2 and O2 strains, respectively (Figure 6.4). Interestingly, 
the method detected 0.85% of FS
-1 in total frameshift proteins for the P2 strain, 
although this approach did not find FS
-1 for the PSP3 strain.  
 
6.6 Discussion 
In the present study, nLC-ESI-MS/MS using MRM detected 20.4 ± 1.9% and 23.2 
± 1.7% of FS
-1 in total frameshift proteins in HIV-1 group M type B and group O 
derived PRF signals. Our results are consistent with previous studies. Jacks et al. 
performed in vitro translation of HIV-1 group M type B frameshift cassette and 
observed 20-25% of FS
-1 in total frameshift proteins by Edman degradation [1].  
Yelverton et al. examined the translation of 15-17 nucleotides of HIV-1 frameshift 
motif in E. coli and found about 30% FS
-1 in total frameshift proteins with Edman 
degradation [7]. The difference in the fraction of FS
-1 in total frameshift proteins may 
result from different reporter systems being used or different detection methods being 
employed. In addition, the fraction of FS
-1 in total frameshift proteins observed by 
Edman degradation was an approximation because: (1) the peak intensity was not 
consistent for the same amino acid at different positions, suggesting that the peak 
intensity may not truly reflect the concentration; (2) minor peaks were present in 
addition to the major peak in one Edman degradation cycle, which may interfere with 
the detection of the major peak. Because these previous studies did not provide the 
correlation of the peak height and the concentration of a certain amino acid in the 
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Figure 6.4. Compositions of the frameshift proteins from four PRF cassettes by nLC-
ESI-MS/MS using MRM. Error bars denote standard deviations.  
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peptide, Edman degradation may be less applicable for quantification. On the other 
hand, nLC-ESI-MS/MS using MRM has been previously used for peptide 
quantification [18]. Our study observed good correlations for peptide concentrations 
and peak areas observed in the MS (Figure 6.2). In addition, peptide fractions 
correlated well with peak area ratios (Figure 6.3). These result suggested that our MS 
method is suitable for the quantification of the relative population of the frameshift 
proteins.  
 
The study by Christie et al. successfully sequenced frameshift protein E+E’ and 
identified FS0 in bacteriophage P2 [17]. In our study, 0.85% of FS-1 in total frameshift 
proteins was detected in the strain with PRF signal from bacteriophage P2. To our 
knowledge, this is the first report to demonstrate the presence of FS
-1 in the E+E’ 
frameshifting in bacteriophage P2. FS
-1 was not found in the strain containing PRF 
motif from the bacteriophage PSP3 genome. It is possible that the PRF motif from the 
PSP3 genome employs only one mechanism to produce frameshift proteins, or the 
level of FS
-1 is too low to be detected by our approaches in this case.  
 
To use the peak area ratios obtained from the MS analysis to represent the 
composition of the frameshift proteins, the following steps were assumed to have the 
same efficiency for FS0 and FS-1: (1) affinity column purification; (2) enzymatic 
cleavage of the polypeptide; (3) the release of the peptide from the gel piece (4) 
ionization of peptides. Additionally, peptides from FS0 and FS-1 are assumed to be 
equally eluted from nLC column. In our reporter system, FS0 and FS-1 are about five 
hundred amino acids in length and they differ only in one amino acid in the linker 
sequence. In addition, their tryptic peptide spanning the PRF cassettes are the same 
length. These two factors make these assumptions more likely. If FS0 and FS-1 result 
  139 
in peptides spanning the recoding site with very different length, the assumptions may 
need to be re-evaluated. Furthermore, the mass spectrometry method requires 
sequences with a certain level of difference. For example, the frameshift cassette in the 
E. coli dnaX gene is A AAA AAG (where spaces separate the zero frame and the P-
site codon is underlined). The zero frame A-site AAG and the -1 frame A-site AAA 
both code for a lysine, making FS0 and FS-1 indistinguishable. Similarly, a 
leucine/isoleucine variation in FS0 and FS-1 are indistinguishable in the MS. Because 
of the isotopic cluster overlap, for the mass difference only about 1 Da in FS0 and FS-
1, e.g. glutamic acid (M.W. 129.12) and lysine (M.W. 128.17), our approach is also 
less applicable.  
 
6.7 Conclusion 
This study applied nLC-ESI-MS/MS using MRM for the relative quantification of the 
ratio of the two kinds of frameshift proteins derived from four PRF cassettes: HIV-1 
group M type B, HIV-1 group O, bacteriophage P2 and bacteriophage PSP3. This 
method detected that 20.4 ± 1.9% and 23.2 ± 1.7% of frameshift proteins incorporated 
-1 frame A-site tRNAs in HIV-1 group M type B and group O derived PRF signals, 
respectively. For the bacteriophage P2 frameshift cassette, 0.85% of frameshift 
proteins incorporated -1 frame A-site tRNAs. This approach detected no frameshift 
proteins incorporating the -1 frame A-site tRNAs in bacteriophage PSP3 frameshift 
site. This MS method provides a platform to investigate frameshift protein production 
through different mechanisms. 
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CHAPTER 7  
KINETIC MODEL ANALYSIS OF THE EFFECT OF DIFFERENT ELONGATION 
STEPS ON -1 RIBOSOMAL FRAMESHIFTING 
 
7.1 Preface 
Chapter 4 describes a kinetic model for +1 programmed ribosomal frameshifting (PRF) 
which reveals the effects of different interactions on +1 PRF. A similar approach is 
applied to understating the mechanism of -1 PRF. This chapger presents a kinetic 
model for -1 PRF. The model predictions are tested experimentally using a dual 
fluorescence reporter system in Escherichia coli. The results suggest that several steps 
in the translation elongation have more prominent effects on -1 PRF efficiency and the 
percentage of the two types of -1 frameshift products.  
 
7.2 Abstract 
Several important viruses including the human immunodeficiency virus type 1 (HIV-
1) and the coronavirus for severe acute respiratory syndrome (SARS-CoV) employ -1 
programmed ribosomal frameshifting (PRF) for their protein expression. Here, a 
kinetic framework is developed to describe -1 PRF. The model yields two possible -1 
frameshift products: those incorporating zero frame A-site tRNAs in the recoding site 
and products incorporating -1 frame A-site tRNAs in the recoding site. Using known 
kinetic rate constants, the individual contributions of different translation steps to -1 
PRF and the ratio between two types of frameshift products are evaluated. A dual 
fluorescence reporter system is employed in Escherichia coli to empirically test the 
model. In addition, the study presents a novel mass spectrometry approach to quantify 
the ratio of the two frameshift products. A more detailed understanding of -1 PRF 
mechanism may provide insight into developing antiviral therapeutics.   
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7.3 Introduction 
Programmed ribosomal frameshifting (PRF) is a process where specific signals in the 
mRNA direct the ribosome to switch the reading frame at a certain efficiency. In -1 
PRF, the ribosome slips one nucleotide towards the 5’-end of the mRNA during 
translation. Several viruses, including human immunodeficiency virus type 1 (HIV-1) 
and the coronavirus for severe acute respiratory syndrome (SARS-CoV), employ -1 
PRF to synthesize precursors of enzymes for their replication [1,2] and the ratio of the 
zero frame and -1 frame products is important to the vitality of the organism [3,4]. As 
such, altering -1 PRF efficiency may damage viral replication (see review by Dinman 
et al., [5]), which suggests that -1 PRF can serve as a target for the development of 
antiviral therapeutic.   
 
-1 programmed ribosomal frameshifting usually consists of three essential mRNA 
elements: (1) a ’slippery’ heptanucleotide X XXY YYZ (X can be any nucleotide, Y is 
A or U and Z is not G in eukaryotes; spaces separate the initial reading frame), where 
the ribosome changes the reading frame [3,6]; (2) a downstream stimulatory mRNA 
secondary structure [7-9]; and (3) a spacer between the slippery sequence and the 
stimulatory signal. It has been suggested that the stimulatory signal promotes -1 PRF 
efficiency by making the ribosome pause over the slippery sequence [10-12]. The 
length of the spacer has also been shown to affect frameshift efficiency [6,8,13].  
 
As PRF occurs during translation elongation, the models of -1 PRF should be 
described within this context. The elongation cycle can be divided into four stages. 
First, the ribosome selects the cognate aminoacyl-tRNA (aa-tRNA) according to the 
codon at the decoding center (decoding, DC in Figure 7.1). Second, the aa-tRNA 
moves from A/T entry state into the A/A state to be accommodated into the ribosome 
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(aa-tRNA accommodation, AA in Figure 7.1). Third, the ribosome catalyzes the 
peptidyl transfer, resulting in a peptidyl tRNA in the A-site and a deacylated tRNA in 
the P site (peptidyl transfer, PT in Figure 7.1). Fourth, the peptidyl-tRNA moves from 
the A-site to the P-site, carrying the mRNA along, and the deacylated tRNA moves 
out of the P-site into the E-site from where it dissociates (translocation, TL in Figure 
7.1). Translocation opens up the ribosome A-site and the ribosome moves on to 
another aa-tRNA selection.  
 
Two major hypotheses have been proposed for the mechanism of -1 PRF. One 
hypothesis proposes that -1 PRF takes place during the accommodation of the aa-
tRNA [7,14,15]. The simultaneous-slippage model by Jacks et al. [7] suggests that 
peptidyl- and aa-tRNAs slipped to base pair with the -1 reading frame during aa-tRNA 
accommodation. In the model by Farabaugh [14], -1 PRF occurs when aa-tRNA and 
peptidyl-tRNA are located in the A/T entry and P/P site. In agreement with these 
models, Plant et al., [15] further proposed a 9Å model for -1 PRF. During the 
accommodation, the movement of the anticodon loop of the aa-tRNA is about 9 Å 
[16]. The 9Å model suggests that the movement of 9Å by the anticodon loop is 
constrained in the presence of the stimulatory RNA, causing a tension that can be 
relieved by -1 slippage of the tRNA. Consistently, mutations altering aa-tRNA 
accommodation were found to affect -1 PRF [17-19]. However, these models do not 
explain the role of the sequence upstream of the slippery site, which is shown to affect 
the -1 PRF efficiency [20,21]. The second hypothesis proposes that -1 PRF occurs 
during translocation. Weiss et al. [22] suggests that after peptidyl transfer, the two 
tRNAs move to P/E and A/P states, where the two tRNAs may dissociate from the 
mRNA and re-pair with the new reading frame. Cryoelectron microscopy imaging 
reveals that a pseudoknot interacts with the ribosome to block the mRNA entrance  
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Figure 7.1. A mechanistic model of -1 programmed ribosomal frameshifting. Two 
translation elongation cycles are depicted on the top: the ribosome undergoes decoding 
(DC), aa-tRNA accommodation (AA), peptidyl transfer (PT) and translocation (TL) 
twice to add two amino acids into the polypeptide sequences. The shift of the reading 
frame may occur at the first TL step and the ribosome decodes a -1 frame A-site codon 
at the recoding site. Alternatively, -1 PRF may occur during the second AA step, in 
which the ribosome has decoded a zero frame A-site codon. The translation of -1 
reading frame starts at the following cycle.   
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channel, compromising the translocation process during -1 PRF [23]. In the model by 
Leger et al. [21], -1 PRF is triggered by an incomplete translocation and ribosome E-, 
P- and A-sites are all involved in the process. Their model suggests that in the 
presence of a stimulatory signal, the translocation is incomplete and a transition 
intermediate is formed. The entry of the new aa-tRNA into the ribosome and the 
tendency of tRNAs to revert to stable states drives the shift of the reading frame. The 
model is supported by evidence that mutations altering E-site tRNA binding affect -1 
PRF [21]. However, these incomplete translocation models do not explain two types 
of frameshift proteins being found in HIV-1 frameshifting, which will be described 
next. 
 
Protein sequencing has confirmed the -1 PRF site for HIV-1 is U UUU UUA (where 
the P-site of the ribosome during frameshifting is underlined), located within the 
gag/pol overlap [1]. Interestingly, about 70% of the frameshift products contain Phe-
Leu (derived from UUU UUA decoding) and 30% of the products contain Phe-Phe 
(derived from  UUU UUU decoding) at the frameshift site [1,24]. Previous studies 
suggested that the product with Phe-Phe at the frameshift site may result from a single 
P-site tRNA slippage [1,24,25]. Consequently, the -1 frame aa-tRNA is recruited to 
the ribosome. However, the precise mechanism that drives the process is not clear. To 
date, no model has been proposed to explain the formation of different frameshift 
proteins simultaneously. Here, we develop a kinetic model for -1 PRF to explain 
previous experimental observations, reveal major steps in translation elongation that 
affect -1 PRF, and reconcile various models for -1 PRF discussed in the literature. In 
addition, -1 PRF efficiency was tested in vivo by a dual fluorescence reporter and the 
composition of different frameshift proteins was analyzed by mass spectrometry. In 
agreement with the model predictions, the experimental perturbation of different steps 
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in translation results in different levels of -1 PRF efficiency as well as the composition 
of two types of frameshift proteins. 
 
7.4 Kinetic model  
In our previous study, a kinetic model successfully presented the effect of ribosome E-
, P-, and A-site interactions on +1 PRF [26]. A similar approach can be applied to 
understanding the mechanism of -1 PRF. The mechanistic model in the present study 
proposes that -1 PRF can occur during translocation and aa-tRNA accommodation. 
When -1 PRF occurs during translocation, the ribosome moves two, rather than three, 
bases toward the 3’ end of the mRNA, thus shifting the reading frame. In this case, a  
-1 frame codon will be present in the A-site. Consequently, the -1 frame translation 
starts at the A-site of the recoding site. When -1 PRF occurs during aa-tRNA 
accommodation, the two tRNAs in the ribosome P- and A- sites slip to base pair with 
the -1 reading frame. Consequently, the -1 frame aa-tRNA incorporation starts one 
codon downstream of the frameshift site (Figure 7.1). 
 
An elegant series of biochemical analyses have established detailed kinetic models of 
translocation [27] and aa-tRNA selection [28]. Translocation involves EF-G binding to 
the pretranslocational ribosome, GTP hydrolysis, unlocking conformation change, Pi 
release, tRNA movement, relocking conformation change, and dissociation of EF-G 
from the posttranslocational ribosome. This concept is illustrated along the top of 
Figure 7.2 from component PA (pretranslocational ribosome) to E0P0 
(posttranslocational ribosome). The selection and accommodation of aa-tRNA 
involves initial binding of the ternary complex EF-Tu:aa-tRNA:GTP, codon 
recognition, EF-Tu GTPase activation, GTP hydrolysis, dissociation of EF-Tu from 
the ribosome, and accommodation of the acceptor end of the aa-tRNA into the A-site  
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Figure 7.2. The kinetic framework for -1 PRF. Top: the procedure from PA to E0P0 
represents translocation, which involves reversible EF-G binding (r1, r-1), GTP 
hydrolysis (r2), unlocking conformation change (r3), tRNA movement and Pi release 
(rTL0), re-locking conformation change (r4), and EGFP dissociation (r5). The E0P0 
complex then undergoes aa-tRNA selection: from E0P0 to P0A0. The selection of aa-
tRNA involves: reversible EF-Tu binding (k1, k-1), reversible codon recognition (k2,  
k
-2), GTPase activation (k3), GTP hydrolysis (k4), EF-Tu conformation change and 
dissociation (k5), aa-tRNA rejection by proofreading (k6) or aa-tRNA accommodation 
(k7). The elongation cycle without any PRF event will result in forming non-frameshift 
proteins (NFS). Pathway I in green suggests that -1 PRF occurs during the relocking 
step in translocation, which leads to the formation of FS
-1. Pathway Ia indicates the 
E02P02 complex may interact with a zero frame aa-tRNA and eventually produce FS0. 
Pathways II and III suggests that -1 PRF occurs during aa-tRNA selection and 
accommodation, resulting in producing FS0.   
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or the rejection of the aa- tRNA by proofreading. These aa-tRNA selection steps are 
illustrated in the process from E0P0 to NFS in Figure 7.2.  
 
Our kinetic model suggests three reaction pathways that generate -1 frameshift 
proteins (Figure 7.2). In Pathway I, a secondary structure blocks the entrance of the 
mRNA channel and induces -1 PRF during translocation. Specifically, the shift of the 
reading frame occurs between the tRNA movement and Pi release (rate constant rTL0) 
and the relocking step (rate constant r4). Weiss et al. [22] suggested that when the two 
tRNAs move from P/E and A/P to E/E and P/P states, they can un-pair from the 
mRNA and re-pair with the -1 reading frame. In our model, rt represents the rate 
constant for a ribosome:EF-G:GDP complex with two tRNAs in the E- and P-sites 
(E0P0EFGgdp) to re-pair with the -1 reading frame (E02P02EFGgdp). This motion is 
reversible, and r
-t denotes the rate constant for the reverse reaction. This step is 
followed by a relocking conformation change and EF-G release from the ribosome 
complex.
 
The resulting E0P0 and E02P02 will then move on to the aa-tRNA selection, 
according the codon presented in the empty A-site. Here, E0P0 and E02P02 are 
ribosomes with E- and P-sites occupied without EF-G binding, where subscript 0 
means a zero frame tRNA pairs with the zero frame; subscript 02 means a zero frame 
tRNA pairs with the -1 frame. E0P0 may generate non-frameshift product NFS, or 
enter Pathway II or III described below. E02P02 can generate frameshift product FS-1, 
which incorporates a -1 frame aa-tRNA in the frameshift site. In addition, it is also 
possible that the ribosome complex E02P02 recruits a zero frame aa-tRNA (A0) and 
accommodates this aa-tRNA into the -1 frame. In this case, frameshift product FS0, 
which incorporates a zero frame aa-tRNA in the frameshift site, is produced (Pathway 
Ia).  
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In the second and third pathways, a secondary structure slows down the ribosome 
movement and induces -1 PRF during aa-tRNA accommodation. Pathway II suggests 
that a slippage of P- and A-site tRNAs occurs before GTP hydrolysis. In Figure 7.2, 
the process from P0A0GTPase* to P02A02GTPase* with the rate constant kpas1 describes the 
slippage in Pathway II. The ribosome complex (P02A02GTPase*) will proceed to the 
remaining steps of the aa-tRNA selection to reach the peptidyl transfer step. 
Therefore, Pathway II can generate FS0. Pathway III suggests that a slippage of P- and 
A-site tRNAs occurs before peptidyl transfer. In Figure 7.2, the process from P0A0 to 
P02A02 with the rate constant kpas2 describes the slippage in Pathway III. P0A0 and 
P02A02 then go through peptidyl transfer, generating NSF and FS0, respectively.  
 
7.5 Materials and methods 
7.5.1 Computation of the kinetic model 
All pathways were mathematically described as systems of ordinary differential 
equations (see Supplementary data). Assuming steady state, the expressions of 
intermediate concentrations in terms of initial reactant (PA) were solved by Matlab 
v.R2008a (Mathworks Inc., Natick, MA). By applying the empirically-determined rate 
constants and assumed ranges of rate constants of incomplete translocation, P- and A-
site tRNA slippage (Table 7.S1-7.S4 in Supplementary data), the amount of non-
frameshift proteins NFS (P0A0pt in the kinetic model) and two types of frameshift 
proteins, FS
-1 (P02A2pt in the kinetic model) and FS0 (P02A02pt in the kinetic model) 
were calculated. The frameshift efficiency (FS%) in the model is defined as the 
amount of frameshift proteins divided by the amount of total proteins and multiplied 
by 100 % (Eq.1). The fraction of FS
-1 is calculated as the amount of FS-1 divided by 
the amount of total frameshift proteins and multiplied by 100 % (Eq.2).   
 
  151 
 
                                                                Eq.1 
 
                                                                Eq.2 
 
7.5.2 Plasmids and bacterial strains 
Escherichia coli XL1 blue MRF’ (Stratagene, La Jolla, CA) was used in all 
experimental studies. All constructs were verified by DNA sequencing at the Cornell 
Bioresource Center. The construction of the dual fluorescence reporter was performed 
as described previously [26,29] and in Chapter 6, except that different linker 
sequences were incorporated into the reporter plasmid (Table 7.1). These sequences 
are derived from the frameshift signal in HIV-1 group M subtype B [21]. For MB2 
strain, the linker sequence was made from complementary oligonucleotides 
(Integrated DNA Technology, Coralville, IA) and then cloned into SalI and BamHI 
sites between the coding sequence of DsRed and EGFP in the reporter plasmid. For 
the MB2CCC strain, the nucleotide sequence was mutated by site-directed 
mutagenesis according to the manufacturer’s protocol (Qiagen, Valencia, CA). 
 
7.5.3 In vivo fluorescence assay 
Cells with the appropriate plasmids were cultured in 1 ml Luria-Bertani (LB) medium 
containing 100 µg/ml ampicillin and with or without 0.75 µg/ml chloramphenicol in a 
24-well plate for 24 hours at 250 rpm and 37oC. The fluorescence was then measured 
by a plate reader (SpectraMax M5, Molecular Devices, Sunnyvale, CA). The 
fluorescence measurement was performed as described previously [26,29]. 
Experimental frameshift efficiency (FS%exp) was obtained as the ratio of green 
fluorescence to red fluorescence for the test strains, normalized against the  
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Table 7.1 Linker sequences and corresponding E. coli strains in Chapter 7. The 
heptanucleotide slippery motifs in the sequence are underlined. 
 
Linker sequence between the two fluorescence reporter coding 
sequence 
Strain 
GCT AAT TTT TTA GGG AAG ATC TGG CCT TCC TAC AAG 
GGA AGG CCA GGG AAT TTT CTT GGA TAA AG 
MB2 
GCC CCT TTT TTA GGG AAG ATC TGG CCT TCC TAC AAG 
GGA AGG CCA GGG AAT TTT CTT GGA TAA AG 
MB2CCC 
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fluorescence ratio of the control strain. Statistical analysis was applied to all datasets 
according to Jacobs et al. [30]. Twenty-three to forty-six replicates for test strains and 
control strains were performed to satisfy the minimum sample requirement for 
statistical significance.  
 
7.5.4 Protein purification and trypsin digestion 
The method for protein purification and trypsin digestion was performed as described 
in Chapter 6.  
 
7.5.5 Mass spectrometry analysis 
Protein samples were analyzed by nano-flow liquid charomatography electrospray 
tandem mass spectrometry (nLC-ESI-MS/MS) using multiple reaction monitoring 
(MRM) as described in Chapter 6. Table 7.S5 lists the parameters for MRM. 
 
7.6 Results 
7.6.1 Mathematical model 
The kinetic model allows for the evaluation of the effect of different translation steps 
on FS% and the fraction of FS
-1. In addition, sensitivity analysis reveals several 
parameters that have a greater influence on FS% (Supplementary data). Therefore, the 
model results will focus on these higher impact parameters.  
 
In Pathway I, -1 PRF occurs during translocation. Two parameters play important 
roles in Pathway I in the kinetic model. In the model, rt represents the rate constant for 
incomplete translocation. An increase in rt while other parameters in the model remain 
constants leads to an increase in FS% (blue line in Figure 7.3.a). Both the levels of  
FS
-1 and FS0 increase when rt increases (green and red lines in Figure 7.3.a). Because 
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the rise in the FS
-1 level is larger, increasing rt results in a larger FS-1 fraction (Figure 
7.3.b). The rate constant r4 accounts for the relocking step during translocation. A 
decrease in r4 while other parameters in the model remain constant results in an 
increase in FS% (blue line in Figure 7.4.a). Both the levels of FS
-1 and FS0 increase 
when r4 decreases (green and red lines in Figure 7.4.a). The increase in the FS-1 level 
is larger, leading to a larger FS
-1 fraction with a decrease in r4. The results suggest that 
translocation perturbations by a downstream mRNA secondary structure, mutations or 
chemical inhibitors may result in a higher FS%, primarily due to a larger amount of 
FS
-1 being produced. Notably, manipulating rt values causes larger changes in FS% 
and the FS
-1 fraction compared to the effect of r4, suggesting a dominant role of rt on  
-1 PRF in Pathway I. Previous experimental studies observed that mutating the E-site 
codon in the recoding site and the presence of a translocation inhibitor altered FS% 
[21] which is consistent with our observations.  
  
In Pathways II and III, -1 PRF occurs during aa-tRNA accommodation. In Pathway II, 
the slippage of P- and A-site tRNAs occurs before GTD hydrolysis, while in Pathway 
III, the slippage occurs before peptidyl transfer. Sensitivity analysis reveals that the 
parameters in Pathway II have relatively little impact on FS%. On the other hand, the 
analysis shows that the rate constant kpas2, representing the slippage in Pathway III, has 
a more significant impact on FS%. Figure 7.5.a shows that a higher kpas2 results in a 
higher FS%. Interestingly, the larger FS% results from an increase in FS0 while the 
level of FS
-1 remains at a similar level (Figure 7.5.a). Therefore, the fraction of FS-1 
decreases when kpas2 increases (Figure 7.5.b). 
 
In the model, kpt represents the rate constant for peptidyl transfer, which is the last step 
of all three pathways. The model predicts that a decrease in kpt would result in a higher 
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FS% and FS0, and a similar level of FS-1 (Figure 7.6.a). Consequently, a smaller 
fraction of FS
-1 is observed when kpt decreases (Figure 7.6.b). The model results are 
consistent with previous experimental observations that peptidyl transferase inhibitors 
affect FS% [31]. 
 
7.6.2 Experimental results 
To examine the model predictions, the frameshift efficiency was tested in vivo using a 
dual fluorescence reporter system. In addition, the composition of frameshift proteins 
was analyzed by mass spectrometry. A more detailed evaluation of the MS method for 
frameshift protein analysis is described in Chapter 6.  
 
Chloramphenicol can inhibit peptidyl transfer during translation [32]. Addition of this 
drug into the culture should decrease the rate of peptidyl transfer, i.e. a decrease in kpt 
in the model. The model predicts that a smaller kpt causes a higher FS% and a lower 
fraction of FS
-1 (Figure 7.6). Consistently, a 2.1-fold increase in FS%exp is observed in 
the E. coli culture with 0.75 µg/ml chloramphenicol compared to the culture without 
the drug. The fractions of FS
-1 for the culture with and without chloramphenicol are 
17.3% and 20.4%, respectively (Figure 7.7.a). Although a slight decrease in the 
fraction of FS
-1 is observed in the presence of the drug, the difference is not 
statistically significant (p>0.05).   
 
The frameshift sequence for HIV-1 is U AAU UUU UUA, where a space separates 
each zero frame codon and the P-site is underlined. The E-site tRNAGUUAsn may form 
one canonical base pairing with the -1 frame UAA. In the MB2CCC strain, the 
sequence was mutated to C CCU UUU UUA (mutations shown in bold). The E-site 
tRNAGGGPro can form three canonical base pairings with the -1 frame CCC. Because  
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Figure 7.3. The effect of incomplete translocation (represented by rt) on -1 PRF. All 
the other parameters are assumed to be constant. (a) The effect of rt on the level of 
frameshift efficiency (FS%, blue line), frameshift protein incorporating a -1 frame aa-
tRNA at the recoding site (FS
-1, green line) and frameshift protein incorporating a zero 
frame aa-tRNA at the recoding site (FS0, red line). (b) The effect of rt on the fraction 
of FS
-1.
(a)
(b)
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Figure 7.4. The effect of the relocking step during translocation (represented by r4) on 
-1 PRF. All the other parameters are assumed to be constant. (a) The effect of r4 on the 
level of frameshift efficiency (FS%, blue line), frameshift protein incorporating a -1 
frame aa-tRNA at the recoding site (FS
-1, green line) and frameshift protein 
incorporating a zero frame aa-tRNA at the recoding site (FS0, red line). (b) The effect 
of r4 on the fraction of FS-1.
(a)
(b)
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Figure 7.5. The effect of the slippage of P- and A-site tRNAs before peptidyl transfer 
(represented by kpas2) on -1 PRF. All the other parameters are assumed to be constant. 
(a) The effect of kpas2 on the level of frameshift efficiency (FS%, blue line), frameshift 
protein incorporating a -1 frame aa-tRNA at the recoding site (FS
-1, green line) and 
frameshift protein incorporating a zero frame aa-tRNA at the recoding site (FS0, red 
line). (b) The effect of kpas2 on the fraction of FS-1. 
 
(a)
(b)
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Figure 7.6. The effect of the peptidyl transfer (represented by kpt) on -1 PRF. All the 
other parameters are assumed to be constant. (a) The effect of kpt on the level of 
frameshift efficiency (FS%, blue line), frameshift protein incorporating a -1 frame aa-
tRNA at the recoding site (FS
-1, green line) and frameshift protein incorporating a zero 
frame aa-tRNA at the recoding site (FS0, red line). (b) The effect of kpt on the fraction 
of FS
-1.
(a)
(b)
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Figure 7.7. Experimentally perturbing the system results in different levels of 
frameshift efficiency (FS%exp) and the fraction of FS-1. The total height of the column 
represents FS%exp. The green and the red portions in columns demonstrate the fraction 
of FS
-1 and FS0, respectively. The value for the fraction of FS-1 is also shown under 
each column. Error bars indicate the standard deviation for FS%exp. (a) The presence 
of chloramphenicol (Cm) results in higher FS%exp. The fraction of the FS-1 with and 
without the drug is not significantly different (p>0.05). (b) The MB2CCC strain 
results in higher FS%exp and FS-1 fraction compared to MB2 (linker sequences listed in 
Table 7.1). 
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incomplete translation (Pathway I) involves E- and P-site tRNAs to interact with the -1 
frame, CCC as the -1 frame E-site codon may enhance this reaction, i.e. an increase in 
rt in the model. The model predicts that a larger rt results in a higher FS% and a higher 
fraction of FS
-1. Consistently, a 1.5-fold increase in FS%exp is observed for the 
MB2CCC strain compared to the MB2 strain (Figure 7.7.b). In the MB2CCC strain, 
90.3% of the frameshift products are FS
-1. This result suggests that by changing the 
sequence to favor incomplete translocation, the composition of the frameshift product 
can be dramatically altered.     
 
7.7 Discussion 
In this study, a mathematic framework is developed for -1 PRF. To our knowledge, 
this is the first kinetic model to explain the existence of two types of -1 frameshift 
proteins. A ribosome can switch the reading frame during incomplete translocation, 
producing a frameshift product incorporating a -1 frame aa-tRNA in the frameshift site 
(FS
-1). Alternatively, a ribosome can switch the reading frame due to a slippage of P- 
and A-site tRNAs, generating a frameshift product incorporating a zero frame aa-
tRNA (FS0) in the frameshift site. Previous studies suggested that FS-1 may result from 
a single slippage of P-site tRNA [1,24,25]. However, it is not clear that when and how 
this single slippage of P-site tRNA occurs. In addition, the single slippage model does 
not explain the experimental evidence regarding the influence of translocation on -1 
PRF [21,22]. Our model suggests that both mechanisms, the incomplete translocation 
and the slippage of P- and A-site tRNAs, participate in making frameshift proteins at 
various extents for different -1 PRF signals. The frameshifting of the HIV-1 sequence 
was reported to generate 70% FS0 and 30% FS-1 [1,24], which may indicate a stronger 
influence of the slippage of P-site and A-site tRNAs than the incomplete translocation 
on FS%. Notably, our protein analysis showed about 80% FS0 and 20% FS-1 for the 
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frameshifting signal in HIV-1 group M subtype B. The discrepancy may due to the use 
of different reporter systems or the quantitative methods employed for the assay, 
which is discussed in Chapter 6. Frameshift products from other -1 PRF signals were 
analyzed previously [2,33]. For SARS-CoV frameshifting, FS
-1 was not found [2]. For 
Alphavirus coding sequence 6k, both FS0 and FS-1 were found in the frameshift 
products, but the exact ratio was not determined [33].  
 
In the presence of chloramphenicol, a 2.1-fold increase in FS%exp was observed while 
the fraction of FS
-1 was not significantly different compared to the culture condition 
without the chemical (Figure 7.7.a). The model predicts that kpt has a relatively 
smaller effect on FS% and the fraction of FS
-1 than rt and kpas2 (Figure 7.6). A dual 
fluorescence reporter can sensitively detect small change in FS% in E. coli and 
mammalian cells [26,29,34]. On the other hand, analyzing the composition of the 
frameshift products relies on steps of protein purification, gel electrophoresis, in gel 
trypsin digestion, liquid chromatography, and mass spectrometry. The multistage 
preparation may cause variation in the sample yield, making the detection of a small 
change difficult.  
 
Mutation of the -1 frame E-site sequence to CCC in the HIV-1 frameshift site may 
enhance incomplete translocation by allowing more interactions between E-site tRNA 
and the -1 frame. A significant increase in the fraction of FS
-1 was observed in the 
MB2CCC strain (Figure 7.7.b). This result is consistent with the model that two 
mechanisms exist and participate in making frameshift proteins to different extents. 
The creation of a favorable condition for one pathway can affect the composition of 
frameshift proteins significantly. To date, no mutations to change the composition of 
frameshift proteins have been reported in the literature. Notably, our experimental 
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results show that in one case, FS% increases significantly without a change in the 
composition of frameshift products (Figure 7.7.a), while in another condition FS% 
increases a smaller amount but the composition of frameshift products change 
dramatically (Figure 7.7.b).  
 
7.8 Supplementary data 
7.8.1 Mathematic model 
In the kinetic model (Figure 7.2), the formation rate of each component can be written 
as the following:  
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By assuming steady state, the formation rates of the intermediates equal to zero. The 
expressions of non-frameshift proteins NFS (P0A0pt), frameshift proteins FS-1 
incorporating -1 frame aa-tRNAs in the frameshift site (P2A2pt) and frameshift proteins 
FS0 incorporating zero frame aa-tRNAs in the frameshift site (P02A02pt) in terms of PA 
are solved by Matlab v.R2008a (MathWorks Inc., USA). Table 7.S1-7.S4 lists the 
parameter values used in the model. 
 
 
Table 7.S1 The rate constants for different steps during translocation at 37oC.  
 Step  Symbols  Rate constants (s-1) 
 EF-G:GTP binding  r1  150 a,b   
   r
-1  140 a   
 EF-G catalyzed GTP hydrolysis  r2  250 a  
 EF-G conformation change  r3  35 a 
 tRNA movement  rTL0  500 c 
 Rearrangement of ribosome  r4  5 a  
 EF-G dissociation  r5  20 a 
  rt  1 d 
  r
-t  10 d 
 
a Wintermeyer et al. [35]  
b
 µM-1s-1 
c
 Assumed value in the study. A rapid reaction according to Wintermeyer et al. [35] 
d
 Assume value in the study 
 
  167 
 
 
 
 
 
 
 
Table 7.S2 The rate constants for different steps in aminoacyl-tRNA selection at 20oC. 
The rate constants used in the model equal the rate constant at 20 oC multiplied by fold 
change from 20oC to 37oC (Table 7.S3). 
 
 Step  Symbols Rate constants (s-1) 
Initial binding  k1, ki  110 a,b 
   k
-1, k-i  25 a 
Codon recognition  k2, ki2   100 a 
   k
-2, k-i2   0.2 a 
GTPase activation and GTP hydrolysis*  k3, k4, ks4 
  
 260 a 
EF-Tu conformational change 
(dissociation)  k5, ks5  60
 a
 
tRNA rejection  k6   0.3 a 
Accommodation  k7, ks7  7 a 
  kpt  50 c 
Simultaneous slippage before GTP 
hydrolysis  kpas1  1
d
 
   k
-pas1  10 d 
Simultaneous slippage before peptidyl 
transfer  kpas2  1
 d
 
  k
-pas2  10 d 
 
a Rodnina et al. [36]. 
b
 µM-1s-1 
c
 Rate constant at 37oC; Katunin et al. [37]  
d Assumed values in the model 
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Table 7.S3 The activation energy for different steps in the model and the fold change 
of the rate constants (k310K/k293K, from 20oC to 37oC). 
     
 
  
 
 
 
 
 
 
 
 
 
 
a
 Rodnina et al. [38].  
b
 Thompson et al. [39]. 
c
 Gromadski et al. [40]. 
d
 Karim et al. [41] 
e
 Assumed values in the model 
 
 
 
 
 
Table 7.S4 The concentration of the components used in the model.  
 
Components Symbols Parameter values 
Initial reactant  PA 1a 
Zero-frame aa-tRNA A0 (%) 10a 
-1 frame aa-tRNA A2 (%) 10a 
 
a
 Assumed value in the model (µM). 
 
 
 Ea (kJ/mol) k310k/k293k 
k1, k1s 10 ± 6a 1.25 
k
-1, k-1s 46 ± 5 a 2.82 
k2, k2s 38 ± 8a 2.36 
k
-2, k-2s 44 ± 5 a 2.7 
k3, k3s 55b 3.45 
k4, k4s 55b 3.45 
k5, k5s 155 d 33  
k6, k6s 55 e 3.45  
k7, k7s 55 e 3.45  
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Table 7.S5 The list of target peptides and their MRM parameters. All peptides were 
confirmed by a Mascot search of their MS/MS spectra against a custom-made 
database (p<0.05). 
 
a
 Type of frameshift products 
 b
 Theoretical molecular weight (Da) 
c
 Precursor ion m/z 
d
 Fragment ion m/z 
e
 Charge state 
f
 Collision energy (V) 
 
 
7.8.2 Sensitivity analysis 
A program was developed in Matlab v.R2008a to perform an n-way analysis of 
variance (ANOVA). Each parameter can vary for 5 levels: a base line value, ± 25% 
of the base line, ± 50% of the base line. Randomly selected 10,000 parameter sets are 
used to calculate FS%. The analysis calculates F statistic value for each tested 
parameter (Figure 7.S1). A higher F statistic indicates a larger impact of the parameter 
on FS%.  
 
 
7.9 Conclusion 
A mathematic framework is developed for -1 PRF upon the translation elongation 
cycle. The model presents not only the change in frameshift efficiency, but also the 
change in the composition of frameshift products under different conditions. In 
addition, the model identifies dominating parameters, representing steps in the  
translation elongation, on -1 frameshifting. Experimentally targeting these steps results 
in different levels of frameshift efficiency, which are consistent with model 
predictions. A mutation in the -1 frame E-site sequence was shown to dramatically 
Strain FSa Sequence Theor MWb Prec m/zc Frag m/zd ze CEf 
MB2/MB2Cm FS0 HSTGAASTANFLR 1331.68 444.90 620.40 3 22.580 
MB2/MB2Cm FS
-1 HSTGAASTANFFR 1365.58 456.20 654.30 3 23.073 
MB2CCC FS0 HSTGAASTAPFLR 1314.67 439.23 532.32 3 22.326 
MB2CCC FS
-1 HSTGAASTAPFFR 1348.63 450.55 566.30 3 22.824 
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Figure 7.S1. Sensitivity analysis using n-way analysis of variance (ANOVA). A 
higher F statistic value suggests a more significant impact of the parameter on FS%. 
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change the composition of frameshift products, suggesting an important role for the 
sequence upstream of the slippery site. Our results suggest that not only the frameshift 
efficiency, but also the compositions of the frameshift products are worth investigated 
to advance our knowledge for -1 PRF.  
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CHAPTER 8 
FROM SNPS TO FUNCTIONAL POLYMORPHISM: THE INSIGHT INTO 
BIOTECHNOLOGY APPLICATIONS 
 
8.1 Preface 
During my Ph.D studies, I was given an opportunity to learn and write about a 
different aspect of molecular biology that can impact protein expression. A single 
nucleotide polymorphism (SNP) is the most common genetic variation in the human 
genome. SNP studies provide opportunities to understand how nucleotide variations 
contribute to altered gene expressions, which may result in different phenotypes. This 
chapter is a review for SNP analysis and its potential for biotechnology applications. 
 
8.2 Abstract 
Single nucleotide polymorphisms (SNP) are the most common form of genetic 
variation in the genome. Scanning a genome for SNPs can help identify millions of 
potentially informative biomarkers. SNPs have been extensively used as molecular 
markers in human disease genetics, pharmacogenetics, and breeding, but SNPs have 
not been widely used in the bioprocess community. In biotechnology applications such 
as bioprocess development, SNPs may serve as genetic markers for phenotypes of 
interest such as those related to cell growth and viability, specific productivity, or 
stability. Furthermore, SNPs that relate to particular phenotypes may be targets for 
metabolic and cellular engineering. This review introduces study designs that have 
been used to link SNPs and phenotypes. The review then focuses on the downstream 
effects of the SNPs at DNA, RNA and protein levels. Finally, this review discusses 
specific examples to apply SNPs for breeding, strain evolution, and biomolecule 
production. Large scale SNP studies represent an opportunity to apply new genome-
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scale technologies to address current limitations and questions relevant to the 
biotechnology community such as cell line generation and selection. 
 
8.3 Introduction 
A single nucleotide polymorphism (SNP) is a nucleotide variation at a specific 
location in the genome (Figure 8.1). (Table 8.1 provides a glossary of terms in SNP 
studies). Typically, SNPs are bi-allelic and by definition found in more than 1% of the 
population [1]. In practice, tri- or tetra-allelic SNPs, insertions, deletions and 
variations found in less than 1% of the population are also referred as SNPs. SNPs are  
the most abundant variations in the human genome [2,3]. The International HapMap 
Project has characterized over 3.1 million human SNPs, indicating a SNP density of 
approximately one per kilobase [4]. 
 
Discrimination of genetic variants has great potential to unravel the molecular basis 
for “super producer strains” and to gain insight into functional genomics for 
biotechnology applications. Although genotyping of common recombinant hosts (e.g. 
Chinese hamster ovary or CHO cells) has not been reported in the literature, SNP 
analysis has been widely used in human disease genetics, pharmacogenetics, and 
breeding. These studies attempt to predict diseases, drug responses, and breeds with 
higher economic value based on the variations in the genetic sequences. We believe 
that these same approaches may help the bioprocess research community predict strain 
performance by searching for specific SNPs in relevant recombinant host cells. 
Furthermore, an understanding of the downstream effects of the genetic variation is 
critically important and can provide targets for metabolic and cellular engineering 
studies to design hosts with specific phenotypic characteristics of interest to the 
bioprocess community. For example, newly introduced transgene sequences can be 
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Figure 8.1. An example of single nucleotide polymorphisms (SNPs) and the haplotype 
observed in six subjects (concept adapted from [2]). Four SNPs (A/G, C/T,G/A, and 
C/G/T) are found, where A/G,C/T and G/A are bi-allelic SNPs and C/G/T is a tri-
allelic SNP. Theoretically, these four SNPs allow 24 haplotypes, but only five 
haplotypes are found in the six subjects.  
   
TCGACTACTCTA...CGTTCAGGCGT...ACGCATTACGGCGTCC
TCGACTGCTCTA...CGTTTAGGCGT...ACACATTAGGGCGTCC
TCGACTACTCTA...CGTTCAGGCGT...ACACATTACGGCGTCC
TCGACTGCTCTA...CGTTCAGGCGT...ACGCATTACGGCGTCC
TCGACTACTCTA...CGTTCAGGCGT...ACACATTATGGCGTCC
TCGACTACTCTA...CGTTCAGGCGT...ACACATTACGGCGTCC
A-C-G-C
G-T-A-G
A-C-A-C
G-C-G-C
A-C-A-T
SNP A/G                        C/T            G/A         C/G/T
Haplotype
Subject 1
Subject 2
Subject 3
Subject 4
Subject 5
Subject 6
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Table 8.1 Glossary of terms in single nucleotide polymorphism (SNP) studies 
Term Description 
Alleles Alternate forms of a gene of chromosomal locus that differ in DNA 
sequence 
Biallelic Only two of the four common nucleotides are found in a specific 
position 
Expressed sequence 
tag 
Short sub-sequence of a transcribed cDNA sequence that may be 
used for gene identification 
Genotype Inheritable genetic constitution carried by living organisms  
Haplotype A set of alleles located at neighboring genes or genomic sequences 
that tend to be inherited together 
HapMap Genome-wide database of common genetic sequence variation in 
human 
Non-synonymous 
SNP 
A single nucleotide variation in the coding sequence that results in a 
change in amino acid sequence 
Pharmacogenomics  The study to understand the effect of genetic polymorphisms on 
drug responses 
Phenotype The physical manifestation of genetic information 
Single nucleotide 
polymorphism (SNP) 
A single nucleotide variation in the genetic sequence 
Synonymous SNP A single nucleotide variation in the coding sequence that results in 
no change in amino acid sequence 
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adjusted to ensure optimal production or host metabolism can be modified to favor the 
recombinant protein expression. Figure 8.2 shows a proposed framework from SNP 
identification to potential bioprocess applications. Following this framework, this 
review first introduces how SNPs are discovered and associated to a phenotype of 
interest. The second part describes different mechanisms of how SNPs can contribute 
to phenotypes. Finally, several biotechnology applications will be discussed. 
 
8.4 SNP analysis 
The recent availability of high-throughput genotyping technologies has made large 
scale genome scans possible. Several reviews are available for genotyping 
technologies [5-8] and our goal here is not to present an extremely detailed treatment 
of all available technologies; we direct the reader to those reviews for such an 
analysis. In general, SNP analysis involves three steps. First, SNPs are identified and 
mapped onto known gene sequences or genomes. Second, the genome sequence can 
be scanned for the presence or absence of known SNPs. Third, SNPs in the genome 
are linked to a specific phenotype.   
 
8.4.1 SNP discovery  
Several methods are used for SNP discovery. One of the most straightforward ways to 
discover novel SNPs is to sequence DNA fragments amplified by polymer chain 
reaction (PCR). PCR primers are designed to amplify both strands of DNA from genes 
or other single copy genomic sequences. PCR products are sequenced and aligned into 
gene sequences, allowing novel SNP identifications. The International HapMap 
project has primarily used this approach to discover SNPs in the human genome [3].  
SNP discovery by sequencing amplified DNA fragments is very reliable, with the false 
discovery rate below 5% [6]. However, this method is costly and requires enormous 
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Figure 8.2. A possible framework for SNP applications in the biotechnology industry. 
The approach starts with identifying phenotypes of interest. The genetic sequences of 
different subjects are tested for variations. Relevant SNPs are investigated further for 
their functionalities. The knowledge of functional genomics can provide insight into 
genetic engineering for biotechnology applications. In addition, functional genomics 
also help researchers to identify candidate genes for SNP analysis. The molecular 
markers associated with a specific phenotype can also be directly used as selective 
markers for strain developments in biotechnology.    
 
SNP genotyping and association studies 
Functional genomics
Biotechnology applications
Identify associated 
variations
Identify 
candidate genes
Identify phenotypes of interest  
Molecular 
markers
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effort because specific primers have to be developed and large numbers of sequences 
need to be amplified and sequenced.  
 
SNP identification can be based on expressed sequence tags (ESTs), which are 
generated by single-run sequencing of cDNAs. The resulting sequences are relatively 
short and low quality fragments. Because the majority of EST libraries have been 
obtained from different individuals, assembly of overlapping sequences for the same 
region permits novel SNP discoveries. As a result, EST data provides a valuable 
resource for SNP mining, especially when a reference genome is not available [9-11]. 
However, because many sequence variations may result from poor quality sequencing, 
this method has higher false discovery rate from 15 to 50% [6].  
 
Recent advances in so-called next generation sequencing technology enables millions 
of sequence reads in parallel, allowing whole genome sequencing in a fast and a low 
cost manner [12]. With a reference genome, re-sequencing using this technology 
provides a high throughput platform for the SNP discovery [8]. If no reference 
genome is available, next generation sequencing technology can be applied to 
sequence ESTs to allow an efficient SNP discovery, although this approach is limited 
to discovering SNPs in known expressed genes.    
 
8.4.2 SNP detection 
Once a large number of SNPs has been identified, it is critical to quantify the presence 
of the variation in a larger scale study. Specifically, the gene sequences, or genomes, 
of different subjects are tested for a set of known SNPs. Kim et al. summarized 
detection methods, analysis scales, strengths and applications for different genotyping 
technologies based on selected SNPs [7] and the reader is referred to that article for a 
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detailed treatment. Medium- to high-throughput genotyping technologies, such as 
BeadArrayTM (Illumina, San Diego, CA) or MassEXTENDTM (Sequenom, San Diego, 
CA), can assay several hundred SNPs simultaneously [7]. Genechip® (Affymetrix, 
Santa Clara, CA), a microarray based genotyping technology, can assay 104 to 105 
SNPs throughout the genome [7]. Because genotyping technologies usually involve 
primer extension near a SNP site or hybridization of sequences spanning a SNP site, 
the major challenge for these technologies is the requirement of prior knowledge of 
SNPs. An additional challenge is that most of the technologies available for SNP 
detection can detect only binary variations. Interestingly, next generation sequencing 
technology allows SNP discovery coupling with SNP detection and is not limited to 
binary variations. Although this approach is mostly used in SNP discovery to date, 
further technology development may lead to a next generation SNP analysis method if 
appropriate bioinformatic tools become available.   
 
8.4.3 Study designs to relate a SNP to a phenotype 
Two approaches are commonly used to link SNPs to a phenotype of interest: 1) a 
candidate gene association study and 2) a genome-wide association study (Table 8.2). 
Although these approaches are developed for human disease genetics, they are 
applicable to strain characterizations in the biotechnology industry.  
 
A candidate gene association study begins with genes that are suspected to associate 
with a phenotype of interest [13]. These candidate genes are usually identified from 
specific biological pathways based on a literature search. This type of the study 
compares candidate genes in case and control populations. The number of genes under 
investigation could be 1 to 2 (single-gene based), 10 to 20 (gene family based), or 50 
and up (biological pathway based). Because of a small to medium scale analysis, both 
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the direct sequencing of candidate genes and the use of a genotyping technology to 
detect known SNPs are applicable for candidate gene association studies. Among 
these two methods, direct sequencing of candidate genes may lead to novel SNP 
discoveries. With the completion of the sequencing and annotation of the human 
genome, where about 45,000 genes have been identified and over twenty-five million 
SNPs reported in National Center for Biotechnology Information’s website, a 
candidate gene association study becomes an effective approach for identifying  
phenotype-causing variations in humans. One major challenge for candidate gene 
association studies is their dependence on prior knowledge about genes or biological 
pathways, which may be incomplete. Thus, candidate gene association studies are less 
likely to identify variations in a new gene associated with a phenotype. 
 
A genome-wide association (GWA) study assays more than 100,000 SNPs for 
hundreds of unrelated subjects. The relationship between a specific genotype and a 
phenotype is used to characterize susceptibility genes that are associated with 
observable traits. Because of a large scale analysis, GWA studies use high-throughput 
genotyping technologies based on selected SNPs [7]. GWA studies provide the 
opportunity to discover novel genes involved in a phenotype because they do not 
depend upon prior knowledge of the biological pathways. However, the GWA 
approach has a potential for false-positive or false-negative results related to the 
selection of study participants and genotyping errors [14].  
 
8.5 How SNPs lead to different phenotypes 
SNPs are not evenly distributed across the genome. In general, SNPs occur much less 
frequently in coding regions of the genome than in noncoding regions [15]. SNPs in 
regulatory sites of a gene can affect transcription rates, thereby changing the  
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Table 8.2 Different types of genetic studies to connect SNPs to a phenotype 
Method Description 
Candidate 
gene studies 
Variations in genes suspected to associate with a phenotype are compared. 
Pros. Increased statistical efficiency of association analysis of polygenic 
phenotype 
Cons. May be based on imperfect understanding of the biologic pathways  
Genome-
wide 
Association 
(GWA) study  
SNPs associated with observable traits across given genomes are identified 
by using high-throughput genotyping technologies.  
Pros. Search the entire genome for associations without assuming 
candidates. 
Cons. Has potential for false-positive and false-negative results and for 
biases related to selection of study participants and genotyping errors 
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expression of corresponding proteins. In coding regions, exonic SNPs can be 
categorized into two classes: non-synonymous SNPs that alter the amino acid 
sequence of the protein products and synonymous SNPs that do not affect primary 
sequence of the products. Non-synonymous polymorphisms have been more widely 
characterized because their effects are relatively easy to detect computationally and 
experimentally. Proteins with the same sequence derived from synonymous SNPs 
were previously assumed to exert no discernible effect on a gene function or a 
phenotype. These gene variants are often termed “silent mutations”. However, several 
synonymous mutations have been reported to alter gene expression or protein folding 
[16-18]. Recently, a synonymous codon library has been shown to result in different 
levels of gene expression [19]. These reports demonstrate that synonymous SNPs can 
also produce different phenotypes.  
 
The molecular effects of SNPs are now better understood in many cases. Several 
bioinformatic tools have been developed to predict functional SNPs [20]. Based on the 
central dogma, SNPs should affect phenotypes at the DNA, RNA and protein levels. 
The following section discusses several mechanisms for how SNPs affect phenotypes. 
It is import to note that these mechanisms are not exclusive. For example, a non-
synonymous SNP may affect gene expression at both RNA and protein levels.  
 
8.5.1 DNA level: from DNA to RNA 
Regulatory polymorphisms can potentially cause variations in gene expression. An 
early study observed that about a third of the promoter variants in the human genome 
may alter gene expression by 50% or more [21]. Regulatory polymorphisms can be 
classified into two groups: a cis-acting polymorphism affects genes in or near the 
locus and a trans-acting polymorphism in one gene affects the expression of another 
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gene at a different locus.  
 
A SNP in a regulatory DNA binding site may alter the affinity with the regulatory 
protein, resulting in different gene expressions (Figure 8.3). SNPs in the osteopontin 
promoter have been shown to modify DNA binding affinity to transcription factors 
SP1/SP3 [22]. A GWA study revealed a G-to-A substitution in the 5’ untranslated 
region (5’-UTR) of the FOXE1 gene to associate with thyroid cancer susceptibility  
[23]. Recently, this variant was found to alter the recruitment of USF1/USF2 
transcription factors [24]. The T-to-C substitution located in the 5’-UTR of the GDF5 
gene causes a different interaction with DEAF-1, a trans-acting factor for GDF5, 
leading to a reduced gene expression [25]. In addition, a SNP in 3’-UTR of GDF5 can 
alter the gene expression independent of the SNP in 5’UTR, highlighting the 
complexity of this gene regulation. 
 
8.5.2 RNA level: from RNA to protein 
SNPs can alter mRNA folding and thus affect mRNA stability (Figure 8.4.a). In the 
dopamine receptor D2 gene, a synonymous variation C957T resulted in different 
mRNA structures [26]. The authors suggested that different folding caused the mRNA 
carrying C957T to be degraded more rapidly than the wild type sequence. As a result, 
less of the encoded protein is made, leading to cognitive disorders. An intragenic SNP 
in the CDSN gene (CDSN*971T) decreased the transcript affinity for a 39 kDa RNA 
binding protein, which increased mRNA stability two-fold and up-regulated the CDSN 
product, corneodesmosin, in patients with Psoriasis, a chronic skin disorder with 
multifactorial etiology [27]. Similarly, the characterization of two nonsynonymous 
SNPs, C74A and G223A, in the mTPH2 gene revealed that A-A, C-A and A-G 
haplotypes increased mRNA stability and enzyme activity as compared to wild-type 
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Figure 8.3. An example of the effect of a SNP on DNA and transcriptional levels. 
Regulatory SNPs may alter DNA affinity to a transcription factor, resulting in 
different mRNA levels.  
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C-G haplotype [28]. Because mTPH2 synthesizes neuronal serotonin, the up-
regulation of the protein activity is hypothesized to lead to psychiatric disorders. 
 
The different structures of mRNA caused by SNPs may also alter the protein synthesis 
rate (Figure 8.4.b). In catechol-O-methyltransferase, three haplotypes result in 
different mRNA local stem-loop structures. The most stable structure is correlated 
with the lowest protein levels and enzymatic activity [29]. Because catechol-O-
methyltransferase is a key regulator of pain perception [30], variations in enzyme 
activities cause changes in pain sensitivity in patients.  
 
SNPs can affect the efficiency of translation initiation (Figure 8.4.c). In the Kozak 
sequence of the hCD40 gene, C-T, T-T and C-C haplotypes were shown to result in 
similar mRNA levels but different protein levels. The authors suggested that the C 
polymorphism in the Kozak sequence allowed the ribosome to initiate translation more 
efficiently, resulting in a higher protein level [31]. 
 
By modifying translation elongation, SNPs may alter protein conformations (Figure 8. 
4.d). Synonymous codon substitutions may lead to different kinetics of protein 
translation, thus yielding a protein with a different final conformation and function 
[32]. Kimchi-Sarfaty et al. reported that a naturally occurring synonymous SNP can 
result in altered drug interactions of P-glycoprotein (P-gp) [33]. The authors suggested 
that the synonymous polymorphism affects the timing of cotranslational folding and 
the insertion of P-gp into the membrane, thereby altering the structure of substrate and 
inhibitor interaction sites. This result indicates that synonymous SNPs might 
contribute to development and progression of certain diseases and should not be 
neglected. 
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Pre-mRNA splicing is a complex mechanism that relies on the correct recognition of 
protein coding sequences (exons) from the non coding sequences (introns) on RNA 
transcripts [34]. Figure 8.4.e illustrates how SNPs might affect mRNA splicing. 
Natural mutations D565G and G576A and several site-directed silent substitutions in 
the cystic fibrosis transmembrane-conductance receptor (CFTR) exon 12 were shown 
to induce a variable extent of exon skipping [35]. Skipping of this exon removes a part  
of the first nucleotide-binding domain of CFTR, rendering the protein non-functional.  
 
MicroRNAs (miRNAs) are a class of noncoding RNAs that can regulate gene 
expression by base pairing with target mRNAs at the 3'-UTRs, leading to an mRNA 
cleavage or translational repression [36]. SNPs in miRNA genes may alter miRNA 
processing while SNPs around the miRNA binding sites in the target mRNAs may 
affect miRNA function. SNPs in miRNA-125a and miRNA-K5 were reported to 
impair miRNA processing [37]. Sun et al. tested 24 human X-linked miRNA variants 
in schizophrenia and autism and reported that SNPs in miRNA genes can impair or 
enhance miRNA processing as well as alter the sites of processing [38]. 
 
8.5.3 Protein level: from polypeptide formation to post-translation modification 
At the protein and post-translational levels, a substantial effort has been invested in the 
function of non-synonymous SNPs because their downstream effects are relatively 
easy to characterize. Several reviews have described how non-synonymous SNPs 
affect protein functions and interactions [39-41]. The following section presents the 
change in protein activities in terms of protein stabilities, binding affinities, catalytic 
properties, and post-translational modifications (Figure 8.5).   
 
Variation in protein stability due to SNPs in coding sequences can cause different 
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Figure 8.4. Several examples of the effects of SNPs on mRNA and translational levels. 
(a) A SNP may alter mRNA folding and increase stability, allowing higher level of 
protein production. (b) A SNP may increase the stability of the mRNA structure, 
permitting less protein translation. (c) A SNP in Kozak sequence alters the efficiency 
of translation initiation, resulting in different protein levels. (d) A SNP in the coding 
sequence changes the kinetics of protein translation, resulting in proteins with 
different conformations. (e) A SNP in the exon region induces an exon skipping, 
resulting shorter products. 
 
degradation
5’
mRNA
SNP
ribosome
5’
mRNA
degraded 
mRNA
Protein
(a)
Protein
5’
mRNA
5’
mRNA
ProteinSNP
ribosome
(b)
Kozak sequence 
SNP
ribosome
Protein Protein
5’
mRNA
5’
mRNA
SNP
ribosome
Protein with 
conformation A
Protein with 
conformation B
5’
mRNA
5’
mRNA
Exon1 Exon2 Exon3
Intron1 Intron2
RNA 
transcript
Mature RNA 
transcript
Exon1
Exon2 
with a 
SNP Exon3
Intron1 Intron2
SNP
(c) (d)
(e)
  192 
levels of enzyme activities. Thiopurine S-methyltransferase (TPMT) catalyses the S-
methylation of thiopurine drugs. Several human TPMT variant alleles that alter the 
encoded amino acid sequence of the enzyme generate less stable proteins [42]. 
Therefore, patients with those alleles have very low TPMT activity and suffer severe, 
life-threatening drug toxicity when treated with ‘standard’ doses of thiopurine drugs  
[43]. A non-synonymous SNP (A428G) in human S-adenosylhomocysteine hydrolase 
(AdoHcyase) is found in patients with AdoHcyase deficiency [44]. This mutation 
decreased the unfolding temperature by 7 oC as compared to a wild-type protein. The 
mutant protein is more sensitive to temperature change and undergoes accelerated 
aggregation with increasing temperature [45].  
 
Non-synonymous SNPs may alter protein binding affinities and catalytic properties. A 
SNP is known to alter the regulation of arginine biosynthesis in E. coli K12 and B 
strains [46,47]. In E. coli K12, arginine represses the expression of arginine 
biosynthesis genes and the absence of arginine activates the expression of these genes. 
In E. coli B, these genes are constitutively expressed at low levels regardless of the 
presence of arginine [48]. These different regulatory patterns result from a SNP at site 
70 in the arginine repressor (ArgR) sequence, where the proline of ArgRK12 is replaced 
by leucine in ArgRB [47]. X-ray crystallography [49,50] indicated that Pro70Leu 
mutation may alter communications between the DNA-binding domain and the 
arginine-binding domain by increasing peptide main-chain flexibility. In the absence 
of arginine, ArgRB has a higher binding affinity to the DNA operator than ArgRK12. In 
the presence of arginine, arginine-ArgRB has a lower binding affinity to the DNA 
operator than arginine-ArgRK12. As a result, E. coli cells carrying ArgRB are capable 
of neither full induction nor complete repression and remain weak constitutive for 
arginine biosynthesis gene expression, whereas those carrying ArgRK12 are strongly 
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Figure 8.5. An example of the effect of a SNP on the protein and post-transcriptional 
levels. A non-synonymous SNP alters amino acid sequence, which may change 
protein conformation. Variations in protein folding may result in different protein 
stabilities, binding affinities, catalytic properties, and post-translational modifications  
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regulated. Non-synonymous SNPs in the fimH gene can alter the affinity of type 1 
fimbriae of uropathogenic E. coli for mono-mannose urothelial receptors [51,52]. The 
stronger adhesion strains conferred increased virulence in the mouse urinary tract. 
Pregnane X receptor (PXR) is a master transcriptional regulator of many 
drug/xenobiotic-metabolizing enzymes. Functional analysis of four naturally occurring 
human PXR variants showed that the Arg98Cys variant altered the DNA binding 
ability and thus failed to transactivate a reporter containing a PXR responsive element 
[53]. Melanoma is the most lethal of all skin cancers. Gartside et al. reported that 10% 
of melanoma tumors and cell lines harbor mutations in the fibroblast growth factor 
receptor 2 gene [54]. With crystal structure mapping, in vitro and in vivo studies, these 
mutations were shown to damage protein functions by altering ligand binding affinity, 
impairing receptor dimerization, destabilizing of the extracellular domains, and 
reducing kinase activity. 
 
Non-synonymous SNPs can affect post-translational modifications. Because protein 
phosphorylation is one of the key elements in signal transduction, an altered 
phosphorylation pattern can cause different responses to the environment. The human 
ERG1 channel polymorphism is associated with cardiac arrhythmias [55]. Gentile et 
al. reported that a SNP leading to a Lys897Thr substitution creates a phosphorylation 
site in ERG1, which in turn inhibits channel activity for the downstream signal 
transduction [56]. Trypsinogen is the most abundant digestive proenzyme produced by 
the pancreas in human [57]. Ronai et al. identified a naturally occurred SNP causing 
Asp153His substitution in the PRSS2, an anionic trypsinogen [58]. Because Asp153 is 
the main determinant of tyrosine sulfation in anionic trypsinogen, Asp153His 
substitution would result in a complete loss of trypsinogen sulfation in PRSS2. 
Although tyrosine sulfation had no significant effect on the activation of anionic 
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trypsinogen, the sulfation may play a role in stimulating autoactivation of a cationic 
trypsinogen, PRSS1.   
  
8.6 Applications to the biotechnology industry 
Although not yet widely applied in the context of biochemical engineering and the 
biotechnology industry, we believe that knowledge of SNPs may be applied in three 
ways. First, SNPs are genetic markers for a desired phenotype. For example, most 
conventional trait markers and molecular markers for animal or crop breeding are 
based on SNPs. Second, SNPs identified in adaptive evolution help to characterize 
strains and understand biological pathways. Finally, the molecular effects of SNPs can 
be used to improve biomolecule production. The following sections will provide 
examples for each use from the literature that demonstrate the power of SNP 
knowledge.  
 
8.6.1 Breeding 
SNPs have been extensively used in animal breeding. Because SNPs may alter the 
expression of the genes participating in inflammation, SNPs are used to define an 
animal's risk of developing chronic infection. A SNP (C1185T) in IL-10Ralpha is 
significantly associated with somatic cell score, a trait highly correlated with the 
incidence of mastitis [59]. In the same study, the haplotype in IL-10Ralpha A-A-T 
showed higher somatic cell score compared to the most common haplotype. As a 
result, these markers could serve as risk factors for dairy herd breeding. SNPs can be 
used as selective markers to improve product quality. Kim et al. identified a C-to-T 
SNP in the 5’ UTR of the myogenin gene to associate with muscle fiber and lean meat 
production in pig breeding [60]. Schennink et al. genotyped several candidate genes, 
FASN, OLR1, PPARGC1A, PRL and STAT5A, in cows and found that an A-to-G 
  196 
substitution in FASN and a C-to A substitution in OLR1 have a significant effect on 
milk-fat percentage [61]. 
 
Recently, SNP markers have gained importance in crop breeding. A SNP causing a 
Lys71Asn substitution in rice alternative oxidase gene was found to contribute to 
different low temperature tolerance [62]. To obtain effective and durable fungal 
resistance wheat cultivars, Lagudah et al. analyzed variations in the Lr34 gene [63]. 
This study identified three polymorphisms, a SNP in intron 4, a 3bp deletion in exon 
11 and a SNP in exon 12, to differentiate pathogen susceptible and resistant wheat 
cultivars. Therefore, these variations can be used as markers to predict pathogen 
resistance trait in wheat breeding. Wang et al. suggested that gene variants can help to 
determine the shelf life in apples [64]. A SNP in the coding region of the apple ACS3a 
gene causes a Gly289Val substitution in the active site, rendering the enzyme, 1-
aminocyclopropane-1-carboxylic acid synthase (ACS), non-functional. This enzyme 
plays a key role for ethylene production, driving the ripening process. Apple cultivars 
such as Kitaro and Koukou containing this SNP show much lower ACS activity and 
maintain fruit firmness for a longer period of time. We believe that the application of 
SNPs to identify strains of interest, whether animals, rice, apples, or Chinese hamster 
ovary or E. coli cells, represents an important step forward. 
 
8.6.2 Strain evolution  
SNPs can provide insight into adaptation processes to the environment. Particularly, 
several studies have used SNPs to characterize epidemic pathogens. Zhang et al. 
analyzed 1199 chromosomal genes and 92,721 bp of the large virulence plasmid 
(pO157) of eleven outbreak-associated E. coli O157 strains [65]. A total of 906 SNPs 
in 523 chromosomal genes was identified. The systematic analysis of SNPs is useful 
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for outbreak investigations, because the result can provide insights to an 
epidemiologic assessment of associations between bacterial genotypes and disease 
[66]. Pseudomonas aeruginosa causes entailing acute pneumonia and sepsis 
accompanying with various mortality rates in human [67]. Smith et al. performed 
whole genome sequencing for early and late P. aeruginosa isolates [68]. The study 
revealed several SNPs in the late isolate that were advantageous to for living in hosts. 
Interestingly, many genes involving in virulence lost their functions in the late isolate, 
indicating that these gene products may become a burden once the chronic infection 
has established. The genetic difference between early infectious strains and late 
adaptive strains may offer new therapeutic opportunities. Influenza viruses can 
develop antiviral drug resistance, a major challenge for public health epidemiology. 
Sheu et al. identified SNP markers to monitor influenza resistance to two antiviral 
drugs, oseltamivir and zanamivir [69]. By using SNP markers, they also detected a rise 
in oseltamivir resistance among A (H1N1) viruses isolated from untreated patients. 
Because oseltamivir is the most frequently prescribed antiviral agent in the United 
States for the control of seasonal influenza infections, monitoring the drug resistance 
by SNPs provides an efficient surveillance system for the public health care agency.  
 
Strain evolution studies based on SNPs are not limited to pathogens. Several non-
synonymous SNPs in the MalT activator protein are associated with glucose-limited 
adaptation in E. coli [70]. MalT is a central protein in maltose regulon [71]. The 
maltose regulon can control the expression of the LamB protein, which, in turn, 
controls outer membrane permeability for nutrient uptake [72]. In another study of E. 
coli glucose-limited chemostats, a single T-to-A substitution upstream of the gene 
encoding acetyl CoA synthetase was believed responsible for the semiconstitutive 
overexpression of this synthetase [73]. The higher level of acetyl CoA synthetase may 
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contribute to the crossfeeding phenotype, in which one type of cell secretes acetate 
that another cell can use as a resource in a glucose-limited condition. Herring et al. 
studied the genetic basis of the adaptation to glycerol minimal medium for five E. coli 
populations [74]. The study confirmed 17 SNPs in the five E. coli clones. These SNPs 
lead to several key genes for glycerol adaptation in E. coli: all clones had mutations in 
the gene for glycerol kinase (glpK), which catalyzes the first step in glycerol 
catabolism; mutations in genes encoding the two major subunits of RNA polymerase 
(rpoB and rpoC) contributed to 48%–65% of the total change in growth rate for 
glycerol adaptation. These results provide insight for glycerol metabolism in E. coli. 
Interestingly, there are SNP hotspots in core genes of E. coli under short term positive 
selection [75]. This observation suggests that mutations are likely to occur in specific 
position in genes to modify the function of encoded proteins in a specific, fine-tuned 
manner. Taken together, strain evolution studies based on SNPs analysis offer a 
systematic methodology to identify candidate genes for future manipulations. 
 
8.6.3 Biomolecule production 
Because SNPs can affect gene regulation and protein function, knowledge of 
functional SNPs can be applied to genetic engineering to create phenotypes of interest.  
To enhance an extracellular secretion system in E. coli, a hypersecreter strain (B41) 
was created by chemical mutagenesis [76]. B41 strain was found to secrete four-fold 
more hemolysin (HlyA) protein relative to the parent strain via the Type I secretion 
pathway. The genomes of the parent and the B41 strains were later sequenced by a 
Illumina Genome Analyzer [77]. A G-to-T substitution in ycdC gene was found in 
B41 strain but not in the parent strain. This SNP caused a premature termination of the 
encoded protein, RutR, suggesting a role of RutR on Type I secretion pathway in E. 
coli. This study demonstrates the usage of SNP analysis to characterize a recombinant 
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host, allowing better phenotype predictions in the future.  
 
The detoxified beta-toxoid is a putative vaccine component, which can be produced 
and secreted by Bacillus subtilis. However, the secretion yield for beta-toxoid is low 
because of rapid degradation. Nijland et al. identified a single amino acid substitution 
in the beta-toxoid sequence to alter protein folding, which slows down the degradation 
and increases secretion yield [78]. This result demonstrates that in addition to host 
adaptation, the intrinsic properties of a heterologous protein can affect its own 
productions. 
 
The Sindbis viral expression system provides a rapid production of recombinant 
protein in mammalian cells [79]. This expression, however, is typically limited to 
transient production because of the cytotoxicity of the virus. A SNP (C3855T) leading 
to a Phe726Ser substitution in a non-structural viral protein, nsP2, was found to reduce 
viral cytotoxicity [80-82]. A C3856T variant causing Phe726Leu mutation in the same 
protein also results in noncytopathic infection [83]. As a result, Phe726Leu and 
Phe726Ser mutations were engineered into a Sindbis virus replicon to enable a 
sustained expression of recombinant proteins [81,84].  
 
Recombinant adeno-associated virus 2 (AAV2) vectors are used as gene delivery 
vehicles in several Phase I/II clinical trials, but relatively large vector doses are needed 
to achieve therapeutic benefits [85]. To reduce dose while achieving similar clinical 
benefit, a point mutation causing Tyr-to-Phe substitution was introduced into the 
AAV2 vector [86]. This mutation helps the AAV2 prevent capsid ubiquitination and 
improve intracellular trafficking to the nucleus. The tyrosine mutant vector achieves 
therapeutic levels of human Factor IX at an about 10-fold reduced vector dose. This 
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study provides a strategy using single nucleotide substitution to improve human gene 
therapy. 
 
Polyhydroxyalkanoate synthase (PhaC) has been introduced into E. coli to produce 
biopolymer, poly(3-hydroxybutyrate) (PHB). It was found that PhaC with a Gly4Asp 
substitution resulted in higher level of PhaC and PHB productions [87]. This mutation 
was further applied to enhance PHB production in Corynebacterium glutamicum [88]. 
 
8.7 Challenges and the future  
Currently, genetic engineering in biotechnology is mostly based on candidate gene 
mutagenesis and screening. As mentioned above, candidate gene studies rely on prior 
knowledge of biological pathways and are less likely to discover novel gene targets. 
On the other hand, genome-wide association studies have identified SNPs in novel 
gene targets associated with human disease and quantitative traits. In addition, 
genotyping technologies have also been applied to characterize epidemic 
microorganisms. Recent attempts to identify SNPs for differentiating regional 
Mycobacterium ulcerans strains demonstrate the strength of a genome-wide SNP 
analysis [89]. These biomedical studies will provide insight into SNPs analysis for 
strain developments in biotechnology applications.    
 
The lack of SNP databases for commonly used recombinant hosts such as E. coli, B. 
subtilis and Chinese hamster ovary cells (CHO) makes genome-wide scale SNP 
analysis difficult at this time. Next generation sequencing technology allows SNP 
detections and novel SNP discoveries. For example, Monsanto has applied next 
generation sequencing platform to identify SNPs and to characterize genetic variation 
in maize lines. A United States Department of Agriculture study used an Illumina 
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Genome analyzer to genotype 66 cattle, identifying and validating approximately 
23,000 new bovine SNPs [90]. This research led to a bovine genotyping array now 
commercialized by Illumina. Importantly, for recombinant hosts generated by 
mutagenesis, SNPs may occur at any position in the genome. Thus a chip-based 
detection for known genetic variations is less applicable and the next generation 
sequencing may be a stronger tool in detecting random mutations. 
 
Another challenge for CHO cell SNPs analysis is the lack of a reference genome. 
Reduced complexity approaches such as EST sequencing can provide adequate 
sequence depth for SNP discovery without sampling the complete genome. To analyze 
the uncharacterized Eucalyptus grandis genome, Novaes et al. used Roche 454 
technology to sequence and assemble 148 Mbp EST sequences [91]. By aligning 
sequencing reads from multiple genotypes, 23,742 SNPs were predicted, 83% of 
which were validated. In addition, it is also possible to combine long-read and short-
read next generation sequencing to identify SNPs for species with no available 
reference genomes. Importantly, Wlaschin et al. has established EST libraries for the 
CHO cells [92], and the same group later reported a scaffold for the CHO genome 
[93]. Recently, bacterial artificial chromosome libraries were created to further 
characterize the CHO genome [94]. It is important to note that, however, EST based 
approaches cannot address the issue of SNPs in noncoding regions of the genome. As 
the knowledge of the CHO genome grows, genome wide scale SNP analysis will 
become more feasible. 
 
SNP detection is an unexplored tool for improving and accelerating high-producer cell 
line generation and selection. Although not yet applied to biotechnology platform 
organisms, the availability of next generation sequencing technology provides a 
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significant opportunity to allow this community to embrace a new approach to cell line 
characterization and process platform development. While large-scale analysis is 
initially based on individual SNPs, the focus will soon shift to haplotype-specific 
SNPs for more efficient association studies as it is done in the human genome 
analysis. Haplotype-based SNPs identified in recombinant hosts will open up an 
efficient management of genetic diversity in the strain development on a whole 
genome level. 
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CHAPTER 9 
CONCLUSION AND FUTURE DIRECTIONS 
 
9.1 Summary 
This research dissertation focuses on developing computational and experimental tools 
to understand the mechanism of +1 PRF and -1 PRF. The objective is to find a 
systematic way to analyze a complex, but critically important, biological event. 
 
Three computational programs were developed in this dissertation project. First, a 
kinetic model was developed for +1 PRF. The model demonstrated that stimulatory 
signals leading to the release of deacylated tRNA in the E-site, a slippery site allowing 
the P-site tRNA to re-pair with the new reading frame, and an A-site codon with a low 
aminoacyl-tRNA concentration synergistically promoted efficient +1 frameshifting. 
Second, motivated by the +1 PRF model prediction, a bioinformatic program, FSscan, 
was constructed to search +1 frameshift hot spots in the Escherichia coli genome. 
FSscan calculated scores for a 16-nucleotide window along a gene sequence according 
to different effects of the stimulatory signals, and ribosome E-, P-, and A-site 
interactions. FSscan predicted yehP, pepP, nuoE, and cheA as +1 frameshift 
candidates in the E. coli genome. Finally, a kinetic model was built for -1 PRF. The 
model yielded two possible -1 frameshift products: those incorporating zero frame A-
site tRNAs in the recoding site and products incorporating -1 frame A-site tRNAs in 
the recoding site. The model calculated not only the change in frameshift efficiency, 
but also the change in the composition of frameshift products under different 
conditions. In addition, the model identified high impact parameters, representing 
steps in the translation elongation, on -1 frameshifting.  
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For experimental tools, a dual fluorescence reporter system was developed in E. coli 
and yeast S. cerevisiae. Different PRF sites were inserted between two fluorescence 
reporter genes, monomeric DsRed and EGFP. The red and green fluorescence for 
different strains were directly measured in vivo by a microwell plate reader. The 
system allows an easy comparison of frameshift efficiency for different recoding sites 
with the normalized fluorescence ratio because the assay requires neither cell lysis nor 
additional chemical reactions. In addition, frameshift proteins derived from this dual 
fluorescence reporter can be further purified and analyzed by mass spectrometry. 
Using the dual fluorescence reporter system in E. coli to study RF2 frameshifting, 
higher +1 frameshift efficiency was observed for a E-site codon with a weaker 
codon:anticodon interaction. When examining candidate genes by FSscan, sequences 
from yehP, pepP, nuoE, and cheA revealed +1 frameshift efficiency significantly 
higher than a randomly design sequence. Experimentally targeting steps in the -1 PRF 
model resulted in different levels of frameshift efficiency, which were consistent with 
model predictions. The -1 frameshift proteins were further purified and analyzed by 
mass spectrometry, empirically demonstrating the fraction of the two types of 
frameshift products.  
 
9.2 Future directions 
9.2.1 Dual fluorescence reporter system in mammalian cells for therapeutic 
screening  
The dual fluorescence reporter systems in E. coli and yeast S. cerevisiae allow fast 
screening for the effect of different genetic backgrounds or chemicals on PRF. 
However, to develop an antiviral therapeutic screening method, a proper host cell line 
provides more relevant information. For example, the PRF motif in HIV-1 is 
translated by a human ribosome in nature. Conditions altering bacterial or yeast 
  214 
ribosomes in translating PRF signals may not affect human ribosomes in doing so. 
Plant et al. compared HIV-1 frameshifting in E. coli and human T-cell and found that 
phylogenetic differences in ribosome structure can affect frameshift efficiency [1]. 
Recently, a dual fluorescence reporter has been developed in the mammalian system, 
COS-7 and HEK 293T cells [2], supporting the high potential of the dual fluorescence 
reporter system for an anti-viral drug screening. In the present dissertation, several 
combinations of the fluorescent reporter proteins have been constructed. These 
reporters can be modified and integrated into the genome of the mammalian cells, 
preferably a human T-cell line (Jurkat cells). The antiviral therapeutic screening can 
then be done in a 24-, 96- or 384-well microplate format. In addition, the reporter cell 
lines will allow a library screening using fluorescence-activated cell sorting (FACS). 
In an E. coli system, Dulude et al. constructed a RNA binding peptide library and co-
expressed with a dual fluorescence reporter in a separate plasmid. The study reported 
candidate peptides that reduced frameshift efficiency by 50% [3]. Interestingly, 
Olsthoorn et al., observed that a small 12nt- to 13nt-RNA complementary to the 
downstream of a slippery site stimulated -1 ribosomal frameshifting from 0.4% to 
~15% in an in vitro translation system [4]. Oligonucleotides annealed to the 
downstream of a shift-prone site UCC UGA were also shown to enhance +1 
frameshifting in vitro and in mammalian culture cells [5]. Because cell growth can be 
monitored along with the in vivo dual fluorescence reporter assay, the system provides 
a platform to identify compounds targeting only the PRF without damaging the host. 
Specifically, several potential therapeutic strategies can be addressed further: 
(1) Screening current Food and Drug Administration approved drugs as well as 
potential chemicals that may affect PRF in the mammalian cells. Which drugs reveal 
high potential? Once the candidates are identified, it is worthwhile to investigate how 
these drugs affect PRF. 
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(2) Establishing a general rule for a peptide which can influence PRF in the 
mammalian culture. How long should the peptide be? What types of the amino acid 
should be incorporate? Will the peptide target all PRF signal or is it specific to one 
type of the signal?  
(3) Developing a strategy to design the antisense to affect PRF in the mammalian 
culture. How long should the antisense be? What should be the distance between the 
antisense and the slippery site? Is there an optimal time to induce the antisense 
expression?    
The answers to these questions would provide insight into the drug development for 
viral diseases or other PRF related disorders.  
 
9.2.2 Genome-wide scale PRF cassette identification 
The dual fluorescence reporter system allows an easy in vivo assay for PRF efficiency. 
This system may be used for a genome-wide screening for PRF cassettes. A genomic 
library can be inserted as a linker sequence between the two fluorescent reporters. 
Using FACS, cells with relatively high green to red fluorescence ratio are potential 
candidates containing PRF sequences. The major challenge for this study is the control 
of the reading frame. Any DNA fragment in the library containing one or two more 
nucleotides can change the reading frame of egfp and affect the result. Therefore, a 
DNA purification method at a single nucleotide resolution is required. However, this 
method has not been reported in the literature. Alternatively, one can design a set of 
the reporter to account for the three reading frame (pRGlib0, pRGlib1 and pRGlib2 in 
Figure 9.1). Construction of a genomic DNA library by endonuclease digestion 
restricts the DNA fragmentation pattern. To ensure that each fragment will have the 
opportunity to combine with a downstream egfp in different frames, a library should 
be cloned into all three reporters. In this system, various lengths of the DNA fragment 
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would result in different fluorescence patterns. For example, if a DNA fragment 
renders egfp in the zero frame, the intensity of the green fluorescence is expected to be 
high. If a DNA fragment renders egfp in the +1 frame, +1 PRF candidates may reveal 
the green fluorescence higher than a background. These patterns are summarized at the 
bottom of Figure 9.1. The system assumes that for PRF-dependent egfp expression, 
the green to red fluorescence ratio is lower than an in-frame egfp. Therefore, cells with 
a medium level of green fluorescence are more interesting candidates. On the other 
hand, this assumption may reject PRF candidates with high efficiency. As a result, 
selecting cells within a range of the fluorescence pattern to investigate further become 
a critical issue.    
 
9.2.3 Investigating yehP, pepP, nuoE, and cheA 
In this work, FSscan identified several +1 PRF candidates, yehP, pepP, nuoE, and 
cheA in the E. coli genome. These genes were identified because they contained 
sequences with a potential to interact with anti-SD sequence in the 16S ribosome, a 
weak E-site interaction, a slippery P-site, and a hungry A-site codon. Whether an 
mRNA secondary is involved in these PRF is not clear. A saturation mutagenesis 
study for each candidate sequence may reveal other novel PRF enhancing elements.  
 
+1 PRF occurring in yehP, pepP, and cheA sequences will result in a shorter 
polypeptides and +1 PRF occurring in the nuoE sequence would result in a longer 
polypeptide compared to non-frameshift proteins. To date, the function of YehP is not 
known. A yehP knockout E. coli strain was previously shown to result in a different 
swarming phenotype [6]. Other candidate genes have a better known function: nuoE 
codes for NADH:ubiquinone oxidoreductase, chain E, pepP codes for proline 
aminopeptidase P II, and cheA codes for a histidine protein kinase sensor of  
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Figure 9.1 A reporter system for a genome-scale screening for programmed ribosomal 
frameshift (PRF) cassette. Top: representative sequence structures for three reporters, 
pRGlib0, pRGlib1, and pRGlib2. Red and pink boxes represent the coding sequence 
for DsRed. Green and light green boxes represent the coding sequence for EGFP. Gray 
boxes represent a stop codon in frame with DsRed. Light blue boxes represent 
nucleotide insertions for adjusting the reading frame of egfp. Using pRGlib2 as an 
example, cloning DNA fragments with various lengths would render egfp in different 
frames, which may result in different fluorescence patterns. A summary of the 
different green fluorescence patterns is listed at the bottom of the figure.  
DNA fragment: a multiple of three 
 egfp in the -1 frame
No PRF: low
-1 PRF: medium
+1 PRF: low
DNA fragment: a multiple of three plus one 
 egfp in the zero frame
No PRF: high
-1 PRF: low
+1 PRF: low
DNA fragment: a multiple of three plus two
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No PRF: low
-1 PRF: low
+1 PRF: medium
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-1 PRF: medium
+1 PRF: low
No PRF: low
-1 PRF: low
+1 PRF: medium
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chemotactic response [7]. The present work has confirmed the presence of peptide 
derived from the PRF cassette in yehP-egfp fusion construct. The polypeptide 
sequences should be investigated for pepP, nuoE, and cheA to further confirm the 
frameshift site. Moreover, functional analysis of the frameshift products derived from 
these genes may provide more information regarding if +1 PRF in these genes are 
involved in gene regulation or protein function.  
 
9.2.4 Applying FSscan to other genomes 
In this dissertation, FSscan searched for +1 PRF hotspots in the E. coli genome. 
Because bacteriophage genes are translated by prokaryotic ribosomes, FSscan can 
potentially identify +1 PRF candidate in these genes. Additionally, the algorithm can 
be extended to other organisms with adjustments for the scoring system. In principle, 
the scoring system should account for stimulatory signals, tRNA: ribosome and tRNA: 
mRNA interactions, and the tRNA pool specific to the organism. Because the known 
+1 PRF cassettes are relatively diversified, caution needs to be taken for which 
organism-specific PRF features being incorporated into the program. 
 
9.2.5 Compositions of frameshift proteins in other -1 PRF cassettes 
This work developed mass spectrometry methods to differentiate two types of 
frameshift proteins generated from a -1 PRF cassette. As a proof of principle, the 
approaches were used to study PRF motifs from HIV-1 and bacteriophage P2 and 
PSP3. In addition, nano-liquid chromatography tandem mass spectrometry using 
multiple reaction monitoring revealed the change of the composition of the frameshift 
proteins when different steps in the translation cycle were perturbed. In a newly 
developed database Recode 2 [8], 257 genes are reported to involve -1 PRF. Whether 
these -1 PRF cassettes generate two types of frameshift proteins remain unclear. It is 
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possible that certain sequences trigger one pathway but suppress other pathways in the 
-1 PRF kinetic model. The investigation of other PRF motifs will advance our 
knowledge of how different sequence elements play their roles on -1 PRF in more 
detail.   
 
9.3 Conclusion 
Programmed ribosomal frameshifting is an extension of genetic decoding that allows a 
ribosome to produce two types of polypeptides from a single mRNA. PRF occurs 
during translation elongation and involves several cis-acting elements. Computational 
and experimental tools developed in the present work allow analyzing this complex 
biological event from a systemic point of view. Kinetic models for +1 PRF and -1 PRF 
successfully explained experimental observations in the literature as well as identified 
critical steps in the mechanisms. Empirical examining model predictions in the dual 
fluorescence reporter system in E. coli demonstrated consistent results. The 
computational tools can be further adjusted to include more features in PRF. The dual 
fluorescence reporter system can be used for a large-scale anti-viral drug screening. 
The mass spectrometry method for the analysis of two types of frameshift proteins can 
be applied for other PRF signals to further understand the extent of different -1 PRF 
pathways. In conclusion, this dissertation work presents tools and strategies to 
effectively target critical steps in an important biological mechanism.  
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